Antioxidants and air pollution in relation to indicators of asthma and COPD by Grievink, L.

STELLINGEN 
1. De antioxidant p-caroteen heeft wel vitamine A activiteit, maar vitamine A heeft 
nauwelijks antioxidant activiteit. 
2. Vitamine E concentraties in de voeding en in bloed zijn niet in gunstige richting 
geassocieerd met CARA-indicatoren. (dit proefschrift) 
3. Een goede p-carateen status of suppletie met antioxidanten biedt gedeeltelijke 
bescherming tegen acute effecten van luchtverontreiniging, (dit proefschrift) 
4. Kortademigheidsklachten zijn geassocieerd met risicofactoren voor hart- en 
vaatziekten, (dit proefschrift) 
5. O m de resultaten tussen onderzoeken te vergelijken is een kwantitatieve schatting 
van de sterkte van de associaties belangrijker dan de significantie niveau's van 
deze associaties. 
6. Kwaliteitsbewaking is essentieel bij gegevensverzameling in grootschalig 
epidemiologisch onderzoek. 
7. Voor een goede interpretatie van onderzoeksresultaten is het noodzakelijk dat 
onderzoekers zelf betrokken zijn bij de gegevensverzameling. 
8. Alhoewel in de epidemiologie van zowel voeding als luchtverontreiniging kleine 
gezondheidseffecten worden gevonden kunnen deze grote gevolgen voor de 
volksgezondheid hebben. 
9. De bewering in de reclame dat antioxidanten in huidverzorgingsprodukten de 
veroudering van de huid kunnen tegengaan, berust niet op gedegen 
wetenschappelijk onderzoek en is daarom misleidend. 
10. Vergaderingen verlopen efficiënter als ze op vrijdagmiddag worden gehouden. 
11 . 'Mastermind' is binnen 5 beurten op te lossen mits er verschillende kleuren worden 
gebruikt. 
12. Geen tijd is geen prioriteit. 
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ABSTRACT 
Two main research questions were specified in this thesis. First, whether acute respiratory 
effects of air pollution can be modulated by antioxidants. Second, whether dietary or plasma 
antioxidants were associated with indicators of asthma and COPD. 
Two intervention studies investigated a possible modulation of the acute respiratory 
effects of ozone by antioxidant supplementation. In addition a panel study examined a 
possible modulation of the acute respiratory effects of winter air pollution by antioxidants in 
diet and serum. The first intervention study in 1994 was a pilot study among 26 cyclists who 
performed lung function measurements (192 observations) before and after exercise. Half of 
the group was randomly assigned to the supplementation group and were given a daily 
antioxidant supplementation of vitamins C, E and p-carotene. The control group did not 
receive a placebo. We repeated the study in the summer of 1996 with a similar design but 
this time the study was placebo-controlled. In this study, 38 subjects (380 lung function 
measurements) participated until the end of the study and the antioxidant supplementation 
consisted of a cocktail of vitamins C and E. Both intervention studies suggest that there was 
an effect of ozone on FEV, and FVC in the control group. There was no change in lung 
function when ozone levels were high in the supplementation group. The difference in ozone 
effect between the groups for both studies was statistically significant for FEV, and FVC. In 
the analysis of the panel study, we included only subjects with chronic respiratory symptoms 
because these subjects showed clear acute respiratory effects of air pollution. The results 
suggest that subjects with low levels of plasma p-carotene showed an effect of air pollution 
on large PEF decrements, in particular, for PM10 and black smoke, whereas subjects with 
high levels of plasma p-carotene did not show an effect of air pollution. No difference in 
acute respiratory effects of air pollution was observed for a high versus a low dietary intake 
of vitamin C, E and p-carotene or for plasma a-tocopherol. 
The second research question was investigated within the MORGEN study. This 
study is a cross-sectional investigation on the prevalence of risk factors for chronic diseases 
using self-administered questionnaires and a physical examination in a randomly selected 
sample of the Dutch population. First, we examined the relations between dietary 
antioxidants (vitamins C, E and p-carotene) and the prevalence of a number of respiratory 
symptoms and lung function in a population based sample of 6,555 adults. Our results 
suggested that a high dietary vitamin C and p-carotene intake was associated with a higher 
FEV, and FVC. Dietary vitamin E was not associated with lung function. None of the dietary 
antioxidants were consistently associated with the prevalence of a number of respiratory 
symptoms. Second, we studied the relation between plasma levels of p-carotene or a-
tocopherol and respiratory symptoms in a case-control sample of never and long-term 
former smokers. Our results suggested that cases (subjects with one or more chronic 
respiratory symptoms; n=491) tended to have lower plasma p-carotene levels than controls 
(n=496). Plasma a-tocopherol was not associated with asthma and chronic bronchitis 
symptoms but was positively associated with dyspnea. This adverse association of plasma\ 
a-tocopherol could not be explained by adjustment for cardiovascular risk factors and 
remains puzzling. Third, we evaluated the relation between plasma antioxidants (p-carotene 
and a-tocopherol) and lung function in a random sample (n=367) of the MORGEN study. We 
found that subjects with a high plasma p-carotene concentration tended to have a higher 
FVC and FEV, than subjects with a low plasma p-carotene concentration but this was not 
statistically significant for FEV). Plasma a-tocopherol was not associated with lung function. 
In conclusion, an elevated antioxidant status suggests to protect partly against respiratory 
effects of air pollution. More research is needed to investigate if antioxidants (vitamin C, 
P-carotene) are really the beneficial agents in relation to (indicators of) asthma and COPD. 
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General Introduction 
CHAPTER 1 
2 Chapter 1 
Background 
There is a growing recognition that air pollution even at low levels could have 
adverse health effects 1 . Several epidemiological studies suggested that air 
pollutants, such as ozone and particulate matter are related to acute respiratory 
effects, such as a decrease in pulmonary function and an increase in respiratory 
symptoms 2" 6 . There is also an increasing recognition that the incidence and the rate 
of mortality of asthma have been increasing in the Netherlands and in other Western 
countries 7 - 8 . Additionally, Chronic Obstructive Pulmonary Disease (COPD) is 
currently one of the important chronic diseases 9 . For both the acute respiratory 
effects of air pollution and the occurrence of asthma and COPD, oxidant processes 
and free radical reactions are involved in the mechanisms. Therefore, antioxidants 
have been suggested to be protective factors in relation to acute respiratory effects 
of air pollution 1 0 - 1 2 and in relation to chronic conditions, such as asthma and COPD 
13-23'; 
A possible modulation of the acute respiratory effects of short-term exposure 
of air pollution by antioxidants has been suggested in some small experimental 
studies 1 0 " 1 2 . Antioxidants have also been investigated in relation to indicators of 
asthma and COPD, such as lung function 1 3 " 1 S , respiratory disease or symptoms 1 6 " 1 9 
and bronchial reactivity 2 0 " 2 3 . 
Two main research questions were (1) can antioxidants modulate the acute 
respiratory effects of air pollution under ambient conditions and (2) is there a relation 
between antioxidants (in diet and blood) and respiratory symptoms and lung 
function. 
Antioxidants 
What are antioxidants? Antioxidants are defined by their mechanistic action. 
Antioxidant mechanisms are any cell process that (1) prevents the formation of free 
radicals, (2) converts oxidants to less toxic species, (3) separates reactive species 
away from vital cellular structures, or (4) repairs oxidant injury 2 4 . As a first line of 
defence in the lungs, there are the antioxidant enzymes, such as superoxide 
dismutases which convert superoxide anion radicals to hydrogen peroxide, catalase 
which reduces hydrogen peroxide to w a t e r 2 5 , and enzymes of the glutathione redox 
cycle, such as glutathione peroxidase which is selenium dependent. In the second 
line of defence operates uric acid and the antioxidant (pro)-vitamins, such as 
vitamins E, C and (3-carotene that are derived from diet 2 4 . Uric acid scavenges 
hydroxyl, superoxide, and peroxyl radicals 2 5 and prevents the oxidation of vitamin C. 
Vitamin C or ascorbic acid is water-soluble and is mainly derived from fruits, 
vegetables and potatoes in the Dutch diet. It is present in both extracellular and 
General introduction 3 
intracellular fluids in the lungs. Vitamin C can scavenge oxygen radicals and 
neutralises the extracellular oxidants released from stimulated neutrophils 2 4 . 
Vitamin E comes mostly from vegetable oils and margarines in the 
Netherlands and consists of four lipid-soluble tocopherols (a , B, 5, y-tocopherol). a -
Tocopherol is the most active antioxidant of the four tocopherols 2 6 and is present in 
the lipid membranes and in the extracellular fluids. It can convert oxygen radicals 
and lipid peroxyl radicals to less reactive forms and is in this way able to break the 
lipid peroxidation chain reaction. The formed a-tocopherol radical can be reduced 
back to a a-tocopherol molecule by reduction of ascorbic acid 2 7 . 
B-Carotene is a pro-vitamin A and is mostly present in vegetables. It is a lipid 
soluble antioxidant available in membranes of tissues 2 4 and it is able to scavenge 
superoxide anion and peroxyl radicals 2 5 . A synergistic interaction between a -
tocopherol and B-carotene has been suggested in vitro with an increased inhibition of 
lipid peroxidation in rat liver microsomes 2 8 . 
Evidence: antioxidants in relation to the acute effects of air pollution 
Table 1 summarises the design and results of studies on modulation of acute 
respiratory effects of air pollution by antioxidant supplementation. Some of these 
studies used controlled exposure to single pollutants. Other studies were conducted 
under ambient conditions of exposure to pollutant mixtures. 
The first experimental studies have investigated a possible protective role of 
antioxidants on acute effects of ozone and N 0 2 . The first two experiments did not 
find a protective role of supplemental vitamin E alone for 10 to 12 weeks on lung 
function or respiratory symptoms after exposure to a single exposure of 1,000 ug/m 3 
ozone for 2 hours while the subjects were exercising 2 9 . However, a combination of 
supplemental vitamin C and vitamin E was shown to protect partly against acute 
effects of ozone (600 ug/m 3) for 2 hours with exercise on lung function 1 0 . The acute 
effects of N 0 2 on lipid peroxidation were measured in one study 3 0 and on 
hyperresponsiveness to metacholine in another study 1 2 . After supplementation with 
a cocktail of vitamin C and E, subjects had lower levels of lipid peroxidation products 
in lung lavage and higher levels of arantitrypsin in the alveolar lining fluids after 
exposure to 7,520 j ig /m 3 N 0 2 compared to subjects in the placebo group 3 0 . Vitamin 
C supplementation alone showed an improvement of airway responsiveness after 
exposure to N 0 2 (3,760 ug/m 3) compared to placebo 1 2 . No exercise was performed 
during exposure in both studies. 
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Table 1: Evidence of acute effects of air pollution being modulated by antioxidant supplements 
Study Design Subjects Exposure Suppl. Outcome Asso-
ciation 
Hackney double- 34 healthy 2-h 1000 u.g/mJ 0.8 g/day vit E symptoms & -
e t a l 2 9 blind* adults 0 3 + exercise for 10 wks lung function 
double-blind 22 healthy 2-h 1000 ng /m 3 1.6 g/day vit E symptoms & -
adults 0 3 + exercise for 12 wks lung function 
Chatham double-blind 14 healthy 2-h 600 ng /m 3 1 g vit C once lung function + 
e t a l 1 0 cross-over adults 0 3 + exercise 0.8 g/day vit E 
for 2 wks (?) 
Mohsenin double-blind 11 healthy 1-h 3760 ng /m 3 0.5 g vit C airway + 
e t a l 1 2 cross-over adults N0 2 4 times /day reactivity to 
for 3 days metacholine 
Mohsenin double-blind 19 healthy 3-h 7520 u.g/m3 1.5 g vitC/day lipid + 
e t a l 3 0 adults N0 2 1.2 g vitE/day peroxidation & 
for 4 weeks a rantitrypsin in 
alveolar fluids 
Bucca double-blind 20 healthy 2-h traffic 2 g vit C once MEF 5 0 & airway + 
e t a l 1 1 cross-over policemen directing In city reactivity to 
during winter histamine 
double-blind 20 healthy 4 days traffic 2 g vit C/day PEF + 
cross-over policemen directing In city for 4 days 
during winter 
Romieu double-blind 49 street mean ambient daily 650 mg vit repeated lung + 
e t a l 3 1 cross-over workers level 0 3 C, 75 mg function 
163 ng /m 3 vit E, 15 mg measurements 
p-carotene 
Trenga double-blind 17 asthma 45 min 240 500 mg vitC, PEF + 
e t a l 3 2 cross-over patients ng /m 3 0 3 + 400 mg vit E 
exercise duration? 
Samet double-blind 30 healthy 2-h 800 ng /m 3 2-w daily 250 FEV-i, FVC + 
e t a l 3 3 placebo adults 0 3 + exercise mg vit C, 100 
mg vit E, Inflammatory -
vegetable markers (BAL) 
cocktail 
The term double blind denote placebo-controlled 
Suppl.: Supplementation; Association: - = no association; + = beneficial association 
There has only been one small study investigating a possible modulation of the 
acute effects of ambient winter air pollution on lung function by vitamin C in two 
experiments 1 1 . During winter concentrations of ozone are usually low, whereas 
concentrations of particulate matter tend to be higher. The exact levels of exposure 
to air pollutants were, however, unclear in this study. In the first experiment, vitamin 
C supplementation was suggested to prevent a decrease in lung function ( M E F 5 0 ) 
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and airway responsiveness to histamine. In the second experiment, vitamin C was 
supplemented and peakflow ( P E F ) measurements before and at the end of the 
working day were performed in policemen during four consecutive days of traffic 
directing. In this experiment, the P E F decreased during the working day in the 
control group but not in the vitamin group. 
Most of these earlier studies were under experimental conditions investigating 
one pollutant during only one or two exposures and with a small number of subjects. 
The levels of ozone and N 0 2 were very high in these studies. All of these studies 
were supplementing subjects for short periods with high doses of vitamin C or E. 
These doses were at least eight to 16 times the US Recommended Dietary 
Allowances (RDA) of vitamin C (60 mg/day) and 100 times the RDA of vitamin E (8 
mg/day for women and 10 mg/day for m e n ) 3 4 . 
Recent studies have addressed conditions in which the levels of ozone 
exposure and the doses of the supplements were mostly lower. One experimental 
study was performed in asthmatics 3 2 . After a 45 min of exposure to ozone (240 
ug/m 3) with exercise, subjects were challenged with two concentrations of S 0 2 (0.10 
& 0.25 ppm) for 10 minutes. Preliminary results suggest that a cocktail of vitamin C 
and E protected against PEF decrements from S 0 2 challenges after ozone exposure 
in only the group of severe asthmatics (n=6). The duration of supplementation in this 
study was unclear. The other recent experimental study exposed healthy subjects to 
relatively high levels of ozone (800 u.g/m3) for 2 hours while the subjects were 
exercising 3 3 . Subjects were placed on a diet low in vitamin C for 3 weeks and after 
that they were supplemented for 2 weeks with a relatively low level of vitamin C (250 
mg). Preliminary results of the first 18 subjects suggest that a supplemental cocktail 
of vitamin C, E and vegetables protected against pulmonary function decrements but 
not against an increase in inflammatory markers. It is unclear what the time was 
between ozone exposure and broncho-alveolar lavage measurements for 
determination of the inflammatory markers. Next to the studies described in this 
thesis, there has been one study investigating modulation of the acute effects of 
ambient ozone on lung function 3 1 . This placebo controlled cross-over study was 
among street workers in Mexico-city and the measurement periods were from half 
March to end of May and from half June to half August 1996. The results suggest 
that supplementation of vitamin C, E and B-carotene protected against decrements 
of F E V L FVC and PEF, in particular, in the first period. The control group in the 
second period did not show an ozone effect probably because the subjects had still 
elevated plasma levels of the antioxidants due to the supplementation in the first 
period. 
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Epidemiological evidence: antioxidants in relation to asthma and COPD 
Most studies were observational (prospective or cross-sectional) in design. There 
has been one intervention study (the alpha-tocopherol beta-carotene cancer 
prevention study) investigating supplementation of a-tocopherol (50 mg/day) and p-
carotene (20 mg/day) for six years among smokers (n=29,133) on the incidence of 
C O P D symptoms; the results showed no effect of this supplementation 1 9 . Very 
recently an abstract was published with data from the CARET trial investigating the 
effect of 11 year supplementation of p-carotene (30 mg/day) and retinyl palmitate 
(25,000 lU/day) on lung function decline in 3,056 subjects 3 5 . In this trial the annual 
decline in lung function did not differ between the supplementation group and the 
placebo group. 
Early publications suggested a beneficial effect of fruit consumption on lung 
function in a cross-sectional study (n=2,859) 3 6 and the 25-years incidence of chronic 
non-specific lung disease in middle-aged men (n=793) 1 6 . Recently fruit, salad and 
green vegetable consumption was associated with a higher lung function, but not 
with the prevalence of wheeze in children (n=2,650) 3 7 . Vegetable consumption 
(excluding legumes and potatoes) of more than seven servings per week was 
associated with a lower prevalence of self-reported chronic bronchitis and bronchial 
asthma compared to less than seven servings per week in 46,693 subjects aged 15 
years or over in Italy 3 8 . The suggested specific antioxidants in fruits and vegetables 
that might be responsible for the observed beneficial effect on asthma and C O P D 
are vitamin C, carotenoids and flavonoids 1 6 , 3 6 . 
The evidence for relations between vitamin C (dietary and blood levels) and 
(indicators of) asthma and COPD is summarised in Table 2. Dietary intake of vitamin 
C was not associated with 25-year incidence of CNSLD 1 6 and 10-year incidence of 
asthma 1 7 while serum vitamin C was associated with a lower prevalence of wheeze 
and chronic bronchitis 1 8 . Serum vitamin C was, however, not associated with 
respiratory symptoms in a small study among elderly (n=96) in which the subjects 
were measured 6 times over one y e a r 3 9 . In this study, data on respiratory symptoms 
(not specified) were collected for a relatively short period, that is, the past fortnight. 
One study investigated bronchial reactivity in relation to dietary antioxidants 2 2 . This 
study showed that subjects with an airway hyperreactivity (20% fall in FEV-i) after a 
metacholine challenge had lower dietary intake of vitamin C compared to healthy 
subjects. In several large (N >1,500) cross-sectional studies, dietary and plasma 
vitamin C were positively associated with lung function 1 3 1 4 ' 4 0 . Two smaller studies, 
one in elderly 1 5 and one in children 3 7 did, however, not show an association 
between vitamin C and lung function. In a small study among elderly (6 times 
measured in one year) a positive association between serum vitamin C and FEVi 
was found 3 9 . 
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Table 2: Evidence of a relation between vitamin C and (indicators of) asthma and COPD 
Study Design No. of 
subjects 
Gender & age 
range (yrs) 
Vitamin C 
measured in 
Outcome Asso-
ciation 
Miedema et a l 1 6 Prosp. 793 d 40-60 Diet 25-years CNSLD -
Troisi et a l 1 7 Prosp. 77,866 9 34-68 Diet 10-years asthma -
Schwartz et a l 1 8 Cross. 9,074 d" 9 30-75 Serum wheeze + 
bronchitis + 
Khaw et a l 3 9 Cross. 96 d* 9 65-74 Serum resp. symptoms -
FEV, + 
Soutar et a l 2 2 Cross. 87 cf 9 mean: 37 Diet PD 2 0 metacholine + 
Schwartz et a l 4 0 Cross. 2,526 cf 9 30-74 Diet FEV, + 
Britton et a l 1 3 Cross. 2,633 c f 9 18-70 Diet FEV,, FVC + 
Ness et a l 1 4 Cross. 1,860 a* 9 45-75 Serum FEV,, FVC + 
Dow et a l 1 6 Cross. 178 cf 9 70-96 Diet FEV,, FVC -
Cook et a l 3 7 Cross. 278 c f 9 9-11 Serum FEV, -
Cross. = Cross-sectional; Prosp. = Prospective; 9 women, d men 
Association: - = no association; + = beneficial association 
The evidence for relations between vitamin E (diet and blood levels) and (indicators 
of) asthma and COPD is summarised in Table 3. A high dietary intake of vitamin E 
was associated with a decreased 6-years incidence of adult-onset asthma 1 7 , a lower 
prevalence of C O P D symptoms in male smokers 1 9 and a higher lung function in 
elderly subjects 1 5 . However, dietary vitamin E was not associated with lung function 
in a large cross-sectional study after adjustment for vitamin C 1 3 and with 
hyperreactivity 2 2 . Additionally, blood levels of vitamin E were also not associated 
with the development of airway obstruction during five subsequent years 4 1 . 
Table 3: Evidence of a relation between vitamin E and (indicators of) asthma and COPD 
Study Design No. of Gender & age Vitamin E Outcome Asso-
subjects range (yrs) measured In ciation 
Troisi et a l 1 7 Prosp. 77,866 9 34-68 Diet 6-years asthma + 
10-years asthma -
Rautalahti et a l 1 9 Cross. 29,133 cf 50-69 Diet& COPD symptoms + 
Serum 
Dow et a l 1 5 Cross. 178 d 9 70-96 Diet FEV,, FVC + 
Britton et a l 1 3 Cross. 2,633 c f 9 18-70 Diet FEV,, FVC -
Soutar et al 2 2 Cross. 87 d 9 mean 37 Diet PD20 metacholine 
Morabia et al 4 1 Prosp. 83 d 50-79 Serum FEV, < 75% FVC -
Cross. = Cross-sectional; Prosp. = Prospective; 9 women, cf men 
Association: - = no association; + = beneficial association 
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The evidence for a relation between p-carotene (diet and blood levels) and 
(indicators of) asthma and COPD is summarised in Table 4. Dietary p-carotene was 
not associated with 25-year incidence of CNSLD in men 1 S . However, dietary p-
carotene was borderline significantly associated with a lower 10-year incidence of 
adult-onset asthma in women 1 7 and significantly with a lower prevalence of 
hyperreactivity 2 2 . Additionally, both serum and dietary p-carotene were associated 
with a lower prevalence of COPD symptoms in male smokers 1 9 . 
The intake of total carotene was not associated with FEVi and FVC in a 
cross-sectional study 4 Z . The authors pointed out, however, that the different 
carotenoids might have different effects on lung physiology. 
Table 4: Evidence of a relation between ß-carotene and (indicators of) asthma and COPD 
Study Design No. of Gender & age p-carotene Outcome Asso-
subject 
s 
range (yrs) measured in ciation 
Miedema et a l 1 6 Prosp. 793 a 40-60 Diet 25-years CNSLD -
Troisi et a l 1 7 Prosp. 77,866 9 34-68 Diet 10-years asthma + (BS) 
Soutar et a l 2 2 Cross. 87 o* 9 mean 37 Diet PD2o metacholine + 
Rautalahti et a l 1 9 Cross. 29,133 c? 50-69 Diet & Serum COPD symptoms + 
Morabia et a l 4 1 Prosp. 83 a 50-79 Serum FEV, <75% FVC -
Chuwers et a l 4 3 Cross. 816 a 45-74 Serum FEV,, FVC + 
Shahar et a l 4 2 Cross. 10,416 c? 9 45-64 Diet (total FEV,, FVC -
carotene) 
Crass. = Crass-sectional; Prosp. = Prospective; 9 women, o* men 
Association: - = no association; + = beneficial association; BS = borderline statistically significant 
To our knowledge studies on the relation between the intake of p-carotene and lung 
function have not been published before. Blood levels of p-carotene were related to 
lung function in two studies. A high level of serum ß-carotene was not associated 
with the development of airway obstruction during five subsequent years 4 1 while 
serum ß-carotene was positively associated with lung function in a cohort of men 
exposed to asbestos 4 3 . 
In conclusion, most studies that have been investigating dietary or blood 
vitamin C in relation to respiratory outcomes suggested a possible beneficial 
association in particular for lung function. No consistent pattern arises from the few 
studies on the relation between dietary intake or blood levels of vitamin E and ß-
carotene and (indicators of) asthma and COPD. 
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Rationale and outline of the thesis 
This thesis has two distinctive parts. The first part studies the relations between 
antioxidants and the acute respiratory effects of ambient air pollution in the summer 
and winter. The second part investigates the relations between antioxidants and 
indicators of asthma and COPD, such as respiratory symptoms and lung function. 
Antioxidants in relation to the acute respiratory effects of air pollution 
In spite of the experimental evidence under controlled conditions to a single air 
pollutant, there is almost no evidence on a possible modulation of the acute 
respiratory effects of air pollution under ambient conditions with exposure to pollutant 
mixtures. In addition, the doses of supplementation were relatively high in these 
experimental studies and there have been no studies published on dietary or blood 
concentrations of antioxidants. So we specified the following (alternative) 
hypotheses: 
1. The acute effect of ambient ozone on lung function is reduced by antioxidant 
vitamin supplementation. 
2. The acute respiratory effects of winter air pollution are smaller in subjects with a 
high intake or a high serum level of antioxidants compared those with a 
respectively low intake or a low serum level of antioxidants. 
The first hypothesis was investigated in two intervention studies. The results of the 
first intervention study are presented in Chapter 2. This was a pilot study during the 
summer of 1994 among cyclists who were supplemented with a cocktail of 
antioxidant (pro-) vitamins C, E and p-carotene during 10 weeks. Chapter 3 deals 
with the same hypothesis as chapter 2 but this intervention study was placebo-
controlled and the cyclists were supplemented with the antioxidant vitamins C and E 
for 15 weeks during the summer of 1996. W e chose to study vitamin C and E alone 
in this second intervention study mainly for two reasons. First, at the start of our 
second intervention study the results of two large long-term supplementation studies 
of p-carotene on cancer incidence were published suggesting an adverse effect on 
lung cancer and this might have kept possible respondents from participating 4 4 , 4 5 . 
The second reason was practical namely; p-carotene was not commercially available 
in powder or any other substance, which was necessary for making our own 
capsules. Chapter 4 focuses on the second hypothesis and combines the results of 
two panel (observational) studies during the winter of 1993/1994 and the winter of 
1994/1995. In these studies, the investigated antioxidants were serum levels of a-
tocopherol and p-carotene and the dietary intake of vitamins C, E and p-carotene. 
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Antioxidants in relation to indicators of asthma and COPD 
Most of the epidemiological studies have been investigating one outcome in relation 
to one or two antioxidants in diet or blood. W e had the opportunity to investigate the 
dietary intake of several antioxidants (vitamin C, vitamin E, and p-carotene) in 
relation to the prevalence of a number of respiratory symptoms and lung function 
simultaneously. In addition, we were able to study plasma antioxidants a-tocopherol 
and p-carotene in relation to respiratory symptoms and lung function. The following 
(alternative) hypotheses were specified: 
1. Subjects with a high intake of antioxidants (pro)-vitamins have a lower 
prevalence of respiratory symptoms and a higher lung function compared to 
subjects with a low intake of antioxidants. 
2. Subjects with a high plasma level of antioxidant (pro)-vitamins have a lower 
prevalence of respiratory symptoms and a higher lung function compared to 
subjects with a low plasma level of antioxidants. 
These hypotheses were investigated in different population samples of the cross-
sectional M O R G E N study (the monitoring project on risk factors and health in the 
Netherlands). Chapter 5 evaluated hypothesis 1 in all subjects measured in 1994 
and 1995 with dietary vitamins C, E and p-carotene as exposure variables. In 
Chapter 6, the focus was on the first part of hypothesis 2; a case-control sample 
(subjects with and without chronic respiratory symptoms) of never and long-term 
former smokers was selected from the MORGEN-study within the period of July 
1994 to May 1995 for determination of plasma levels of p-carotene and a-tocopherol. 
In Chapter 7 a random sample from 1995 of the MORGEN-study was available with 
plasma levels of p-carotene and a-tocopherol for studying the relation with lung 
function (hypothesis 2). 
Finally in chapter 8, the results of these studies (both part one and two of the thesis) 
are discussed in the context of possible biases, such as missclassification of 
exposure, selection bias, confounding and the choice of study design. In addition, 
the magnitude of the associations found in our studies will be compared with other 
closely related studies and the biological plausibility of the associations will be 
addressed. 
W e decided to study in this thesis the following antioxidants: vitamin C, E and 
p-carotene because these antioxidants are present in the lung lining fluids 4 6 , 4 7 
suggesting that they might be able to have a beneficial effect in the lungs. In 
addition, these antioxidants can be altered by diet. W e measured plasma 
concentrations of a-tocopherol and p-carotene (chapter 6 and 7), which are 
suggested to be valid markers for dietary intake 4 8 , whereas plasma vitamin C is not 
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because of an existing homeostatic control 4 9 , 5 ° . In addition, plasma levels of a-
tocopherol and p-carotene might be good markers for the concentration available in 
the lung tissue 4 6 . 

CHAPTER 2 
Acute effects of ozone on pulmonary function 
of cyclists receiving antioxidant supplements: 
a pilot study 
Abstract 
Background The aim of this investigation was to identify whether acute lung function effects 
of ozone can be modulated by antioxidant vitamin supplementation. 
Methods Amateur cyclists (n=26) were studied in the summer of 1994 in the Netherlands. 
Repeated lung function measurements were performed with a rolling-seal spirometer after 
training session or competitive race on 4 to 14 occasions. The cyclists were assigned to two 
study groups. The supplementation group (n=12) received antioxidant supplements (15 mg 
p-carotene, 75 mg vitamin E and 650 mg vitamin C) once a day for 3 months. The control 
group did not receive supplementation. For each subject, post-exercise lung function was 
regressed on the previous 8-hour mean ozone concentration. The individual regression 
coefficients were pooled for each study group and weighted with the inverse of the variance. 
Results The 8-hour mean ozone concentration was 101 u.g/m3 (30 to 205 u.g/m3). For the 
supplementation group, there was no effect of ozone on FVC, FEV,, Peak Expiratory Flow 
(PEF) and Maximal Mid-Expiratory Flow (MMEF). For the control group the mean 
coefficients were negative, except for MMEF. The difference between the groups was 2.08 
(95%CI: 1.31, 2.85) ml/u.g/m3 for FVC, 1.66 (95% CI: 0.62, 2.70) for FEV,, 6.83 (95%CI: 
3.17,10.49) for PEF and 0.42 (95%CI: -1.38, 2.22) for MMEF. 
Conclusion The results suggest that antioxidant vitamin supplementation protects against 
acute effects of ozone on lung function in heavily exercising amateur cyclists. 
Published as: 
Linda Grievmk, Saskia M. A. Jansen, Pleter van't Veer, Bert Brunekreef. Acute effects of ozone on 
pulmonary function of cyclists receiving antioxidant supplements. Occup Environ Med 1998;53:13-17. 
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Introduction 
There is now a growing recognition that air pollution, and more specifically ozone, 
has adverse health effects 1 , 5 1 . Several investigators have studied pulmonary 
function relative to ozone and exercise. Most of these studies were conducted under 
controlled laboratory conditions 5 2 " 5 4 . After exposure to different ozone levels (160-
400 u.g/m3) lung function decreased 5 2 - 5 4 and lower respiratory tract symptoms 
increased 5 3 . Low levels of ambient ozone on respiratory effects have been studied 
before in amateur cyclists. The difference between pre- and post-exercise lung 
function was negatively related to ozone concentrations during exercise. Shortness 
of breath, chest tightness and wheeze were increased after ozone exposure 5 5 . 
A possible mechanism for decrements in lung function after ozone exposure 
is its oxidant role, inducing (in)direct injury to lung tissues by attracting inflammatory 
cells. Antioxidant (pro-)vitamins, such as vitamins E, C and p-carotene, can possibly 
modulate the reactivity of oxidants by reacting with them before they injure the lung 
tissue 5 6 . Few laboratory studies have investigated this hypothesis, suggesting a 
protective role for vitamin C and a combination of vitamins C and E 1 0 , but not for 
vitamin E a l o n e 2 9 . 
As all studies were performed under laboratory conditions, it is unknown 
whether antioxidants can play a role in the respiratory health effects of ambient 
ozone in healthy adults. W e explored this hypothesis in a small study measuring lung 
function among amateur cyclists with and without supplementation of antioxidants 
during summer. 
Methods 
Study design 
Two amateur cycling clubs in Ede and Arnhem, both located in the east of the 
Netherlands were asked to participate in the study. From 28 June until 1 September 
1994, lung function was measured in each subject before and after each training 
session or competitive race on a number of occasions. All training sessions and 
races took place in rural areas. There were no large industrial areas or cities in the 
surroundings. Ozone concentration data were obtained from the nearest station 
(Wageningen, Loenen) measured by the National Air Quality Monitoring Network 
operated by the National Institute of Public Health and the Environment (RIVM) in 
Bilthoven. Training sessions and races took place in the late afternoon and early 
evening when ozone levels tend to peak. The exact times were recorded for each 
participant in order to calculate the individual ozone exposure (8-hour mean ozone 
concentration before the end of exercise) and to calculate the duration of exercise. 
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Meteorological data were obtained from the nearest station (Deelen) operated by 
Royal Netherlands Meteorological Institute (KNMI) at the Bilt. 
Study population 
From 29 volunteers, 23 subjects were randomly assigned to the supplementation or 
control group. Five subjects were directly allocated to the control group, as they 
refused to take any supplementation or entered the study half way through. One 
subject who regularly took vitamin and/or mineral supplements and refused to stop 
was allocated to the supplementation group. At the beginning of the study, subjects 
completed a questionnaire about chronic respiratory symptoms and other relevant 
characteristics. 
Supplementation 
The supplementation group received 650 mg vitamin C, 75 mg vitamin E and 15 mg 
of B-carotene daily starting one week before the measurements started for 70 days 
(June-September). This supplementation was commercially available in two different 
pills. The control group did not receive a placebo. Before and after supplementation 
plasma was collected as a marker of compliance. 
Data collection 
Blood specimens were collected in ethylene diamine tetra-acetic acid (EDTA) 
vacutainer tubes, stored in a box on ice, and centrifuged within 5 hours to obtain 
plasma. Aliquots were then stored at -80 °C until analyses. Concentrations of a-
tocopherol and B-carotene were measured by High Performance Liquid 
Chromatography (HPLC) together in one run. The column was a pre-packaged 25 
cm x 4.6 mm Vydac 201TP54, C 1 8 300 A (Hesperia, CA, USA). Detection after 
separation was performed by two UV detectors, one for determination of retinol and 
carotenoids (UV2000) at wave-lengths of 325, 450 and 470 nm. The second detector 
(UV1000) was used for determination of the tocopherols at wave-lengths of 325 nm 
and 292 nm. 
For compliance with exertion, continuous heart rate was measured with Polar 
sport testers (Polar Electro, Finland). This was measured on a number of different 
occasions in all subjects during trainings and races. The volumes of inhaled air were 
estimated with heart rates in the equations of the study of Colucc i 5 7 . 
Lung function was measured before and after cycling with spirometry. All lung 
functions tests were conducted indoors at most 30 min. before and 10 to 60 min. 
after the exercise. Measurements were performed according to the ECCS guidelines 
5 B . The subject was seated in an upright posture, with a fixed mouthpiece adjusted 
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for height of every individual and without a noseclip. For each measurement, 
subjects had to perform at least three technically acceptable and reproducible forced 
manoeuvres (according to ECCS 1983 criteria), with Vicatest 5 dry rolling seal 
spirometers. These spirometers were coupled to a microcomputer for storage of the 
data. Data handling was according to the ECCS guidelines 5 8 . T h e spirometers had 
no internal temperature sensor; however, room temperature was recorded at all 
times. For logistic reasons, spirometers were brought into the rooms (local 
clubrooms with low ceilings) shortly before the pre-exercise measurement started. 
W e therefore had no opportunity to control indoor conditions and high temperatures 
(> 30 °C ) occurred regularly in these locations. The air in the spirometer bell may 
not have adapted to the air temperature in the clubrooms on hot days when pre-
exercise tests were performed, which may have resulted in an underestimation of the 
pre-exercise lung function 5 9 . For this reason we focused the analyses on the post-
exercise lung function measurements which were conducted after the spirometers 
had been in the clubrooms for several hours. 
Data analysis 
Before data analyses, the maximum value of three manoeuvres of each 
measurement was calculated for each subject for each of the following lung function 
variables: FEVi (forced expiratory volume in 1 second), FVC (forced vital capacity), 
PEF (peak expiratory flow) and MMEF (maximal mid-expiratory flow). At the end of 
the study, a range of four to 14 observations was available for each subject - that is, 
lung function measurements after exercise (post-exercise lung function). Subjects 
with a range in ozone exposure of less than 50 u.g/m3 (n=3) were excluded from 
analyses because their estimated regression coefficients would be highly unstable. 
Individual regression analyses were performed in each subject using SAS 'PROC 
REG' procedure 6 0 with the post-exercise lung function variable (FEV|, FVC, PEF or 
MMEF) as the dependent variable and with the previous 8-hour mean ozone 
concentration as the independent variable. The resulting regression coefficients for 
each subject were pooled and group means (with Standard Errors), medians and 
means which were weighted with the inverse of the variance were calculated for the 
control and supplementation group. The effect of supplementation with a 9 5 % 
confidence interval (95% CI) was calculated as the difference between the mean 
regression coefficient of the supplementation and control group. Ambient 
temperature, N 0 2 , and concentrations of particulate matter with a mean diameter of 
10 urn (PM10) were considered as confounding factors. 
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Results 
A total of 26 respondents (n=14 in control group) contributed with 192 observations 
to the data analyses. The average age of the respondents was 27.5 years and did 
not differ between the two study groups (table 1). Three participants were women. In 
the control group, one subject was a current smoker and two reported a doctor 
diagnosed pollen allergy. In the supplementation group more subjects reported 
having respiratory symptoms and allergy than in the control group. One subject 
reported having had ever doctor diagnosed attacks of chest tightness; another 
subject reported shortness of breath when walking at normal pace and one subject 
reported coughing up phlegm almost every day for three months in the last two 
years. Two subjects reported an allergy to pets and house dust mites, and four 
others an allergy to pollen, all diagnosed by a doctor. 
Table 1: Mean and range in age, number of observations, ozone concentration, duration of 
exercise, and heart rate in the two study groups 
Measurements Control group Supplementation group 
(n=14) (n=12) 
Mean Range Mean Range 
Age* (yr.) 28.5 20-41 27.9 16-39 
No. of observations1' (n) 6.9 4-14 7.9 5-12 
Ozone concentration* (ng /m 3) 97.9 30-205 104.2 33-205 
Duration of exercise (min.) 91.1 15-135 92.7 15-135 
Heart rate (beats/min.) 154.0 132-180 153.1 129-196 
age of one subject from the control group is missing 
post exercise lung function measurement 
8-Hour mean ozone concentration 
Table 1 summarises means of number of observations, ozone concentration, 
duration of exercise and heart rate for the two study groups. The average 8-hour 
mean ozone concentration was 101 u.g/m3 (range 30-205 u.g/m3), with no difference 
between the two groups. The figure shows the 1-hour maximum ozone 
concentrations for every day from June until August. Ozone concentrations were 
high from the end of June (at the start of the study) until the end of July, August had 
lower ozone concentrations. 
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Figure: Plot of the 1-hour maximum ozone concentration per day (jjg/m3) from the first of June until 
the first of September. Observation period was from June, 28* until September, 1st 1994 
Eight-hour mean temperature averaged 23°C, with a range of 15 to 31°C. The mean 
(range) duration of the exercise was not different between the two study groups (92 
(15-135) minutes). Heart rate measurements were performed on 179 different 
occasions. During training sessions, mean (range) heart rate was 147 (129-190) 
bpm, and during competitive races, 165 (135-196) bpm. There was no difference 
between the groups. Estimated volumes of inhaled air were 55 L/min. during training 
and 70 L/min. during races. 
Table 2: a-Tocopherol and p-carotene concentrations (fimol/l) in plasma among control and 
supplementation group at baseline and the change during intervention 
Control Group (n=9) Supplementation group (n=11) 
Baseline Change Baseline Change 
Mean (SEM) % (Range) Mean (SEM) % (Range) 
a-tocopherol 23.0 (7.66) 9 (- 7 to 21) 30.0 (8.35) 38 ( 9 to 95) 
B-carotene 0.32 (0.11) 5 (-19 to 26) 0.50 (0.14) 153 (10 to 345) 
Mean individual change (post minus pre divided by pre-intervention) 
Table 3: Post-exercise lung function variables with 8-hour mean ozone concentration by study group (control and supplementation) 
Lung function Control Supplementation Control Supplementation Treatment effect 
Variable (n=14) (n=12) 
Median Median Mean
f (SEM) Mean* (SEM) Difference (95% Cl) f 
FVC -0.39 0.44 -1.83 (0.49) 0.25 (0.24) 2.08 (1.31, 2.85) 
FEV, -0.35 -0.013 -1.86 (0.49) -0.20 (0.60) 1.66 (0.62, 2.70) 
PEF -1.54 2.42 -5.35 (2.03) 1.48 (3.04) 6.83 (3.17,10.49) 
MMEF -0.93 -1.46 -0.93 (0.94) -0.51 (0.93) 0.42 (-1.38, 2.22) 
median coefficients in ml/u.g/m3 
mean coefficients (standard error of mean) in ml/u.g/m3 for FVC and FEVi and in ml/sec/u.g/m3 for PEF and MMEF weighted with inverse of variance; 
Difference = supplementation minus control group; 95% CI: 95% Confidence Intervals 
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Plasma at the beginning and at the end of the study was collected from 20 subjects 
(n=9 control group). The supplementation group had higher base-line concentrations 
of p-carotene and a-tocopherol than the control group (table 2). Individual change of 
P-carotene and a-tocopherol plasma concentrations were used as a marker of 
compliance. The supplementation group had a significantly higher increase in p-
carotene and in a-tocopherol than did the control group, as expected (table 2). 
Table 3 presents the median and weighted mean regression coefficients of 
post-exercise FVC, FEVi , PEF and M M E F with 8-hour mean ozone concentration for 
the control and supplementation group. Median coefficients were more negative, 
except for MMEF, for the control group than for the supplementation group, 
indicating a decrease in lung function at higher ozone concentrations in the control 
group. After weighting the individual regression coefficients with the inverse of the 
variance, mean coefficients of FVC, FEVi and PEF were more negative compared to 
medians in the control group. The MMEF was not associated with ozone. For the 
supplementation group, none of the lung function parameters were associated with 
ozone concentrations. The weighted mean regression coefficients of FVC imply that 
a difference in exposure of 100 u.g/m3 ozone would decrease FVC with 183 ml in the 
control group and increase FVC with 25 ml in the vitamin group. The difference 
between the two groups was statistically significant for FVC, FEVi and PEF. There 
was no statistically significant difference between the study groups for MMEF. 
The Pearson correlation coefficient for ozone with 8-hour mean ambient 
temperature was 0.93. Conventional adjustment for temperature was problematic 
because of this high correlation. Restricting the data to lower ambient temperatures 
was difficult to interpret because of the remaining few observations - that is, < 4 0 % of 
total observations. Adjustment for N 0 2 as an independent variable in the model did 
not change the estimated regression coefficients of ozone on lung function. Neither 
changed the regression coefficients of ozone on lung function after adjustment for 
PM10. 
Discussion 
The results of this study suggest that antioxidant (pro-)vitamin supplementation 
might protect against acute ozone effects on lung function (in particular for FVC, 
FEVi and PEF). 
W e also considered an additional regression analysis on all measurements on 
all subjects. After adjustment for trend, the regression coefficients of FEVi (p=-0.29 
ml/u.g/m 3 in the control group and p=-0.18 in the vitamin group) and FVC (p=-0.92 in 
the control group and p=-0.0014 in the vitamin group) were comparable to the 
medians of the regression coefficients presented in table 3. The difference between 
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the control and supplementation group was statistically significant for FVC. The 
unadjusted regression coefficients for PEF and MMEF were also comparable to the 
presented medians. So, the results were similar independent of the method of 
analysis, with a more negative regression coefficient in the control group compared 
to the supplementation group. 
Adjustment of ambient temperature as a possible confounder was difficult 
because of the very high correlation with ozone. Ambient temperature is, however, 
not such an influential confounder as indicated by other studies 5 5 , 6 1 , 6 2 . Experimental 
studies showed only some potentiation of ozone effects with very high temperatures 
(>35 °C) and high ozone concentrations (>600 u.g/m3) 6 1 , 6 2 . Brunekreef and co-
workers 5 5 also found no temperature effect under ambient conditions with an 
average temperature of 18 °C. 
Adjustment for PM10 did not change the results. Hoek and coworkers 2 also 
did not find an effect of low concentrations of PM10 on the relation of ozone with 
lung function during a summer in The Netherlands. Neither did adjustment for N 0 2 
concentrations change the results. This could be expected since 8-hour mean N 0 2 
concentrations were low during this summer with a mean of 23 j ig /m 3 and a range of 
4 to 60 u.g/m3. In addition, N 0 2 concentrations were not associated with the lung 
function variables (data not shown). 
More subjects with respiratory symptoms and allergies were present in the 
supplementation group. This suggests that randomisation was not completely 
successful. However, the results in the present study were probably not affected 
because several other studies indicated that there was no difference in acute effects 
of ozone between groups with or without respiratory symptoms or allergies 2 , 5 1 . 
Baseline plasma concentrations of p-carotene and a-tocopherol were higher 
in the supplementation group, which could be explained by three subjects in the 
supplementation group who used habitual vitamin supplementation at the start of the 
study. Two of the subjects stopped taking extra supplementation during the study 
and were randomly assigned to the supplementation group. Excluding all three 
subjects from analyses resulted in similar regression coefficients for the 
supplementation group, which implies that results were not affected by these three 
subjects. 
a-Tocopherol and p-carotene in plasma were determined in a part of the 
subjects to investigate group compliance. The increases in this study were 
comparable with other supplementation studies 6 3 " 6 5 . However, comparison can only 
be rough because duration and amount of supplementation differ between the 
studies. p-Carotene and a-tocopherol were combined in one capsule. Therefore, if 
subjects in the supplementation group had a low increase in both antioxidants this 
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would suggest that compliance was not complete. Although the range in individual 
increases in the supplementation group was large (9-95% for a-tocopherol; 10-345% 
for B-carotene), possibly due to individual variation of absorption of the antioxidants, 
there was no subject in this group who had a small increase in both antioxidants. 
The control group did not receive a placebo, so the study was not blinded. It is 
unlikely that this could have affected the results. Both researcher and subject were 
not aware of the ozone concentrations at the moment of lung function measurements 
and therefore anticipation of the effect was not possible. 
The mechanism by which ozone induces acute decrements in pulmonary 
function has been under discussion. Inflammatory cells increase within one hour 
after exposure, but reach a maximum 6 hours after exposure. This increase does not 
correlate well with the measured decrements in pulmonary function decrements after 
ozone exposure 6 6 . The current hypothesis for the acute decrements in lung function 
is a reduction of maximal inspiratory capacity through stimulation of the neural 
receptors in the upper airways 1 6 7 . These receptors are stimulated by 
cyclooxygenase products of arachidonic acid which are released upon ozone 
exposure 6 7 . Vitamins C and E have been shown to affect the arachidonic acid 
metabolism, but the role of antioxidants in this mechanism is not fully understood 
10,20,68 
In summary, this study suggests that one or more of the antioxidants (vitamins 
C, E and p-carotene) may modulate the acute effects of ozone on lung function. 
Randomised placebo controlled studies with more subjects and more observations 
per subject are necessary to increase the precision and confirm the validity of the 
findings. 
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CHAPTER 3 
A double-blind intervention trial on modulation 
by antioxidant supplements of ozone effects 
on pulmonary function 
Abstract 
Background The aim of this study was to investigate whether acute effects of ozone on lung 
function can be modulated by antioxidant vitamin supplementation in a placebo-controlled 
study. 
Methods Lung function was measured in Dutch cyclists (n=38) before and after each training 
on a number of occasions (n=380) during the summer of 1996. The vitamin group (n=20) 
received daily 100 mg vitamin E and 500 mg vitamin C for 15 weeks. 
Results Average ozone concentration during exercise was 77 ug/m 3 (range: 14-186 ug/m3). 
After excluding subjects with insufficient compliance from the analysis, a difference in ozone 
exposure of 100 u.g/m3 would decrease forced expiratory volume in 1 second with 95 ml 
(95% confidence interval (95% CI):-265 to -53 ml) in the placebo group and with 1 ml 
(95%CI - 9 4 to 132 ml) in the vitamin group; for forced vital capacity this was -125 ml (95% 
CI -384 to -36) in the placebo group and -42 ml (95% CI -130 to 35 ml) in the vitamin 
group. The differences in ozone effect on lung function between the groups were statistically 
significant. 
Conclusions The results suggest that supplementation of antioxidant vitamins C and E 
confers partial protection against acute effects of ozone on FEV, and FVC in cyclists. 
Accepted for publication as: 
Linda Grievlnk, Aletta G. Zijlstra, Xiaodong Ke, Bert Brunekreef. A double-blind intervention trial on 
modulation by antioxidant supplements of ozone effects on pulmonary function. Am J Epidemiol; 
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Introduction 
Acute effects of ozone on lung function have been studied in exercising subjects. 
Most of these studies were conducted under controlled laboratory conditions 5 2 - 5 4 ' 5 9 -
7 2 . All of these chamber studies showed that lung function decreased after exposure 
to high levels of ozone (160-700 ug/m 3 ) . However, low levels of ambient ozone (< 
120 ug/m 3 ) were also negatively related to lung function 5 5 in exercising cyclists. 
In addition to lung function decrements, which occur within one hour after acute 
ozone exposure, an increase in inflammatory mediators was shown in 
bronchoalveolar lavage within one hour 7 3 , 7 4 , six hours 6 6 , 18 hours 7 3 , 7 4 , and 24 
hours 6 6 of exposure. This increase of inflammatory mediators was different in time 
for each med ia to r 6 6 ' 7 3 ' 7 4 . Antioxidants, such as vitamin C and E, could modulate the 
airway response to ozone by reducing attraction of inflammatory cells 5 S . Since lung 
function decrements after ozone exposure occur earlier in time compared to the 
increase of inflammatory cells, another hypothesis could explain the modulation of 
ozone effects on lung function: maximal inspiratory capacity is reduced through 
stimulation of the neural receptors in the upper airways by cyclooxygenase products 
of arachidonic acid which are released upon ozone exposure 6 7 ; vitamins C and E 
have been shown to affect this arachidonic acid metabolism, but the role of these 
vitamins in this mechanism is not fully understood 1 0 ' 2 0 ' 6 8 . 
Few experimental studies have investigated a possible protective role of 
antioxidants on acute effects of ozone. One study showed that a supplementation of 
vitamin C and a combination of vitamin C and E protected against decrements in 
lung function in subjects exposed to ozone concentrations of 600 ug/m 3 1 0 . Another 
study did not show a protective role of vitamin E alone on lung function after 
exposure to 1000 ug/m 3 ozone 2 9 . 
W e explored a possible modulation of antioxidants on acute effects of ambient 
ozone in a placebo-controlled study, supplementing cyclists with antioxidant vitamins 
C and E and measuring lung function on a number of occasions in the Netherlands 
during the summer of 1996. 
Methods 
Study design and population 
Two cycling clubs in Apeldoorn and Nijmegen, which are located in the east of the 
Netherlands, were asked to participate in the study. From these clubs both amateur 
and recreational cyclists participated. A recreational club in Maiden, also located in 
the east of the Netherlands, volunteered to participate after an advertisement for new 
subjects. From these three clubs, 46 non-smoking subjects volunteered and were 
randomly assigned to the placebo or vitamin group. An earlier study in 1991 5 5 
suggested that 23 cyclists with on average 12 measurements per cyclist was able to 
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show an effect of ozone with relatively low levels of ozone. So the number of 
subjects in our study (n=46) would allow us to detect an effect of ozone in the control 
group or the absence of an effect in the vitamin group. From 20 May until the end of 
August 1996, lung function was measured before and after each training session or 
competitive race on a number of occasions in each subject. Most training sessions 
and competitive races took place in rural areas in the late afternoon and early 
evening, when ozone levels tend to peak. The exact times of each exercise period 
were recorded for each participant in order to calculate the individual ozone 
exposure (mean ozone concentration during exercise and 8-hour mean ozone 
concentration before post-exercise lung function measurement) and to calculate the 
duration of exercise. Daily concentrations of both ozone and particulate matter with a 
50 percent cut-off diameter of 10 urn (PM10) were obtained from the nearest 
monitoring stations (Loenen, Wageningen) of the National Air Quality Monitoring 
Network which is operated by the National Institute of Public Health and the 
Environment (RIVM) at Bilthoven. Meteorological data were obtained from the 
nearest station (Deelen) operated by the Royal Netherlands Meteorological Institute 
(KNMI). Airborne pollen concentrations were obtained from the department of Lung 
Diseases, Academic Hospital in Leiden. At the beginning of the study, subjects 
completed a questionnaire about chronic respiratory symptoms and other relevant 
characteristics. 
Supplementation 
The vitamin group (n=19) received a daily dose of 500 mg vitamin C and 100 mg 
vitamin E in two capsules starting one week before the measurements for a total 
duration of 15 weeks (May-August). Subjects stopped taking their own vitamin 
supplements (three subjects used daily multivitamins, vitamin C or vitamin E) at least 
one week before the start of the study. The vitamin capsules and the placebos were 
hand made, visually identical and given each a code which was not known to the 
involved researchers and subjects. At the end of the study, the subjects returned the 
remainder of the capsules (a supply for 20 weeks was given) so we could estimate 
compliance. Next to counting the capsules, an additional measure of compliance 
was evaluated; subjects were asked at the end of the study if they had not been 
taking the capsules for longer than a week consecutively. Plasma was collected 
before and at the end of supplementation for determination of a-tocopherol and 
vitamin C as additional markers of compliance. 
Data collection 
Blood specimens were collected in ethylene diamine tetra-acetic acid (EDTA) 
vacutainer tubes, stored in a box on ice, and centrifuged within five hours to obtain 
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plasma. Aliquots were then stored at -80 °C until analyses. Concentrations of a-
tocopherol at base-line and after supplementation in each subject were measured by 
reverse-phase high-performance liquid chromatography (HPLC) together in one run. 
The method was adapted from Hess and coworkers 7 5 . The column was a 
prepackaged 25 cm x 4.6 mm Vydac 201TP54, C i 8 300 A (Hesperia, CA, USA). The 
mobile phase consisted of methanol-tetrahydrofuran-water in the following 
configuration (% v/v/v): 0 min. 89:2:9; 10 min. 98:2:0; 20 min. 97:3:0; 30 min. 
90:10:0; 40 min. 90:10:0 with a flow rate of one ml/min. Detection after separation 
was executed using an ultraviolet (UV) detector (UV1000) for determination of the 
tocopherols at wave lengths of 325 nm for 0-9 minutes and 292 nm for 9-40 minutes. 
Plasma vitamin C was analyzed by a modification of the method developed by Roe 
and Kuether 7 6 at base-line and at the end of the intervention period in these 
subjects. 
Continuous heart rate measurements were performed as a measure of 
exertion, using Polar sporttesters (Polar Electro, Finland) on a number of different 
occasions in all subjects during trainings and competitive races. With these mean 
heart rates during exercise, the volumes of inhaled air were estimated according to 
the equation from the study of C o l u c c i 5 7 for subjects with an age range of 21 to 60 
years. 
Lung function was measured before and after cycling with a heated 
pneumotachometer (Jaeger, Germany). The flow-volume and the volume-time 
curves were observed on the attached computer for all maneuvers during the 
measurement; all data was automatically saved on the computer. Temperature at 
location was measured and controlled for during the measurements by entering the 
temperature into the computer. Next to the calibration with a one liter syringe, the 
researchers measured their own lung function twice at the same time as the cyclists, 
to check for abnormalities of the equipment. All lung functions tests were conducted 
indoors, at most 60 minutes before and on average 17 minutes (range: 5-60 min.) 
after the exercise. Pre- and post-exercise lung function was measured on the same 
pneumotachometer. Measurements were performed according to the European 
Respiratory Society (ERS) guidelines 7 T ; subjects were seated in an upright posture, 
with a fixed mouthpiece adjusted for height of every individual and a nose clip was 
used. For each measurement, subjects had to perform at least three technically 
acceptable of which two reproducible (according to ERS 1993 criteria) forced 
maneuvers. 
Data analysis 
In data analysis, maximum values of the three maneuvers of each measurement 
were used in each subject of the following lung function parameters: Forced 
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Expiratory Volume in 1 second (FEVi) , Forced Vital Capacity (FVC), Peak Expiratory 
Flow (PEF) and Maximal Mid-Expiratory Flow (MMEF). Before data analysis, two 
criteria were set for subjects to be included in the individual regression analysis to 
prevent the occurrence of unstable regression coefficients. First subject had to have 
at least four observations, that is, lung function measurements before and after 
exercise (pre- and post-exercise lung function respectively). Second each subject 
should have a range in ozone or PM10 exposure of more than 40 ug/m 3 . All subjects 
fulfilled this second criterion for ozone exposure during exercise and for 8-hour mean 
ozone exposure. Six subjects had a range of PM10 exposure of less than 40 ug/m 3 
and were excluded from the analysis of PM10 concentrations in relation to lung 
function. PM10 concentrations were calculated as 24-hour mean concentrations 
previous to the post-exercise lung function measurement. In addition, a lag of one 
and two days was calculated. Twenty-four hour mean PM10 concentrations were 
missing for three days but all subjects had still at least four observations for the 
analysis of PM10 in relation to lung function. 
Data were analyzed using Statistical Analysis System (SAS) procedures. For 
each subject, delta lung function (post minus pre-exercise lung function) as 
dependent variable was regressed on the ozone concentration (in |ag/m 3; 1 j ig /m 3 of 
ozone equals to 0.5 ppb) during exercise. W e also considered for each subject post-
exercise lung function measurements as the dependent variable with the previous 8-
hour mean ozone concentration as the independent variable because exposure to 
ozone prior to the exercise could have affected the pre-exercise lung function levels. 
The resulting individual regression coefficients were pooled in both analyses and 
medians and means (with standard errors of the means) were calculated for the total 
group and for the control (placebo) and vitamin group separately. In addition, 
weighted group means were calculated with the inverse of the variance of the 
individual regression coefficient as weight. The 9 5 % confidence intervals (95% CI) 
around the median regression coefficients were calculated with a non-parametric 
method published by Campbell and Gardner 7 S . The difference between the vitamin 
and control group was tested for statistical significance (p<0.05) with the Wilcoxon 
rank-sum test. 
The following potential confounders were taken into account in the regression 
analyses: ambient temperature, absolute humidity, PM10 concentrations with a lag 
of zero, one, two days and an interaction term of ozone and PM10 (a dummy for 
PM10 with a cut-off point at the median times the ozone concentration) and pollen 
concentrations (Poaceae [grass] and Betula [birch]). Pearson correlation coefficients 
were calculated between the independent variables. There were too few subjects 
with self-reported asthma (n=4) and/or inhalant allergies (n=8) to analyze this 
subgroup separately. Therefore, we examined if the regression coefficients were 
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affected when excluding asthmatic or allergic subjects from analyses. The effect of 
insufficient compliance was considered by excluding subjects who returned too few 
or too many capsules (equivalent to more than 110 percent or less than 80 percent 
of the planned cumulative dose respectively). In addition, subjects who reported that 
they had not been taking the capsules for three consecutive weeks or more were 
excluded. 
Results 
Of the 46 subjects at the beginning of the study, eight subjects were excluded from 
analyses; five subjects had less than four measurements, one subject dropped out 
immediately because he could not swallow the capsules and two subjects were not 
able to perform reproducible lung function measurements. 
The 38 remaining subjects had a total of 380 lung function measurements (i.e. 
pre- and post-exercise lung function measurements) with a range of 5-19 
measurements per subject. Three subjects were female with one female subject in 
the control group. Eight subjects reported a doctor diagnosed allergy to pets, house 
dust mite or pollen; four subjects reported doctor diagnosed asthma. A slightly higher 
number of these allergic (n=5) and asthmatic subjects (n=3) were allocated to the 
vitamin group compared to respectively three allergic and one asthmatic subject(s) in 
the control group. Respiratory symptoms and the use of vitamin supplements before 
the start of the study were not different between the groups. 
Table 1 summarizes the mean age, baseline FEVi and FVC, number of 
measurements, compliance by counting the number of the returned capsules, ozone 
concentration during exercise and 8-hour mean ozone concentration. There was no 
difference in means or medians (results not shown) between the groups, except for 
compliance: the control group showed a somewhat higher compliance (97 vs. 86 
percent). Of these 38 subjects, 33 had data on plasma a-tocopherol before and after 
supplementation. Mean baseline plasma a-tocopherol was 27.2 (standard error 1.17) 
mmol/l and plasma vitamin C was 81.2 (standard error 2.9) urnol/l which were both 
not different between the study groups. After supplementation, the mean of the 
individual changes for plasma a-tocopherol was 3.8 percent (range of -12 to 19 
percent) in the control group (n=15) and 48.4 percent (range of -2 to 134 percent) in 
the vitamin group (n=18). For plasma vitamin C the mean individual changes were -
4.3 percent (range - 5 8 . 1 to 37.3) in the control group and 4.1 percent (range - 1 8 to 
49 percent) in the vitamin group. 
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Table 1: Mean and range in age, number of observations, compliance and ozone concentrations in 
the two study groups in 38 Dutch cyclists, 1996 
Characteristics, measurements Control group (n=18) Vitamin group (n=20) 
Mean Range Mean Range 
Age (yr.) 33.1 17-58 33.8 16-59 
Baseline lung function 
FEV, (L) 4.7 3.6-6.0 4.6 2.7-7.2 
FVC (L) 5.9 4.2-7.0 5.8 3.9-8.0 
No. of observations 10.2 5-19 9.9 5-17 
Compliance (%) * 96.8 70-130 86.1 53-101 
Ozone concentration during 75.4 17-181 78.4 14-186 
exercise (ug/m3) * 
Eight-hour mean ozone 84.2 32-199 88.2 33-199 
concentration (ug/m3) 
FEVi: Forced Expiratory Volume in 1 second; FVC: Forced Vital Capacity 
* Compliance for subject expressed as % of the number of capsules which they should have been taken 
* 1 ug/m3 equals to 0.5 ppb 
Figure 1 shows the 1-hour maximum ozone concentrations for every day from May 
until August 1996. 
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Figure 1: Plot of the 1-hour maximum ozone concentration per day (ug/m3) from the first of May until 
the end of August. Observation period was from May, 20th until August, 27* 7996 
The average ozone concentration during exercise was 77 (ag/m3. Mean temperature 
during exercise was 17 °C, with a range of 10 to 25 °C. Eight-hour mean 
temperature was 19 °C with a range from 12 to 28 °C. Mean absolute humidity was 
13 mg/l air with a range of 9 to 20 mg/l air. The average 24-hour mean PM10 
concentration was 41 ug/m 3 with a range of 13 to 144 ug/m 3 . Pearson correlation 
coefficients of 8-hour mean ozone concentration with 8-hour mean temperature was 
0.59, with 8-hour mean absolute humidity 0.28, with 24-hour mean PM10 
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concentrations 0.37. The mean duration of exercise was not different between the 
two groups with a mean of 104 min. (range: 20-216 min.). Heart rate measurements 
were performed on 315 different occasions with an average for training sessions of 
141 bpm (range: 83-182 bpm) and for competitive races of 173 bpm (range: 156-187 
bpm). There was again no difference between the two groups. Mean estimated 
volumes of inhaled air were 55 L/min. during trainings and 92 L/min during races 5 7 . 
Table 2 compares the ozone effects in the vitamin group versus the control 
group for both delta lung function and post-exercise lung function as outcome 
variables. There was a significant negative effect of ozone on delta-FEVi and delta-
FVC but not on delta-PEF and delta-MMEF. Ozone exposure was also negatively 
associated with post-exercise FEVi , FVC and PEF. Further analyses were 
concentrated on FEVi and FVC which were more reproducibly measured and 
showed similar magnitudes of the regression coefficients for both delta lung function 
and for post-exercise lung function compared to PEF and MMEF. Because pre-
exercise lung function could have been influenced to an unknown extent by ozone 
exposure prior to the trainings or races, we decided to focus on post-exercise lung 
function and on 8-hour average exposures as well. The median regression 
coefficients of 8-hour ozone on post-exercise FEVi and FVC were significantly 
different from zero in the control group, whereas the regression coefficients were not 
different in the vitamin group. The differences in the effect of ozone between the 
study groups were not statistically significant (table 2). 
Table 3 compares the effect of 8-hour mean ozone on post-exercise FEVi and 
FVC between the control and vitamin group after adjustment for 24-hour mean 
PM10, 8-hour mean temperature and compliance. After adjustment for PM10 and 
temperature, the differences in ozone effects on lung function between the study 
groups generally became somewhat larger compared to the unadjusted differences 
(table 2). After excluding insufficient compliers, ozone exposure was significantly 
associated with FEVi and FVC in the control group whereas ozone was not 
associated with lung function in the vitamin group. The differences in ozone effect on 
lung function between the groups were statistically significant (table 3). 
Table 2: Median regression coefficients and 95% confidence intervals (95% CI) of ozone on delta lung function and post-exercise lung function 
in the total group of 38 Dutch cyclists and in the control group (n=18) and vitamin group (n=20) separately, 1996 
Lung Dependent variable 
function —• 
parameter D e l t a l u n 9 function1' Post-exercise lung function* 
Total group Study group Total group Study group 
Control group Vitamin group Control group Vitamin group 
Median (95% CI) Median (95% CI) Median (95% CI) Median (95% CI) Median (95% CI) Median (95% CI) 
FEV, -0.99 (-1.89, -0.32) -1.19 (-2.34, -0.39) -0.68 (-2.76, 0.71) -0.67 (-0.96, -0.44) -0.95 (-2.60, -0.62) -0.50 (-0.95, 0.52) 
FVC -1.03 (-1.24, -0.24) -1.03 (-2.99, -0.05) -1.10 (-2.24,-0.09) -1.05 (-1.30, -0.37) -1.18 (-2.78, -0.74) -0.61 (-1.84, 0.31) 
PEF 1.14 (-4.23, 4.24) 1.55 (-5.67, 5.36) 1.14 (-8.05, 8.07) -4.01 (-6.08, -2.90) -3.80 (-6.64, -1.64) -4.36 (-7.29, -1.87) 
MMEF -1.11 (-3.42, 0.16) -2.86 (-4.43, 0.82) -0.43 (-3.42, 3.14) -0.47 (-1.69, 1.33) -0.28 (-2.99, 1.33) -0.88 (-2.07, 2.72) 
FEVi, Forced Expiratory Volume in one second; FVC, Forced Vital Capacity; PEF, Peak Expiratory Flow; MMEF, Maximal Mid-Expiratory Flow 
* Median coefficients of post-exercise minus pre-exercise lung function on ozone during exercise in ml per u.g/m3 ozone for FEVi and FVC and in ml/sec per ng/m3 
ozone for PEF and MMEF 
* Median coefficients of post-exercise lung function on 8-hour mean ozone in ml per u.g/m3 ozone for FEVi and FVC and in ml/sec per u.g/m3 ozone for PEF and MMEF 
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Table 3: Median regression coefficients (in ml per jug/m3 ozone) and 95% confidence intervals (95% 
CI) of post-exercise FEV1 and FVC on 8-hour mean ozone by study group after different adjustments 
in Dutch cyclists, 1996 
Adjustments/ exclusion Total group Study group 
Lung function parameter (rr=38) Control (n=18) Vitamin (n=20) 
Median (95% CI) Median (95% CI) Median (95% CI) 
24-Hour mean PWI10 
FEV, -0.71 (-1.64, -0.35) -1.36 (-2.80, -0.35) -0.65 (-1.64, 1.20) 
FVC -1.33 (-2.06, -0.30) -1.89 (-2.75,-0.82) -0.11 (-1.93, 0.74) f 
8-Hour mean temperature 
FEV, -1.25 (-1.94, -0.20) -1.58 (-2.63, -0.44) -0.08 (-3.21, 2.06) 
FVC -1.69 (-2.66,-0.46) -1.89 (-3.03, -1.31) -0.37 (-4.41, 0.97) 
Excluding insufficient 
compilers * unadjusted (n=28) (n=14) (n=14) 
FEV, -0.67 (-0.95, 0.24) -0.95 (-2.65, -0.53) -0.01 (-0.94, 1.32) f 
FVC -1.00 (-1.30, -0.36) -1.25 (-3.84,-0.36) -0.42 (-1.30, 0.35) f 
vitamin group differs significantly from control group (p < 0.05, Wilcoxon rank-sum test) 
see text in methods 
The crude median regression coefficients after exclusion of insufficient compliers 
imply that a difference in exposure of 100 (xg/m3 ozone would decrease FEVi by 95 
ml and FVC by 125 ml in the control group and decrease FEVt by 1 ml and FVC by 
42 ml in the vitamin group (table 3). After adjustment for PM10 and temperature, the 
median regression coefficients of ozone on lung function of good compliers 
decreased slightly in the control group and increased slightly in the vitamin group 
increasing so the differences between the groups. The unweighted and weighted 
mean regression coefficients of ozone on lung function in both study groups showed 
similar patterns in the results (results not shown). 
Adjustment for pollen concentrations or absolute humidity did not materially 
change the estimated regression coefficients. This was also true when excluding 
asthmatics or allergic subjects (results not shown). PM10 with a lag of zero, one and 
two days were not associated with post-exercise FEVi and FVC. An interaction term 
of PM10 and ozone was not different from zero (results not shown). 
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Figure 2: Boxplot of the distribution of regression coefficients of FEU, m the control group and vitamin 
group with median (center of the box), mean (plus sign), 25th and 75th percentile (borders of the box, 
i.e. interquartile range), range (whiskers) and outliers; (A) all subjects, (B) good compilers only 
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Figure 3: Boxplot of the distribution of regression coefficients ofFVC in the control group and vitamin 
group with median (center of the box), mean (plus sign), 25* and 75th percentile (borders of the box, 
i.e. interquartile range), range (whiskers) and outliers; (A) all subjects, (B) good compilers only 
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Figure 2 shows the distribution of the crude regression coefficients of 8-hour mean 
ozone on post-exercise FEVi for all subjects (figure 2A) and in good compliers 
(figure 2B). Figure 3 shows the same distributions for FVC in all subjects (figure 3A) 
and in good compliers (figure 3B). These figures illustrate that the distribution of 
regression coefficients of ozone on FEVi and FVC was shifted upwards in the 
vitamin group compared to the control group and that this became more clear after 
excluding the insufficient compliers. 
Discussion 
The results of this study show that relatively low concentrations of ozone were 
associated with a decrease in post-exercise FEVi and FVC. The effect was stronger 
in the control group receiving placebo treatment suggesting that supplementation of 
vitamins C and E was able to partially remove acute effects of ozone on lung 
function in heavily exercising subjects. 
Since the subjects were cycling in ambient air and ozone concentrations tend 
to be uniform over large areas in the Netherlands, we assumed that the level of 
ozone at the monitoring site was a good proxy for the level of ozone at the place they 
were cycling. The monitoring sites in our study were less than 50 km from the 
training or racing sites and a correlation coefficient of 0.82 was observed at a 
distance of more than 100 km between two monitoring sites in the Netherlands 2 . It is 
known that ozone concentrations are lower in urban areas but as our monitoring site 
was in a non-urban location and cycling took place in non-urban areas as well, there 
is no reason to believe that the level of ozone exposure of our cyclists was different 
from the measurements of the monitoring network site. 
Adjustment for ambient temperature and absolute humidity did not change the 
results considerably. Experimental studies showed only some potentiation of ozone 
effects with very high temperatures (> 35 °C) and high ozone concentrations (> 600 
u g / m 3 ) 6 1 , 6 2 . Previously, we did not find an effect of temperature or absolute humidity 
under ambient conditions with an average temperature of 18 °C which was very 
comparable to the present study 5 5 . 
Adjustment for PM10 did not essentially change the results. Hoek and 
coworkers 2 did also not find an effect of low concentrations of PM10 on the relation 
between ozone and lung function during a summer in the Netherlands. 
The effect of insufficient compliance (number of pills taken) was investigated. 
There was no change in the control group which is understandable since an intake of 
fewer placebos is unlikely to change the results. There were, however, no longer 
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effects of ozone on lung function in the vitamin group when insufficient compliers 
were excluded. 
Differences in plasma concentrations of oc-tocopherol and vitamin C between 
base-line levels and the end of the study were taken as markers for group 
compliance. However, plasma vitamin C was not a good marker in this study 
because these subjects were young and healthy and their base-line levels of vitamin 
C were already in the plateau phase (68-85 u.mol/1) of the intake 3 4 . So, a higher 
supplemental intake would not lead to higher plasma levels in this group of subjects 
5 0 . Plasma level of ct-tocopherol is considered to be a relatively good marker of the 
intake of vitamin E because they are moderately reactive to vitamin E intake 4 8 
although the absorption of vitamin E may be incomplete (20-80%) 3 4 and variable 
because the absorption declines with increasing dose of vitamin E intake 7 9 . Our 
results showed that there was a clear increase in plasma levels of a-tocopherol in 
the vitamin group whereas this was not so in the placebo group. This was similar to 
our findings in a pilot study conducted in 1994 with a supplementation of 75 mg 
vitamin E and an increase of nine percent and 38 percent in plasma a-tocopherol in 
the control and vitamin group respectively 8 0 . The increase of plasma a-tocopherol in 
this study was also comparable with other supplementation studies 6 4 , 6 5 , although 
comparison can only be crude because the length and amount of supplementation 
differ between the studies. 
Chatham and coworkers 1 0 found that a daily supplementation of vitamin C (1 
g just before ozone exposure) and vitamin E (800 mg daily) protected partly to acute 
effects of ozone (600 ug/m 3 ) on FEVi and FVC in 14 healthy adults. Preliminary 
results of a recent experimental study suggested that peak expiratory flow 
decrements from S 0 2 (0.10 & 0.25 ppm) challenges for two times ten minutes after 
45 minutes of ozone exposure (240 ug/m 3) were significantly less during the vitamin 
regimen (500 mg vitamin C and 400 mg vitamin E) compared to the placebo regimen 
in exercising subjects (n=6) with severe asthma 3 Z . Recently, an experimental study 
3 3 supplemented healthy non-smoking subjects daily with vitamin C (250 mg), a-
tocopherol (100 mg) and vegetable cocktail. After two weeks, the subjects were 
exposed to 800 ug/m 3 (0.4 ppm) for two hours with moderate exercise. Preliminary 
results suggest that the lung function decrements were lower in the antioxidant group 
compared to the placebo group. However, there was no change in the inflammatory 
endpoints between the groups 3 3 . In the summer of 1994, we performed a pilot study 
with a similar design as in the present study among cyclists (n=26) in the 
Netherlands. Half of the subjects were supplemented with a daily cocktail of vitamin 
C (650 mg), vitamin E (75 mg), and beta-carotene (15 mg) for 3 months; the control 
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group did not receive a placebo. Post-exercise lung function was related to 8-hour 
mean ozone concentrations which were slightly higher (101 ug/m 3 ) compared to this 
study; the weighted mean regression coefficients were more negative in the control 
group and less negative in the vitamin group compared to the present study 8 0 . 
Street workers (n=49) in Mexico-city received a similar cocktail as the cyclists of 
1994 in a placebo-controlled study 3 1 . Although the street workers were not 
exercising heavily, the mean one-hour maximum ozone concentration was higher 
(110 ppb, equivalent to 163 ug/m 3 for conditions in Mexico City) and the results 
suggest a beneficial effect of the antioxidants on FEVi , FVC and MMEF. 
In the present study, a supplementation of vitamins C and E might protect a 
decrement in lung function of about two percent for FEVi and 1.5 percent for FVC if 
there was a difference in exposure to ozone of 100 ug/m 3 in the group of good 
compliers. This percentage of protection is about equal to the effect of ozone in the 
control group and might be classified as a mild response to ozone, in particular, in 
this group of healthy subjects 1 . 
In summary, the present study suggests that supplementation of the antioxidant 
vitamins C and E protects partly against the acute effects of low levels of ozone on 
FEVi and FVC in cyclists. 
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CHAPTER 4 
Modulation of the acute respiratory effects of 
winter air pollution by serum and dietary 
antioxidants: a panel study 
Abstract 
Background We investigated whether a high dietary intake or serum concentration of 
antioxidant (pro-) vitamins could attenuate the acute respiratory effects of air pollution in 
panels of 50-70 year old adults (n=227) with chronic respiratory symptoms in the winters of 
1993/1994 and 1994/1995. 
Methods Subjects performed daily peak expiratory flow (PEF) measurements in the morning 
and evening and reported the occurrence of respiratory symptoms in two regions (urban and 
non-urban) each winter. Logistic regression analysis was used with the prevalences of large 
PEF decrements (more than 10% or 20% below the subject-specific median) or respiratory 
symptoms as dependent variables. Analyses were performed separately for subjects below 
and above the median levels of dietary vitamin C and B-carotene and serum B-carotene. 
Results Subjects with low levels of serum B-carotene (<0.30 u.mol/1) had more often large 
PEF decrements when particles <10 u.m in diameter or black smoke levels were high 
compared to subjects with high levels of serum B-carotene. No relation was found with 
dietary vitamin C or B-carotene. 
Conclusions The results suggest that serum B-carotene was able to attenuate respiratory 
effects of air pollution in a panel with chronic respiratory symptoms. Dietary vitamin C and (3-
carotene did not modify the acute respiratory effects of winter air pollution. 
Submitted for publication as: 
Linda Grievink, Saskia C. van der Zee, Gerard Hoek, H. Marike Boezen, Pieter van t Veer, Bert 
Brunekreef. Modulation of the acute respiratory effects of winter air pollution by serum and dietary 
antioxidants: a panel study. 
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Introduction 
The acute effects of air pollution on peak expiratory flow (PEF) and respiratory 
symptoms have been investigated in several panel studies. Some of these studies 
were performed on children 3 ' 5 , 6 and others on adults with chronic respiratory 
symptoms 4 ' 8 1 - 8 2 . The findings of these studies are consistent with an adverse effect 
of particular matter with an aerodynamic diameter less than 10 u.m (PM10) and 
ozone on lung function and respiratory symptoms. 
A possible beneficial effect of antioxidant supplements has been suggested in 
two small experiments investigating the acute effects of winter air pollution on 
respiratory health in policemen directing traffic in a city during the winter (the 
concentrations of air pollutants were unknown) 1 1 . A single supplement of vitamin C 
prevented a decrease in lung function ( M E F 5 0 ) and an increase in airway 
responsiveness to histamine after two hours of traffic directing. The other experiment 
suggested that a vitamin C supplement for four consecutive days on each morning 
before work attenuated a decrease in PEF during the workday that was presumably 
due to air pollution 1 1 . Modulation of the acute effects of N 0 2 by supplemental 
antioxidants was observed in two experimental studies. Three hour of exposure to 
7,520 u.g/m3 N 0 2 showed lower levels of lipid peroxidation products in the lung 
lavage fluid in the group supplemented with vitamins C and E 3 0 . One hour of 
exposure to 3,760 u.g/m3 N 0 2 showed a reduction of airway responsiveness to 
metacholine in the group with vitamin C supplements 1 Z . Most of the evidence of a 
possible beneficial effect of antioxidants comes, however, from studies investigating 
ozone in relation to lung function 1 0 3 1 . 3 2 . 8 0 8 3 . All of these studies evaluated the effect 
of extra supplemental antioxidants above the normal dietary intake. 
Within the framework of a larger panel study on the acute effects of winter air 
pollution on respiratory health of 50-70 years old adults (results will be published 
elsewhere), we investigated whether dietary or serum antioxidant (pro)-vitamins 
were associated with the acute respiratory effects of winter air pollution. In this panel 
study, acute effects of winter air pollution were only observed in the panels of adults 
with chronic respiratory symptoms and we restricted our investigation on antioxidants 
to these panels. 
Methods 
Study design 
The present study was designed within the framework of a large investigation on the 
relation between exposure to winter air pollution (3 subsequent winters) and acute 
respiratory health in selected panels of children and adults with and without chronic 
respiratory symptoms in urban and non-urban control areas in the Netherlands. The 
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results of this investigation will be published elsewhere. The data for the present 
study were collected during two consecutive winters from November to February 
starting in 1993/1994 with four panels during each winter: adults with and without 
chronic respiratory symptoms from an urban area and a non-urban control area. As 
mentioned, the current investigation of modulation by antioxidants is restricted to the 
panels of adults with chronic respiratory symptoms because we found only in these 
panels acute respiratory effects of air pollution. The urban area in both winters was 
Amsterdam, the Netherlands with about 720,000 inhabitants. The control areas 
(Meppel in 93/94, Nunspeet in 94/95) were small towns with about 25,000 to 32,000 
inhabitants. The participants performed daily measurements of peak flow (PEF) and 
completed symptom diaries. Air pollution was monitored daily at fixed sites in each 
area. At the beginning of the study period, subjects underwent a medical 
characterisation which included measurements of lung function, bronchial 
responsiveness, allergen skin prick testing and blood sampling for determination of 
the concentrations of serum total IgE and the antioxidants a-tocopherol and p-
carotene. In addition, participants filled out a semi-quantitative food frequency 
questionnaire and a general questionnaire. This general questionnaire provided 
additional information about chronic respiratory symptoms, medication use, family 
history of asthma and allergies, occupation, demographic, life-style and 
environmental factors. 
Study population 
Subjects were approached by mail and invited to participate in the study. Names and 
addresses from subjects, aged 50-70 years, were obtained by a random sample of 
the municipal registration. Subjects with chronic respiratory symptoms in each area 
were selected with a screening questionnaire, which consisted of selected questions 
of chronic respiratory symptoms (chronic cough, chronic phlegm, productive cough, 
wheeze with shortness of breath and without having a cold or flu, shortness of 
breath) from the Dutch part of the European Community Respiratory Health Survey 
M . In the second winter, two exclusion criteria were added: use of beta-blockers 
(contra-indication for bronchoprovocation test) and work outside of the hometown. 
Only subjects who signed an informed consent were included in the study. In the first 
winter, the planned panel size of subjects with chronic respiratory symptoms was 75 
subjects in each of the urban and non-urban control area resulting in a total of 150 
subjects. In the second winter, the planned panel size was 60 subjects in the panel 
with chronic respiratory symptoms resulting in a total of 120 subjects for the analysis. 
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Data collection 
During the study period, peak flow measurements were performed twice a day 
before breakfast in the morning and before going to bed for three months using Mini 
Wright peak flow meters. The participants were instructed to perform these tests 
before taking medication. Each measurement consisted of three manoeuvres and 
the readings were reported in a diary. 
The diary was also used for reporting the occurrence of acute respiratory 
symptoms and medication use. Symptoms included in the diary were the following: 
cough, phlegm, runny/stuffed nose, woken up with breathing problems, shortness of 
breath, wheeze, attacks of shortness of breath with wheeze, fever, eye irritation and 
sore throat. Subjects had to indicate whether the symptom was absent, slight to 
moderate, or severe. Medication use was assessed by reporting a maximum of three 
names of the medication and the number of units taken. 
Daily measurements of 24-hour average concentrations of particulate matter 
with an aerodynamic diameter less than 10 urn (PM10) and black smoke were 
measured in both winters in urban and control area from 3pm to 3pm. Detailed 
methods are published elsewhere 8 5 . In Amsterdam (urban area), S 0 2 and N 0 2 
concentrations were obtained in both winters from continuous monitors of the 
municipal research agency for the environment and soil mechanics (OMEGAM). For 
the control areas, the concentrations of N 0 2 and S 0 2 were obtained from sites close 
by the study areas (that is, Barsbeek in the first winter and Witteveen in the second 
winter) both being part of the National Air Quality Monitoring Network. 
The intake of the antioxidant vitamins C, E, and B-carotene was measured 
with a semi-quantitative food frequency questionnaire. This questionnaire was 
developed and validated to quantify, in particular, energy and antioxidant intake 8 6 ' 8 7 . 
The structure of this food frequency questionnaire did not allow calculation of the 
nutrient contribution of vitamin supplements, such as vitamins C, E, A and 
multivitamins. 
Blood specimens were stored in the refrigerator (4 °C) until centrifugation at 
the end of the day to obtain serum samples. Aliquots of serum were stored at - 8 0 °C 
until analysis. From each subject, concentrations of a-tocopherol and B-carotene 
were measured simultaneously by reverse-phase high performance liquid 
chromatography (HPLC) in one run at Wageningen Agricultural University in the 
Netherlands. The method was modified as described by Hess and co-workers 7 5 . 
Duplicate samples (n=52) were measured to calculate the coefficient of variation of 
the HPLC-measurementfor B-carotene (10.9%) and for a-tocopherol (3.0%). 
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Data analysis 
Subjects were included in the analysis if they had performed PEF measurements 
and filled out the diary for respiratory symptoms in at least 6 0 % of the total study 
period. In addition, the first two days of each subject were excluded from analysis 
because of a possible learning effect on the PEF measurements. 
Before the analysis, the antioxidant variables were divided in high and low 
levels with a cut-off point at the median of intake or serum concentration of the 
antioxidants. Dietary intake of antioxidants was standardised to energy intake before 
calculating the median. To reduce misclassification of the dietary antioxidant intake, 
subjects who reported daily use of supplements of vitamins C, and A were classified 
in the highest category, that is above the median of dietary antioxidant intake. 
Subjects who used multivitamins were classified in the highest category of the 
dietary antioxidants. 
Each of the four panels was divided into subgroups of high and low 
antioxidant levels. Within these subgroups, the prevalences of respiratory symptoms, 
bronchodilator use and PEF decrements of more than 10% or more than 2 0 % below 
the subject-specific median for the morning and evening were calculated; the method 
for calculation of these prevalences of large PEF decrements has been published in 
detail elsewhere 8 8 . Next, the relations between these prevalences and the different 
air pollutants were calculated with logistic regression analysis 8 9 , 9 ° . The prevalences 
of the PEF decrements, respiratory symptoms or bronchodilater were used as 
dependent variables. The following respiratory symptoms were considered: cough, 
phlegm, lower respiratory symptoms (LRS) and upper respiratory symptoms (URS). 
LRS were defined as the presence of the following symptoms on a day: wheeze, 
shortness of breath, and/or attacks of shortness of breath with wheeze; URS: 
stuffed/runny nose and/or sore throat. Air pollutant concentrations (PM10, black 
smoke, N 0 2 , S 0 2 ) of the same day (lag 0), the previous day (lag 1), the day before 
yesterday (lag 2), and a five-day moving average (mean 5) were used separately as 
independent variables in the logistic regression models. In each model the following 
adjustments were applied with panel-specific parameter estimates: the minimum 
temperature, day of the week (weekend or holiday versus weekday), a time trend 
with the day of the study (number of the day since the start of the study) and a 
squared and cubic term for the day of the study, mean influenza incidence of the last 
six days and the mean influenza incidence between day seven to day 13 prior to the 
reporting date. Data on influenza morbidity were obtained from the Netherlands 
Institute of Primary Health Care (NIVEL). This institute is running a registration 
network of 46 sentinel general practices (GP) covering about 1 % of the Dutch 
population. Since the prevalence of PEF decrements, symptoms and medication use 
was correlated with the prevalence of the previous day, an adjustment for auto-
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correlation was used in the regression models by specifying a first order 
autoregressive model for the residuals 8 9 . 
Finally, meta analysis techniques were used to obtain a combined effect 
estimate for a high versus a low antioxidant intake or serum level from the panel 
specific effect estimates. A statistical test of the homogeneity of the panel specific 
effect estimates was conducted using a chi-square test. Homogeneity was assumed 
if the p-value was greater or equal than 0.25 (conservative cut-off point) and the 
combined effect estimate was then calculated as a weighted average using the 
inverse of the variance of the panel specific regression slopes as the weights. In 
case of heterogeneity (p<0.25) the combined effect estimates were calculated using 
random effect estimation with the non-iterative method with unequal weights 9 1 . The 
results are presented as Odds Ratios (ORs) with 9 5 % confidence intervals for an 
increase in PM10 of 100 u.g/m3 and for an increase in black smoke, SO2 and N 0 2 of 
40 u.g/m3. 
Results 
In the winter of 1993/1994, 168 subjects with chronic respiratory symptoms started 
the study. Of these, 46 were excluded from the analysis because 35 subjects did not 
have at least 6 0 % of the total PEF measurements, 9 subjects did not provide blood 
samples and 2 subjects did not complete the food frequency questionnaire. In the 
winter of 1994/1995, 128 subjects started the study. Of these, 23 were excluded 
from the analysis because 16 subjects did not have at least 6 0 % of the total PEF 
measurements and 7 subjects did not provide blood samples. So, a total of 227 
subjects were available for analysis. 
Table 1 describes relevant population characteristics and the mean intake and 
serum levels of antioxidants. The mean age of the study population was 60 years 
with an equal number of women and men. About 2 5 % of the subjects used daily 
vitamin supplements. The subjects who were excluded from analysis (n=69) did not 
differ in gender, smoking status, total IgE levels or the use of vitamin supplements 
but they were slightly older (62 years) compared to subjects who were included in 
the analysis. 
Preliminary data analysis showed that age, gender, smoking and IgE levels did not 
confound the relation between antioxidants (serum and dietary) and acute effects of 
air pollution on PEF. In addition, preliminary individual linear regression analysis did 
not show a modulation of the acute effects of winter air pollution on PEF by serum a-
tocopherol or dietary vitamin E. Therefore, the further presentation will focus on 
dietary vitamin C and p-carotene and serum p-carotene. After adjustment for energy 
intake of the dietary antioxidants, the Pearson's correlation coefficients between 
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dietary vitamin C and dietary p-carotene was 0.63 and between dietary vitamin C 
and serum p-carotene 0.18; the correlation coefficient between p-carotene in diet 
and serum was 0 .31 . 
The air pollution concentrations in urban and non-urban areas were described 
in detail in another p a p e r 8 5 . Briefly, the mean PM10 and black smoke 
Table 1: Mean (SD) characteristics and median intake and 
serum levels of antioxidants 
Characteristics Mean (SD) 
n=227 
Age (years) 59.8 (6.3) 
Gender (% women) 50.9 
Smokers inside the house (%) 27.3 
High total IgE (%)+ 18.5 
Vitamin supplement users (%)* 25.1 
Dietary intake Median (range) 
Vitamin C (mg) 119.8(35-384) 
Vitamin E (mg) 13.8(4.0-39.0) 
ß-carotene (mg) 2.0 (0.5-6.1) 
Serum concentrations 
a-tocopherol (nmol/l) 36.0 (3.6-70.6) 
ß-carotene (umol/l) 0.30 (0.00-2.07) 
* High total IgE was defined as a level above 100 kU/l 
* Percentage of subjects who daily used vitamin supplements 
of vitamins A, E and C and/or multivitamins 
concentrations were slightly higher in the urban areas than in the non-urban areas 
and higher in the first winter compared to the second winter. Figure 1 shows the 24-
hour mean concentrations for PM10 and black smoke in the urban area for the first 
winter; figure 2 shows the same for the second winter. 
The overall effect of air pollution on respiratory symptoms and PEF 
decrements for the different panels will be described elsewhere. Briefly, PM10 and 
black smoke concentrations were positively associated with the prevalence of the 
PEF decrements larger than 20%, in particular, the morning PEF. 
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Figure 1: Plot of the 24-hour mean PM10 and Black Smoke (BS) concentrations (ng/m3) in the 
urban area for each day during winter 1993/1994 
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Figure 2: Plot of the 24-hour mean PM10 and Black Smoke (BS) concentrations (/jg/m3) in the 
urban area for each day during winter 1994/1995 
Table 2: Association T between the prevalence of PEF decrements of10 and 20% and PM10 for high and low serum p-carotene concentration 
Low serum p-carotene (<0.30 fimol/l) High serum p-carotene (>0.30 umol/l) 
PEF decrements PEF decrements 
Morning Evening Morning Evening 
Range PEF 10% 20% 10% 20% 10% 20% 10% 20% 
prevalences* 5.4-6.2 0.6-2.5 4.6-6.4 0.3-1.7 5.1-8.3 0.6-2.2 3.0-7.6 0.3-2.2 
LagO 1.41 3.26 1.14 2.56 0.91 0.91 1.09 0.20 
(0.91-2.20) (1.34-7.95) (0.75-1.75) (1.01-6.48) (0.57-1.46) (0.40-2.10) (0.66-1.78) (0.014.58) 
Lag 1 1.62 3.43 1.06 1.81 0.98 0.54 0.91 2.93 
(1.10-2.40) (1.35-8.71) (0.71-1.58) (0.10-32) (0.63-1.52) (0.25-1.21) (0.25-3.31) (0.57-15) 
Lag 2 1.16 0.86 0.95 6.25 0.80 0.63 0.62 0.55 
(0.77-1.77) (0.18-4.10) (0.60-1.49) (0.0-45602) (0.53-1.19) (0.14-2.78) (0.24-1.59) (0.19-1.66) 
Mean 5 2.19 3.30 0.90 1.93 0.75 0.14 0.49 0.77 
(1.14-4.19) (0.40-27.2) (0.50-1.61) (0.27-13.9) (0.36-1.57) (0.03-0.67) (0.064.04) (0.03-23) 
* Presented as Odds Ratios (95% confidence intervals) for an increase in PM10 of 100 ng/m 3 
* Range in the mean PEF prevalences of each panel 
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Table 2 shows the associations between PM10 (increase of 100 u.g/m3) and the 
prevalence of PEF decrements larger than 10% or 2 0 % in the morning and evening 
for subjects with high and low levels of serum p-carotene. The prevalences of PEF 
decrements of more than 2 0 % were in most panels lower than 2 % . Subjects with a 
low level of serum p-carotene had mostly odds ratios (ORs) above one, in particular, 
for the morning PEF decrements. Subjects with a high level of serum p-carotene, 
however, had mostly ORs which were not different from one. Table 3 shows that the 
effect of PM10 of the previous day on upper and lower respiratory symptoms or 
medication use was not different between subjects with high and low levels of serum 
P-carotene. The results were similar for different lags of PM10. In addition, the effect 
of PM10 on cough and phlegm was not different for a high versus a low serum p-
carotene concentration. 
Table 3: Association f between the prevalence of respiratory symptoms or medication use and air 
pollution of the previous day for a high and a low serum ß-carotene concentration 
Air pollutant Low serum ß-carotene (<0.30 umol/l) High serum ß-carotene (£0.30 umol/l) 
LRS URS 
Prevalences* 
medication 
use 
LRS URS 
Prevalences* 
medication 
use 
16.2-34.8 25.5-36.8 4.5-18.4 15.3-20.2 19.3-42.0 7.1-16.6 
PM10 1.04 1.10 1.01 1.07 1.13 1.03 
(0.92-1.18) (0.95-1.27) (0.86-1.18) (0.91-1.26) (0.97-1.31) (0.92-1.16) 
Black smoke 1.10 1.17 0.98 0.93 1.16 1.06 
(0.97-1.25) (1.02-1.34) (0.78-1.24) (0.71-1.22) (1.01-1.33) (0.94-1.19) 
* Presented as an Odds Ratios (95% confidence intervals) for an increase in PM10 of 100 ng/m3 and in black 
smoke of 40 ng/m 3 
* Range in mean prevalences of each panel for upper respiratory symptoms (URS), lower respiratory symptoms 
(LRS) and medication use 
Table 4 shows the associations between black smoke (increase of 40 u.g/m3) and the 
prevalence of PEF decrements larger than 1 0 % or 2 0 % in the morning and evening 
for the groups with a high and low level of serum p-carotene. Subjects with a low 
level of serum p-carotene had mostly ORs above one, in particular, for a black 
smoke concentration of the same day, the previous day or a 5-day mean. Subjects 
with a high level of serum p-carotene had mostly ORs that did not differ from zero. 
Table 4: Association f between the prevalence of PEF decrements of 10 and 20% and black smoke for high and low serum ß-carotene concentration 
Low serum ß-carotene (<0.30 nmol/ High serum ß-carotene (>0.30 nmol/l) 
PEF decrements PEF decrements 
Morning Evening Morning Evening 
Range PEF 10% 20% 10% 20% 10% 20% 10% 20% 
prevalences* 5.4-6.2 0.6-2.5 4.6-6.4 0.3-1.7 5.1-8.3 0.6-2.2 3.0-7.6 0.3-2.2 
Lag 0 1.80 5.69 1.04 3.92 1.09 1.01 0.90 0.76 
(1.14-2.82) (2.49-13.0) (0.70-1.56) (1.67-9.20) (0.72-1.66) (0.52-1.97) (0.48-1.72) (0.28-2.04) 
Lag 1 1.67 2.72 1.55 1.63 1.00 0.37 0.83 0.0 
(1.15-2.43) (1.36-5.45) (0.71-3.38) (0.0-1084) (0.69-1.43) (0.09-1.47) (0.48-1.45) (0.0-5*106) 
Lag 2 1.14 0.68 0.86 0.18 0.88 0.22 0.86 0.09 
(0.78-1.65) (0.03-17.3) (0.63-1.19) (0.07-0.47) (0.62-1.23) (0.02-3.04) (0.36-2.08) (0.00-14.1) 
Mean 5 3.90 31.5 1.05 35.1 0.76 0.76 0.30 0.12 
(2.07-7.36) (0.23-4214) (0.62-1.76) (5.96-206) (0.32-1.81) (0.25-2.35) (0.04-2.25) (0.02-0.79) 
* Presented as Odds Ratios (95% confidence intervals) for an increase in black smoke of 40 ng/m 3 
* Range in the mean PEF prevalences of each panel 
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Table 3 shows that the effect of black smoke of the previous day on upper and lower 
respiratory symptoms or medication use was not different between subjects with high 
and low levels of serum p-carotene. The results were similar for different lags of 
black smoke. In addition, the effect of black smoke on cough and phlegm was not 
different for a high versus a low serum p-carotene concentration. 
The effect of N 0 2 and S 0 2 on large PEF decrements was slightly higher in the 
group with low serum p-carotene levels compared to the group of subjects with high 
serum p-carotene levels (results not shown). 
The associations among PM10 of the previous day, 10% PEF decrements in 
the morning, lower respiratory symptoms and upper respiratory symptoms were not 
different for subjects with a low versus a high intake of vitamin C or p-carotene (table 
5). The results were similar for different lags of PM10 en for black smoke, N 0 2 and 
S 0 2 . 
Table 5: Association f between the prevalence of 10% morning PEF decrement, lower respiratory 
symptoms (LRS), upper respiratory symptoms (URS) and PM10 levels of the previous day (lag 1) for 
high and low intake of dietary antioxidants 
Low intake of antioxidants High intake of antioxidants 
Dietary 10% PEF LRS URS 10% PEF LRS URS 
Vitamin C 1.11 1.02 1.18 0.91 1.12 1.13 
(0.79-1.56) (0.88-1.19) (1.00-1.39) (0.60-1.37) (0.97-1.30) (0.99-1.30) 
ß-Carotene 1.49 1.04 1.08 0.76 1.09 1.20 
(0.87-2.55) (0.90-1.21) (0.88-1.32) (0.44-1.29) (0.95-1.25) (0.99-1.46) 
Presented as Odds Ratios (95% confidence intervals) for an increase in PM10 of 100 p.g/m3 
Discussion 
This study shows that subjects with chronic respiratory symptoms and with low 
serum p-carotene levels were more likely to be affected by air pollution than those 
with high serum p-carotene levels were. This effect was most pronounced for the 
effect of particulate matter (PM10 or black smoke) on the prevalence of large PEF 
decrements. There was no difference in air pollution effects between high and low 
intake of vitamin C and p-carotene. 
The results showed that the 9 5 % confidence intervals were very wide for the 
ORs of air pollution on PEF decrements of more than 20%. These wide confidence 
intervals occurred because the prevalences of PEF decrements of more than 2 0 % 
was small in each of the antioxidant groups within panels, often with a mean of less 
than 1%> and a median of 0%. 
Misclassification of the dietary antioxidants is a possible explanation for not 
finding a modifying effect of dietary antioxidants on the acute respiratory effects of air 
pollution. First because of measurement errors occur when the antioxidant vitamins 
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were calculated from the food frequency questionnaires 9 2 . Second because about 
2 5 % of the subjects used daily vitamin supplements. The nutrient contribution of 
these supplements could not be added to the intake of dietary antioxidants due to 
the structure of the food frequency questionnaire. To reduce the misclassification, we 
classified subjects with a daily use of vitamin supplements in the group of subjects 
with an intake above the median. So possibly due to the remaining misclassification, 
a modifying effect of dietary antioxidants would be biased towards the null. 
Whether acute effects of air pollution are modulated by antioxidants can only 
be detected if the range in exposure to antioxidants is sufficient large in the 
population under study. In our study population, the range in dietary antioxidants was 
less then two between the 2 5 t h to 7 5 t h percentile. Dietary vitamin C had a range from 
88 mg to 169 mg and dietary p-carotene had a range of 1.52 to 2.69 mg. These 
dietary ranges were relatively small compared to the range in serum p-carotene 
which was about 2.5 between the 2 5 t h (0.20 u.moI/1) and 7 5 t h percentile (0.48 u.mol/1) 
of serum p-carotene So, a more clear effect of dietary antioxidants might have 
occurred if the range in dietary antioxidants was larger in this study population. 
Selection bias in the relation between air pollution and PEF is not very likely 
because in a panel study each subject is his/her own control in the exposure of air 
pollution. However, some selection could have occurred, since, more health 
conscious subjects were participating in the present study. This was observed 
because of the relatively high percentage of daily supplement users (25%). In a 
random sample of Dutch adults aged 20-59 years measured in 1994 and 1995, the 
percentage of daily supplement use (measured with the same questionnaire) was 
less than 1 0 % 9 3 . Although our study population was slightly older (50-70 years), the 
number of supplement users in these older subjects was not different in the Dutch 
national Food consumption Survey in 1987-1988 compared to other adult age 
groups 9 4 . If subjects would take supplements because of experienced adverse 
health effects of air pollution, a bias towards a positive rather than a negative relation 
between antioxidants and acute respiratory effect of air pollution could occur. Since 
we did not find an effect of dietary antioxidants, the use of supplements was 
probably not associated with the experienced acute effects of air pollution. 
Serum levels of p-carotene could be a better marker for antioxidant exposure 
in the lung tissue than the intake of p-carotene. This was confirmed in a small (n=21) 
study in which p-carotene was measured in lung tissues, serum, and in diet with a 
food frequency questionnaire 4 6 . The questionnaire was designed to measure both 
dietary and supplemental p-carotene. The Pearson's correlation coefficient between 
serum concentration of p-carotene and lung tissue (r=0.72) was higher than the 
correlations between dietary intake of p-carotene and p-carotene concentration in the 
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lung tissue (r=0.54). So the finding4hat we did find a modifying effect of serum B-
carotene on acute effects of air pollution but not for dietary B-carotene might be 
because serum levels of B-carotene are better markers of the B-carotene levels in 
the lung. 
To our knowledge, there has only been one other study investigating a 
possible modulation of the acute effect of winter air pollution on PEF but this study 
focused on vitamin C supplements 1 1 . In this cross-over study, subjects were 
policemen (n=20) directing traffic for four consecutive days receiving a vitamin C 
supplement (2 g) or placebo on each morning before work. Peakflow was measured 
at the beginning and at the end of the working day. The results suggest that the PEF 
decreased during working day in control group but not in the vitamin group. It should 
be noted that the levels of air pollution were unknown and that the dose of 
supplemental vitamin C could not be compared to the levels of dietary intake 
because it was 14 times the mean intake and 4 times the maximum intake of vitamin 
C in our study. So our study was the first study investigating dietary intake and 
serum levels of antioxidants in relation to the acute effects of winter air pollution. 
Most other intervention studies under ambient conditions were investigating a 
possible modulation of the acute effect of ozone by antioxidant supplements. Two 
intervention studies were performed among cyclists performing lung function 
measurements before and after exercise in the Netherlands. In the first study in the 
summer of 1994, twelve subjects were supplemented with a daily cocktail of vitamin 
C (650 mg), vitamin E (75 mg), and B-carotene (15 mg) for 10 weeks. The control 
group (n=14) did not receive a placebo. An acute effect of ozone (8-hour mean 101 
ug/m 3 ) was observed in the control group but not in the vitamin group 8 0 . The second 
study in the summer of 1996 was placebo-controlled. Half of the 38 cyclists received 
daily 100 mg vitamin E and 500 mg vitamin C for 15 weeks. Lung function (FEVi and 
FVC) was negatively associated with ozone concentration (8-hour mean 77 ug/m 3) in 
the placebo group but not in the vitamin group 8 3 . Street workers (n=49) in Mexico-
city received the same cocktail as the cyclists of 1994 in the Netherlands in a 
placebo-controlled crossover study 3 1 . Although the street workers were not 
exercising heavily, the mean one-hour maximum ozone concentration was higher 
(110 ppb, equivalent to 163 ug/m 3 for conditions in Mexico City). The results of this 
study suggest that in particular in the first phase of the study the placebo group had 
a significant effect of ozone on FEVi , FVC and MMEF while the supplementation 
group did not show an ozone effect. Since all these studies under ambient conditions 
supplemented their subjects (about 4 times the mean intake of vitamin C and about 7 
times the mean intake of vitamin E and p-carotene), the question remains if the 
possible beneficial effect of antioxidants could be reached by a higher dietary intake 
alone. 
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The postulated mechanism for lung function decrements after ozone exposure 
is a reduction of maximal inspiratory capacity through stimulation of the neural 
receptors in the upper airways. Cyclo-oxygenase products of arachidonic acid 
stimulate these receptors which are released on exposure to ozone 6 7 , 9 5 . Vitamin C 
and E have been shown to affect this arachidonic acid metabolism but the role of 
antioxidants in this mechanism is not fully understood 2 0 , 6 8 . Another hypothesised 
mechanism of the acute effects of air pollution would be an increase in inflammatory 
mediators which was shown in the bronchoalveolar lavage within one hour 7 3 , 7 4 , six 
hours 6 6 , 18 hours 7 3 , 7 4 , and 24 hours 6 6 after ozone exposure. Antioxidants could 
modulate the airway response to air pollution by reducing the influx of inflammatory 
cells 5 6 . Which of the two postulated mechanisms is relevant to the observed 
modulation in our study remains unclear because we did not measure inflammatory 
markers. To our knowledge, the mechanistic action of a possible protective role of B-
carotene in relation to acute respiratory effects of air pollution has not been 
investigated. 
In conclusion, the results of the present study suggest that serum B-carotene 
attenuated the respiratory effects of air pollution, in particular, the prevalence of large 
PEF decrements in relation to PM10 and black smoke in a panel of subjects with 
chronic respiratory symptoms. A higher intake of dietary vitamin C and B-carotene 
was not related to the acute effects of winter air pollution. 
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CHAPTER 5 
Dietary intake of antioxidant (pro-)vitamins, 
respiratory symptoms and pulmonary function: 
the MORGEN study 
Abstract 
Background A study was undertaken to investigate the relations between the intake of the 
antioxidants (pro)-vitamins C, E and B-carotene and the presence of respiratory symptoms 
and lung function. 
Methods Complete data were collected in a cross-sectional study in a random sample of the 
Dutch population on 6,555 adults during 1994 and 1995. Antioxidant intake was assessed by 
a semi-quantitative food frequency questionnaire. Respiratory symptoms (cough, phlegm, 
productive cough, wheeze, shortness of breath) were assessed by a self-administered 
questionnaire. Prevalence odds ratios for symptoms were calculated using logistic 
regression analysis. Linear regression analysis was used for forced expiratory volume in one 
second (FEV,) and forced vital capacity (FVC). The results are presented as a comparison 
between the 90th and the 10th percentiles of antioxidant intake. 
Results Vitamin C intake was not associated with most symptoms but was inversely related 
with cough. Subjects with a high intake of vitamin C had a 53 ml (95%CI: 23-83) higher FEV-, 
and 79 ml (95%CI: 42-116) higher FVC than those with a low vitamin C intake. Vitamin E 
intake showed no association with most symptoms and lung function, but had a positive 
association with productive cough. The intake of B-carotene was not associated with most 
symptoms but had a positive association with wheeze. However, subjects with a high intake 
of p-carotene had a 60 ml (95%CI: 31-89) higher FEV, and 75 ml (95%CI: 40-110) higher 
FVC than those with a low intake of p-carotene. 
Conclusions The results of this study suggest that a high intake of vitamin C or p-carotene is 
protective for FEV, and FVC compared with a low intake, but not for respiratory s ymptoms. 
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Introduction 
Diet is a relatively new area of interest in the field of asthma and chronic obstructive 
pulmonary disease (COPD). Antioxidant vitamins are considered to be potentially 
protective factors in the respiratory system because antioxidants in the lung can 
scavenge endogenous and/or environmental oxidant sources 9 6 " 9 8 . 
A protective effect of fruit consumption has been reported for lung function 
3 6 3 7 and for chronic non-specific lung disease ( C N S L D ) 1 6 . In cross-sectional studies 
a higher intake of vitamin C 1 3 , 4 0 was associated with larger lung volumes; a higher 
plasma concentration of vitamin C was associated with larger lung volumes in adults 
1 4 but not in children 3 7 , and a lower prevalence of wheeze and chronic bronchitis 1 8 , 
suggesting a protective effect of vitamin C on respiratory disease in adults. The 
prospective Zutphen-study did not show an association between the intake of vitamin 
C or p-carotene and the incidence of CNSLD 1 6 . The Nurses Health Study showed 
no association between dietary vitamin C and the incidence of asthma but dietary p-
carotene and vitamin E were inversely related with adult onset asthma 1 7 . In 
summary, no consistent pattern arises from these studies on the relation between 
antioxidant (pro-) vitamin intake and respiratory disease. To our knowledge no 
results on the relation between dietary p-carotene and lung function have been 
published. 
The M O R G E N study (the monitoring project on risk factors and health in the 
Netherlands) provided the opportunity to investigate the relations between the intake 
of the antioxidants (vitamins C, E or p-carotene) and the prevalence of a number of 
respiratory symptoms and lung function simultaneously. 
Methods 
Study population 
The M O R G E N study is a cross sectional investigation of the prevalence of risk 
factors for chronic diseases using self-administered questionnaires and a physical 
examination in a randomly selected sample of the Dutch population aged 20 to 59 
years in three towns in the Netherlands (Amsterdam, Doetinchem and Maastricht). 
The average response rate of the three towns was 50%. A total of 8,695 subjects 
were enrolled in 1994 and 1995 for questionnaires and physical examination. Of 
these, 683 subjects did not perform a lung function measurement for practical 
reasons that operated randomly, such as non-availability of lung function devices, 
time constraints, etc. Of the remaining 8,012 subjects with lung function 
measurements, we excluded pregnant women (n=47), supplement users (n=688) 
and those with missing values on one or more of the confounders (n=722). Thus, the 
population for data analysis consisted of 6,555 individuals. 
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Data collection 
Invitations to participate in the study were sent to a random sample of the population 
by municipal health services. Those subjects who agreed to participate received two 
self-administered questionnaires (general and semi-quantitative food frequency) and 
underwent a physical examination. The general questionnaire provided information 
about demographic variables, life style factors (smoking, physical activity, alcohol 
consumption), environmental factors (presence of pets, dampness of the house, 
indoor N 0 2 sources), chronic respiratory symptoms and the presence of other 
chronic diseases (diabetes, migraine, low back pain, neck and shoulder pain). The 
physical examination included measurements of height, weight, waist-hip 
circumference, blood pressure, and lung function. Blood (non-fasting) samples were 
taken for determination of glucose, total and HDL-cholesterol. 
For the present analyses we defined chronic respiratory symptoms as positive 
answers to the following questions: 'Do you cough when getting up during winter 
time on most days for at least three months a year?' (cough), 'Do you bring up 
phlegm when getting up during winter time on most days for at least three months a 
year?' (phlegm), 'Have you had productive cough for a period of three weeks in the 
last 3 years?' (productive cough), 'Have you been troubled by wheezing, not due to a 
cold or the flu, in the last twelve months?' (wheeze) and 'Are you short of breath 
when walking with other people of your own age on level ground?' (shortness of 
breath). 'Are you being woken by attacks of shortness of breath?' (nocturnal attacks 
of shortness of breath ). These questions on respiratory symptoms were selected 
from the Dutch part of the European Community Respiratory Health Survey 8 4 , 9 9 . 
Lung function was measured with a heated pneumotachometer (Jaeger, 
Germany). Calibration took place twice a day. Measurements were performed by 
trained paramedics. Subjects were seated in an upright posture with a fixed 
mouthpiece which was adjusted for the height of each individual and, in addition, a 
nose clip was used. A maximum of eight manoeuvres was performed. Subjects who 
did not achieve at least three technically acceptable of which two reproducible 
manoeuvres of BTPS corrected forced expiratory volume in one second (FEVi) or 
forced vital capacity (FVC) according to ERS 1993 criteria 7 7 were excluded from 
either the FEVi or FVC analyses, or both. Analyses were based on the maximum 
value of the reproducible manoeuvres of FEV, and FVC. Pregnant women were not 
considered in data analysis because the actual lung function could have been 
attenuated 1 0 ° . 
The food frequency questionnaire was developed for the M O R G E N study 
which is part of the Dutch cohort of the EPIC study (European Prospective 
Investigation into Cancer and Nutr i t ion) 1 0 1 . The purpose of the questionnaire was, in 
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particular, to quantify energy and antioxidant intake 8 . The habitual consumption 
of 178 food items during the last year was calculated from the questionnaire. Nutrient 
and energy intake were quantified for each individual using an extended version of 
the 1993 computerised Dutch food composition table 1 0 2 . In 1991 and 1992 the 
reproducibility and relative validity of the food groups and nutrients were assessed in 
a validation study 8 6 , 8 7 . The structure of the food frequency questionnaire did not 
allow a calculation of the nutrient contribution of vitamin supplements. About 9 % of 
the total study population had used daily vitamin supplements in the last 12 months 
(vitamin A, C, E and multivitamins; B-carotene is not a common constituent in any of 
the supplements in the Netherlands). Since this number of subjects was too small to 
be considered in separate analyses they were excluded from the data analysis to 
reduce possible misclassification of nutrient intake. 
Definition of variables 
The subjects were grouped into three categories according to their educational level: 
low (intermediate secondary education or less), intermediate (intermediate 
vocational or higher secondary education) and high (higher vocational or university 
education). Current smokers were defined as those smoking one or more 
cigarette(s) a day. Pack-years of smoking were defined for current and former 
smokers, one pack-year being equal to smoking 20 cigarettes a day for one year. 
Data analysis 
The shape of the relation between each antioxidant and respiratory symptoms or 
lung function was investigated by classifying the antioxidants into quintiles of intake. 
The cut-off points for each quintile were based on the distribution of the intake of 
subjects without any chronic respiratory symptoms. Since no essential deviation from 
linearity was observed, the intake of the antioxidant vitamins C, E and B-carotene 
were entered as continuous independent variables in logistic and linear regression 
models. 
The presence of each respiratory symptom (cough, phlegm, productive 
cough, wheeze or shortness of breath, nocturnal attacks of shortness of breath) was 
used as the dependent variable in logistic regression analyses 6 0 . The independent 
variable of interest was the intake of antioxidants as a continuous variable. 
Prevalence Odds Ratios (ORs) with 9 5 % confidence intervals (95% CI) were 
estimated using logistic regression analysis; ORs were presented as a comparison 
of the antioxidant intake in the 90th and 10th percentiles. 
Models for FEVi and FVC were fitted with multiple linear regression 6 0 . To 
select a basic model for FEVi and FVC, taking account of gender, height and age, 
we considered several models using different powers of height and age. The choice 
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of the "best" model was based on assessment of model simplicity, analysis of 
residuals and the percentage of variance in FEVi and FVC explained by the model. 
W e chose the following basic adjusted model: FEVi and FVC divided by height 
squared as dependent variable with age, age squared and gender as independent 
variables. Regression coefficients (in ml) were calculated for a standard height of 
1.70 meter and were expressed as the difference in FEVi and FVC between 
subjects in the 90th and 10th percentiles of antioxidant intake. 
The following confounding factors were considered as independent variables 
in the model: smoking status, pack years of smoking, educational level, town, energy 
intake (to standardise the intake of the antioxidants), body mass index (weight in kg 
divided by height in metres squared), alcohol consumption, physical activity (yes/no), 
the other two antioxidant (pro-)vitamins, medical treatment for hay fever (yes/no), 
and environmental factors such as the presence of pets (never/not 
anymore/currently present), dampness of the house by questions on the presence of 
damp or mould spots on the walls of homes during the last two years, gas cooking 
(yes/no), and presence of an unvented (gas-fired) water heater (yes/no) (as 
predominant indoor N 0 2 source in homes). In the final models the following variables 
were adjusted for: age, gender, energy intake, smoking status and pack years of 
smoking. Adjustment for educational level was considered to be an over-adjustment 
in the relation between antioxidants and lung function or respiratory symptoms so we 
did not adjust for educational level. W e were not able to perform statistical evaluation 
of the presence of effect modification of smoking status on the relation between 
antioxidants and lung function or respiratory symptoms because of the small 
numbers in each group. In addition, we could not study the independent effect of the 
intake of vitamin C and B-carotene adjusting for each other because these two 
antioxidants are present in the same food groups, such as fruits and vegetables 
resulting in a relatively high Spearman correlation coefficient (r=0.60). 
Results 
Of the 6,555 subjects available for analyses, 6,103 had at least three technically 
acceptable lung function manoeuvres of whom 5,740 subjects had reproducible 
measurements for FEV! and 5,633 subjects for FVC. 
Table 1 shows the characteristics of the total study population for subjects 
with and without reproducible FEVi measurements. W e note that the subjects 
without reproducible FEVt measurements consisted of those who could not perform 
three technically acceptable measurements (n=452) plus subjects who met 
acceptability criteria but not the reproducibility criteria (n=363). The characteristics 
for subjects with and without reproducible FVC measurements were similar to those 
62 Chapter 5 
subjects with and without reproducible FENA measurements, therefore we only 
present the latter. 
Table 1: Mean (SD) characteristics for total population (N=6,555) and for subjects with and without 
technically acceptable and reproducible measurements ofFEV1 
Characteristics Total population Reproducible Non-reproducible FENA * 
(N=6,555) FEV, (N=5,740) (N=815) 
Age (yr.) 42.1 (11.0) 41.7 (10.9) 44.7 (10.9) 
Height (m) 1.72 (0.094) 1.72(0.093) 1.69 (0.097) 
Gender (% women) 52.3 51.9 55.6 
Smoking status (%) 
Current smokers 32.4 32.7 30.6 
Former smokers 31.2 31.6 28.5 
Never smokers 36.3 35.7 41.0 
* 
Pack-years 17.4(15.4) 17.2(15.1) 18.8 (16.9) 
Educational level (%) 
Low 48.2 46.2 62.7 
Intermediate 29.3 30.3 21.6 
High 22.5 23.5 15.7 
BMI (kg/m2) 25.4 (3.9) 25.3 (3.9) 26.2 (4.3) 
Physical Activity (%) 64.5 65.8 55.4 
Alcohol use (%yes) 60.9 62.2 51.4 
Respiratory symptoms * {%) 32.7 32.1 36.5 
excluding those subjects who never smoked 
* one or more of the following respiratory symptoms: cough, phlegm, productive cough, wheeze, shortness of 
breath, nocturnal attacks of shortness of breath, ever asthma 
* including those subjects who were not able to perform at least three lung function manoeuvres (n=452) 
For the total population, the mean age was 42 years; approximately one third of the 
study population were current smokers and about half had a low educational level. 
Subjects without reproducible FENA measurements were older, had a lower 
educational level and were less physically active but included more never smokers 
and less alcohol consumers. Table 2 shows that the mean energy and nutrient intake 
was not different in subjects with or without reproducible FEVi measurements; the 
same was observed for non-reproducible versus reproducible FVC measurements 
(results not shown). 
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Table 2: Mean (SD) energy and nutrient intake per day of nutrients for the total population (N=6,555) 
and for subjects with and without technically acceptable and reproducible measurements ofFEV1 
Total Reproducible FEV, Non-reproducible FEV, 
(n=6,555) (n=5,740) (n=815) 
Nutrients Mean (SD) Mean (SD) Mean (SD) 
Energy (MJ) 9.8 (2.9) 9.8 (2.9) 9.7 (3.1) 
Protein (en%) 15.3 (2.3) 15.3 (2.3) 15.3(2.6) 
Fat (en%) * 35.7 (5.2) 35.7 (5.2) 35.6 (5.4) 
Carbohydrates (en%) 45.2 (6.4) ' 45.1 (6.4) 45.6 (6.7) 
Alcohol (en%) * 3.6 (4.6) 3.6 (4.6) 3.2 (4.9) 
Vitamin C (mg) 132.6 (61.7) 132.6 (61.7) 132.5(62.1) 
Vitamin E (mg) 16.3 (6.0) 16.3 (5.9) 16.1 (6.2) 
ß-Carotene (mg) 2.33 (1.11) 2.34(1.10) 2.28 (1.15) 
protein, fat, carbohydrates and alcohol are expressed as a percentage of energy intake 
f including those subjects who were not able to perform at least three lung function manoeuvres (n=452) 
Possible confounding factors, such as gender, smoking status and educational level 
were evaluated. The intake of antioxidants was found to be related to these factors. 
Women had a higher intake of vitamin C and p-carotene but a lower intake of vitamin 
E than men, and current smokers had a lower intake of vitamin C and p-carotene but 
a higher intake of vitamin E than never smokers. The mean intake of the antioxidants 
was highest in the highest educational level. The dependent variables (respiratory 
symptoms, FEVi and FVC) were also related to these factors. The prevalence of the 
respiratory symptoms was higher and the mean FEVi and FVC was lower in current 
smokers than never smokers. Lung function was also associated with educational 
level, with those in the high education category having a better lung function. 
However, the prevalence of respiratory symptoms was not consistently different 
between educational levels. 
The unadjusted prevalence of respiratory symptoms for each quintile of 
antioxidant intake and the unadjusted and adjusted mean of FEVi and FVC for each 
quintile of antioxidant intake is presented in table 3. There is no deviation from 
linearity. 
Table 3: Prevalence of respiratory symptoms (%) and mean FVC (L) and FEV1 (L) by quintiles of antioxidants 
Quintiles1' of vitamin C intake Quintiles1, of vitamin E intake Quintiles1, of p-carotene intake 
1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 
Number of subjects 1392 1314 1249 1263 1335 1247 1333 1249 1330 1396 1319 1283 1295 1262 1396 
Cough {%) 10.2 7.0 6.4 4.7 5.3 6.3 7.1 6.4 6.0 8.0 7.8 6.9 7.1 5.6 6.3 
Phlegm (%) 7.9 6.1 6.8 5.0 4.8 5.0 6.5 5.7 6.3 7.0 6.8 6.9 5.4 4.8 6.8 
Prod. Cough (%) 17.3 17.6 16.0 16.9 19.1 14.1 16.3 17.2 18.6 20.5 16.6 15.2 17.5 17.0 20.4 
Wheeze (%) 10.8 7.7 7.8 6.7 8.8 9.0 8.9 7.7 7.1 9.2 8.0 9.3 7.1 7.6 9.9 
SOB (%) 9.0 4.4 5.7 3.4 5.9 7.6 5.8 4.5 5.2 5.5 6.7 6.3 4.9 5.5 5.2 
Noct. Attacks SOB (%) 6.0 5.5 4.7 4.9 5.6 5.8 6.5 4.3 4.2 6.0 5.1 5.9 4.7 4.7 6.5 
Number of subjects 1199 1170 1103 1114 1154 1069 1164 1117 1168 1222 1131 1118 1141 1111 1239 
FEVi (L), unadjusted 3.50 3.63 3.58 3.65 3.62 3.29 3.48 3.60 3.72 3.84 3.44 3.53 3.62 6.50 3.72 
FEV, (L), adjusted * 3.38 3.50 3.47 3.52 3.52 3.43 3.48 3.48 3.50 3.48 3.41 3.44 3.49 3.51 3.53 
Number of subjects 1191 1150 1072 1080 1140 1051 1143 1100 1141 1198 1116 1105 1124 1080 1208 
FVC (L), unadjusted 4.48 4.60 4.56 4.64 4.56 4.20 4.40 4.55 4.76 4.89 4.41 4.50 4.62 4.64 4.68 
FVC (L), adjusted * 4.29 4.42 4.41 4.47 4.47 4.34 4.41 4.40 4.45 4.44 4.33 4.36 4.44 4.45 4.46 
SOB = shortness of breath 
mean FEVi and FVC adjusted for age, age squared and gender, presented for a height of 1.70 m 
1 the cut-off points for each quintile were based on the distribution of the intake of subjects without any chronic respiratory symptoms 
Table 4: The relation between antioxidants (vitamin C, vitamin E, and p-carotene) and respiratory symptoms or lung function (N=6,555) 
Vitamin C Vitamin E p-carotene 
Dependent variable 
OR* OR* 95% CI * OR* OR* 95% CI * OR* OR* 95% CI * 
Respiratory symptoms 
Cough (n=6533) 0.53 0.66 0.50 to 0.87 1.28 0.85 0.61 to 1.18 0.79 0.86 0.67 to 1.10 
Phlegm (n=6541) 0.67 0.77 0.59 to 1.02 1.32 1.06 0.76 to 1.47 1.04 1.11 0.87 to 1.40 
Prod. Cough (n=6536) 1.08 1.09 0.93 to 1.28 1.47 1.26 1.02 to 1.56 1.20 1.14 0.99 to 1.33 
Wheeze (n=6514) 0.87 1.04 0.83 to 1.30 1.18 1.13 0.85 to 1.52 1.15 1.27 1.04 to 1.55 
SOB (n=6494) 0.75 0.81 0.61 to 1.07 0.88 1.24 0.87 to 1.77 0.87 1.00 0.77 to 1.29 
Noct. Attacks SOB (n=6539) 0.90 0.95 0.72 to 1.25 1.10 1.20 0.84 to 1.71 1.16 1.22 0.96 to 1.56 
Lung function Diff* Diff 5 95% CI s Diff* Diff § 95% CI § Diff* Diff 5 95% CI § 
FEV, (n=5740) 91.1 52.9 23.0 to 82.3 33.0 27.9 -12.9 to 68.7 83.2 60.0 31.4 to 88.6 
FVC (n=5633) 117.8 79.0 42.3 to115.7 66.3 18.2 -32.2 to 68.6 105.4 75.2 40.2 to110.2 
SOB = shortness of breath 
unadjusted prevalence odds ratios (OR), presented for subjects in the 90 m percentile versus those subjects in the 10m percentile of antioxidant intake - that is, for 
vitamin C intake 144.9 mg, for vitamin E intake 14.4 mg and for p-carotene intake 2.50 mg 
* prevalence odds ratios (with 95% Confidence Interval) adjusted for age, gender, energy intake, smoking status, pack-years of smoking, presented for subjects in the 
90 t h percentile versus those subjects in the 10 t h percentile of antioxidant intake 
* difference in FEVi and FVC (in ml for a standard height of 1.70 m) between subjects in the 90 t h percentile and those in the 10 t h percentile of antioxidant intake adjusted 
for age, age squared, gender 
5 difference in FEVi and FVC (in ml for a standard height of 1.70 m) with 95% Confidence Interval (95% CI) between subjects in the 90 t h percentile and those in the 
10 t h percentile of antioxidant intake adjusted for age, age squared, gender, energy intake, smoking status, pack-years of smoking 
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The results of logistic regression analysis with the intake of antioxidants as a 
continuous variable are presented in table 4. The unadjusted and adjusted ORs for 
respiratory symptoms and the difference for FEVi and FVC represent the 
comparison of subjects in the 9 0 t h percentile with those in the 1 0 t h percentile of 
antioxidant intake. After adjustment for the considered confounding factors, the ORs 
of vitamin C intake with most of the symptoms were around 1. The OR of vitamin C 
with cough was statistically significantly below 1 (OR=0.66; 95% CI: 0.50-0.87). FEVi 
was 53 ml (95% CI: 23 to 82 ml) higher in subjects with a high intake of vitamin C 
than in subjects with a low intake; for FVC the difference was 79 ml (95% CI: 42 to 
116 ml). After adjustment, the ORs of vitamin E intake with symptoms were around 
1, with a significantly increased OR for productive cough (OR=1.26; 9 5 % CI: 1.02-
1.56). Vitamin E intake was not associated with FEV| and FVC. The adjusted ORs of 
the intake of p-carotene with symptoms were mostly around 1 with the exception of a 
significantly increased OR for wheeze (OR=1.27; 9 5 % CI: 1.04-1.55). However, 
FEVi was 60 ml (95% CI: 31 to 89 ml) higher in subjects with a high intake of p-
carotene than in subjects with a low intake; for FVC the difference was 75 ml (95% 
CI: 40 to 110 ml). 
The associations between the intake of vitamin C or p-carotene and lung 
function did not change after adjustment for the intake of vitamin E. 
Discussion 
In the present study we observed that a high intake of vitamin C and p-carotene, but 
not vitamin E, was associated with a higher FEVi and FVC than a low intake of these 
antioxidants. No consistent associations were observed with respiratory symptoms. 
This suggests that dietary vitamin C and p-carotene have a protective effect on lung 
function but not on respiratory symptoms. 
Lung function can be considered as a more objective measurement than 
respiratory symptoms. The lack of protective effect of vitamin C and p-carotene on 
respiratory symptoms might be due to reporting bias or due to an altered diet in 
those with respiratory symptoms. Another reason for the lack of agreement between 
the results on lung function and respiratory symptoms could be that the relevant lag 
time for a possible protective effect of antioxidants on lung function differs from that 
for respiratory symptoms. 
Educational level was associated with the intake of antioxidants and with lung 
function but not with respiratory symptoms. This was not observed in other studies 1 3" 
1 5 , 1 8 . However, the present study showed that, after adjustment for educational level, 
the estimated effect between antioxidants and lung function decreased which 
suggest that educational level is a confounding factor. Since subjects in the high 
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educational level are more likely to have a healthy life style which correlates also 
with a higher intake of antioxidants, we considered that educational level would be a 
healthy life style indicator which would lead to over-adjustment of the relation 
between antioxidants and lung function. Other more specific healthy life style factors, 
such as physical activity, alcohol consumption and body mass index, did not 
materially affect the relation between antioxidants and lung function. 
The associations between antioxidant intake and respiratory symptoms or 
lung function may have been biased towards the null due to misclassification of 
exposure. As with most dietary assessment methods, semi-quantitative food 
frequency questionnaires have a tendency to random misclassification. In the 
present study, we used a semi-quantitative food frequency questionnaire with 
correlations similar to those of other validated food frequency questionnaires 8 7 , 1 0 3 " 
1 0 6 . However, the reproducibility and relative validity are often low leading to 
attenuation of the observed associations. 
Subjects who did not meet ERS criteria for technically acceptable and 
reproducible lung function manoeuvres were excluded from the analyses on dietary 
antioxidants and lung function. This raises the question of selection bias. The 
relation between antioxidants and respiratory symptoms was, however, not 
materially different between the total group and in the total group excluding subjects 
who did not meet ERS criteria. Although selection bias can not be totally excluded in 
the relation between antioxidants and lung function, it does not seem very likely in 
this study. 
The results of the present study with respect to the intake of antioxidants and 
respiratory symptoms can only be crudely compared with other studies because 
respiratory symptoms or disease as outcome were not completely comparable. 
W e did not find an association between most symptoms and the intake of 
vitamin C , only cough was significantly negatively associated with vitamin C . In the 
Nurses Health Study 1 7 , dietary vitamin C was not associated with the incidence of 
asthma. NHANES II 1 8 did not show an association between dietary vitamin C and 
wheeze, but dietary vitamin C was associated with the presence of current 
bronchitis. A protective effect of serum vitamin C was observed with wheeze and 
current bronchitis 1 8 . 
W e found that a high intake of vitamin C was associated with a 53 ml higher 
F E V T and 79 ml higher F V C than a low intake. This was consistent with the results of 
other studies investigating the intake of vitamin C 1 3 ' 1 5 4 0 or plasma levels of vitamin 
C 1 4 with lung function. Schwartz and Weiss 4 0 and Britton and co-workers 1 3 showed 
that a higher intake of vitamin C was associated with a higher FEVi ; the size of the 
effect was of the same order of magnitude as in the present study 4 0 . The magnitude 
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of the association between vitamin C and FVC in the study of Britton and co-workers 
1 3 was also comparable to that of the present study. Dow and co-workers 1 5 
investigated the association between the intake of vitamin C with FEVi and FVC. 
After additional adjustment for vitamin E, the associations were of the same order of 
magnitude as in the present and in those of Britton ef a / 1 3 and Schwartz and Weiss 
4 0 , but were not statistically significant possibly because of the small sample size 
(N=178). In summary, these studies suggest a protective effect of vitamin C intake 
on lung function but not on symptoms or disease as outcome. 
The intake of vitamin E was not associated with most of the symptoms or with 
lung function. This is consistent with the study of Britton and co-workers 1 3 which 
showed that the intake of vitamin E was not associated with FEVi or FVC 
independent of the intake of vitamin C. In contrast, Dow and co-workers 1 5 showed 
that the intake of vitamin E was positively associated with lung function independent 
of the intake of vitamin C. Troisi and co-workers observed that a higher intake of 
vitamin E was significantly associated with a lower incidence of asthma 1 7 . Thus, the 
results of these few studies are not consistent. 
The intake of p-carotene was not associated with the prevalence of symptoms 
in the present study. This is consistent with the Nurses Health Study which showed 
no association between the intake of carotene and the incidence of asthma 1 7 . 
However, we observed that the intake of p-carotene was positively associated with 
FEVi and FVC. To our knowledge, no results on dietary p-carotene in relation with 
lung function have been published. The intake of total carotene was not associated 
with FEVi , FVC and the ratio of FEVt/FVC among 10,416 subjects in a cross-
sectional study of Shahar and co-workers 4 2 . They pointed out, however, that the 
different carotenoids may have different effects on lung physiology. Blood levels of p-
carotene were related to lung function in two studies. A high level of p-carotene was 
not associated with airway obstruction (N=83) 4 1 . However, the pilot phase of the 
CARET-study among 816 men exposed to asbestos showed that serum p-carotene 
was positively associated with FEVi and FVC 4 3 . 
In summary, the present study has shown that the intake of vitamin C and p-
carotene has a protective effect on lung function but not on respiratory symptoms. 
The findings on the intake of vitamin C are consistent with those of other studies. 
The intake of vitamin E was not associated with respiratory symptoms or lung 
function which was not completely consistent with the findings of other studies. 
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CHAPTER 6 
Plasma antioxidant (pro-) vitamins in relation to 
respiratory symptoms in non-smokers: 
a case-control study 
Abstract 
Background The aim of this case-control study was to investigate the relations between 
plasma levels of antioxidants, B-carotene and a-tocopherol, and chronic respiratory 
symptoms in a group of Dutch adults (20-59 yrs) who were never or long-term former 
smokers. 
Methods A case-control sample was selected from a population-based cross-sectional study 
and plasma concentrations of antioxidants were determined in 491 cases and 496 controls. 
Cases were subjects who reported one or more respiratory symptoms. Odds ratios (ORs) 
were calculated for the chronic respiratory symptoms using logistic regression analysis and 
are presented for a difference between the 90 t h percentile (high) and the 10 t h percentile (low) 
of plasma antioxidant concentration. ORs were adjusted for age, gender and body mass 
index. 
Results The adjusted OR of plasma B-carotene for respiratory symptoms was below one 
(OR=0.81; 95%CI: 0.63-1.04). The OR of plasma a-tocopherol was slightly elevated for 
respiratory symptoms (OR=1.36; 95% CI 0.98-1.89) but this was mostly because of the 
elevated OR for dyspnea (OR=2.10; 95%CI: 1.28-3.43). Dyspnea is, however, also a 
common symptom in cardiovascular disease. Additional adjustment for cardiovascular risk 
factors did not change the positive association between dyspnea and plasma a-tocopherol. 
Conclusions Cases tended to have lower plasma B-carotene levels than controls. Plasma a-
tocopherol was not associated with asthma and chronic bronchitis symptoms but was 
positively associated with dyspnea. 
Submitted for publication as: 
Linda Grievink, Henriëtte A. Smit, Pieter van 'tVeer, Bert Brunekreef, Daan Kromhout. Plasma 
antioxidant (pro)-vitamins in relation to respiratory symptoms in non-smokers: a case-control study. 
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Introduction 
Antioxidant (pro-)vitamins, such as vitamins C, E and p-carotene, are considered to 
be beneficial for respiratory disease 9 7 , 9 8 because of a possible prevention of lung 
tissue damage by oxidant exposure and/or oxidative processes of inflammation 9 6 . 
So far most studies were on dietary antioxidants measured by questionnaire 
in relation to respiratory disease 1 6 ' 1 7 ' 1 9 ' 9 3 . However, blood concentration of 
antioxidants is an additional marker of the nutritional status 4 8 , 9 6 . This marker is 
probably also closer related to antioxidant concentration in the lung tissue compared 
to dietary antioxidants measured by questionnaire 4 6 , 1 0 7 . To our knowledge, there 
has only been one study on blood levels of antioxidants in relation to respiratory 
symptoms 1 9 . In a cross-sectional analysis, serum levels of p-carotene and a-
tocopherol were associated with a lower prevalence of C O P D symptoms in smokers. 
However, an intervention study within the same publication did not find a change in 
the incidence of C O P D symptoms after supplementation of a-tocopherol or p-
carotene for six years in smokers 1 9 . 
W e chose to study the relation between plasma antioxidants (a-tocopherol 
and p-carotene) and respiratory symptoms. At the time we designed our study, no 
other finding had been published on this relation, so we decided first to study this 
relation in a group of non-smokers. Cigarette smoking as a strong determinant of 
respiratory symptoms additionally affects the antioxidant status 1 0 8 and a relation 
between antioxidants and respiratory symptoms could, therefore, be more difficult to 
establish among smokers. 
Methods 
Study population 
The MORGEN-study (the monitoring project on risk factors and health in the 
Netherlands) is a cross-sectional investigation on the prevalence of risk factors for 
chronic diseases in a randomly selected sample of the Dutch population aged 20 to 
59 years in three towns in the Netherlands (Amsterdam, Doetinchem and 
Maastricht). W e chose for a case-control design based on subjects with and without 
chronic respiratory symptoms. Subjects were eligible for this case-control sample if 
they were not pregnant and were non-smokers (defined as never and long-term 
former smokers who stopped smoking cigarettes more than 10 years ago) to avoid a 
possible recent exposure of high levels of oxidants. First, we determined that a 
sample size of 1,000 subjects (500 cases and 500 controls) would allow us to detect 
an Odds Ratio of two (fifth versus first quintile of antioxidants) at a 5% significance 
level with a statistical power of 80%. Subsequently, cases were selected from the 
most recent study period (before May 1995). Between July 1994 and May 1995, 521 
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eligible subjects who reported one or more chronic respiratory symptoms were 
defined as cases. A random sample of 527 controls was drawn from 1,266 eligible 
non-cases during the same period. Plasma concentrations of a-tocopherol and p-
carotene were determined in these cases and controls. 
Data collection 
All respondents from the MORGEN-project filled out a general and a semi-
quantitative food frequency questionnaire 8 6 , 8 7 and underwent a physical 
examination. The general questionnaire provided information about demographic 
variables, life-style factors, environmental factors, respiratory symptoms and the 
presence of chronic diseases. The questions on respiratory symptoms were selected 
from the Dutch part of the European Community Respiratory Health Survey (see 
appendix) 8 4 , 9 9 . The food frequency questionnaire assessed energy intake, nutrients 
and the self-reported use of diets for diabetes and for fat and cholesterol restriction. 
A physician or dietician did not necessarily prescribe these diets. The physical 
examination included measurements of height, weight, lung function, and collection 
of non-fasting blood (42 ml). Glucose and plasma total cholesterol was measured in 
all subjects routinely and the rest of the blood samples was stored. Plasma 
antioxidants (a-tocopherol and p-carotene) were determined in the selected case-
control sample. The relation between plasma antioxidants (a-tocopherol and p-
carotene) and lung function will be investigated in a random sample because the 
present case-control sample is not an appropriate study design to explore this cross-
sectional relation. 
Cases were defined as subjects who reported one or more respiratory 
symptoms. Controls were drawn from those subjects who did not report any chronic 
respiratory symptoms. In additional analysis, the respiratory symptoms were 
considered separately in three groups of cases: cases with asthma symptoms 
(wheeze with shortness of breath, wheeze without a cold, attacks of shortness of 
breath, ever asthma), cases with chronic bronchitis symptoms (chronic cough, 
chronic phlegm, productive cough) excluding cases with asthma symptoms, and 
cases with dyspnea as a symptom for emphysema (shortness of breath when 
walking actively, shortness of breath when walking compared to persons of the same 
age) excluding cases with asthma and chronic bronchitis symptoms. 
Lung function measurements were used for an additional, more stringent 
definition of cases and controls. The measurements were performed with a heated 
pneumotachometer that was calibrated (Jaeger, G e r m a n y ) 9 3 . Subjects were seated 
in an upright posture with a fixed mouthpiece, which was adjusted for the height of 
each individual. In addition, a noseclip was used. Subjects had to achieve at least 
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three technically acceptable, of which two reproducible, maneuvers of BTPS 
corrected FEVi according to ERS 1993 criteria 7 7 . 
Blood specimens were collected in ethylene diamine tetraacetic acid (EDTA) 
vacutainer tubes and stored in the refrigerator shielded from the light. Within four 
hours after collection, the blood was centrifuged to obtain plasma. Aliquots of plasma 
were stored initially at -20 °C. After six months or less, plasma was stored at -80 °C 
to secure the stability of the antioxidants 1 0 9 . Concentrations of a-tocopherol and B-
carotene in each subject were measured by reverse-phase high-performance liquid 
chromatography (HPLC) in one run. The method was modified as described by Hess 
and co-workers 7 5 . About 7% (n=77) of the samples were measured in duplicate. The 
within-duplo coefficient of variation was 4 . 1 % for plasma B-carotene and 3.1 % for 
plasma a-tocopherol. Due to reasons that occurred randomly, such as not having 
enough plasma or a defective HPLC, plasma antioxidant levels could not be 
determined in 30 cases and 31 controls. 
Data analysis 
Presence or absence of one or more respiratory symptoms was used as the 
dependent variable in logistic regression analyses 6 0 . The independent variable of 
interest was the plasma concentration of B-carotene or a-tocopherol. First, these 
concentrations were analyzed in quintiles to study linearity with the lowest quintile as 
a reference. Cut-off points for each quintile were based on the distribution of the 
plasma antioxidants in the controls. Second, plasma antioxidant concentration was 
entered as a continuous independent variable in the model. The results of the latter 
analysis will be presented for a difference between the 9 0 t h percentile (high) and the 
1 0 t h percentile (low) of the plasma antioxidant levels. Odds Ratios (ORs) with 9 5 % 
Confidence Intervals (95% CI) were estimated. 
Adjustment for plasma total cholesterol is common in studies with 
cardiovascular disease as an endpoint and plasma a-tocopherol as exposure 
variable because plasma total cholesterol is a confounding factor in this relation. W e 
also considered adjustment for plasma total cholesterol in the present study. 
However, plasma total cholesterol is not a known risk factor for lung disease. So, we 
did not adjust for plasma total cholesterol in the relation between plasma a -
tocopherol and respiratory symptoms. 
Additional analysis with FEVi for a more stringent case-control definition was 
performed to increase the contrast between cases and controls. Of the 491 cases 
and 496 controls with plasma levels of antioxidants, 47 cases and 39 controls did not 
perform lung function measurements for practical reasons (non-availability of lung 
function devices, time constraints, etc.) that operated randomly and 69 cases and 59 
controls did not fulfill ERS criteria 7 7 . So, 375 cases and 398 controls were available 
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for additional case-control definition with FEVV Cases were restricted to those with 
an FEVi equal or less than 9 0 % of the predicted FE\A| value and controls with an 
FEVi of equal or more than 100% resulting in 106 cases and 199 controls. Predicted 
FEVi values were calculated with multiple linear regression 6 0 with the following 
model: FEV^ divided by height squared as dependent variable with age, age squared 
and gender as independent variables. The prediction equation was derived from all 
technically acceptable and reproducible lung function maneuvers of healthy never 
smokers without chronic respiratory symptoms (n=1,518) examined in 1994 and 
1 9 9 5 9 3 . 
Results 
Table 1 shows that cases were older, included more women, had a higher body 
mass index (BMI), pack-years of smoking and a lower educational level than 
controls. 
Table 1: Mean characteristics and plasma antioxidant concentrations in cases and controls 
Characteristics Cases (n=491) Controls (n=496) 
Mean (SD) Mean (SD) 
Age (yrs) 43.3 (11.7) 41.0(11.8) 
Gender (% women) 59.9 51.2* 
Smoking history (% former smokers) 30.5 28.0 
Pack-years of past smoking + 11.1 (11.9) 8.1 (8.9)* 
Educational level (%) * 
Low 48.8 40.7* 
Intermediate 27.3 32.3 
High 24.0 27.0 
BMI (kg/m2) 26.5 (4.5) 25.0 (3.7) * 
Physical activity (% yes) 65.8 68.7 
Alcohol use (% yes) 5 53.6 57.7 
Supplement use (% yes)" 7.1 6.7 
Plasma p-carotene (uimol/l) 0.35 (0.21) 0.37 (0.30) 
Plasma a-tocopherol (umoi/l) 31.2 (9.3) 29.3 (7.6)" 
p < 0.05 difference between cases and controls 
+ calculated only for long-term former smokers; one pack-year is equal to smoking 
20 cigarettes a day for one year 
* low (intermediate secondary education or less), intermediate (intermediate vocational 
or higher secondary education) and high (higher vocational or university education) 
§ percentage of subjects whom drinks one or more glass per week 
'1 daily vitamin supplement use of vitamin A, C, E and/or multivitamins in the last twelve months 
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The crude mean of plasma a-tocopherol concentration was slightly higher in cases 
compared to controls; plasma p-carotene concentration was similar in cases and 
controls. BMI was positively related to plasma a-tocopherol and negatively related to 
plasma B-carotene concentration. Pack-years of smoking and educational level were 
not related to plasma antioxidant levels. Thus BMI, age and gender were always 
included in all adjusted analysis. 
Table 2: Relation between respiratory symptoms and levels of plasma p-carotene 
Plasma p-carotene Number of Unadjusted Adjusted 
Quintiles Median5 Cases Controls OR OR 95% CI 
1 f 0.14 108 99 1.0 1.0 
2 0.23 103 100 0.94 0.97 0.65-1.44 
3 0.30 92 100 0.84 0.80 0.53-1.20 
4 0.41 83 98 0.78 0.77 0.51-1.17 
5 0.61 105 99 0.97 0.97 0.64-1.48 
Continuous * 491 496 0.84 0.81 0.63-1.04 
OR = prevalence Odds Ratio; 95% Cl= 95% Confidence Interval 
adjusted for age, gender, BMI 
f reference category 
* presented for the difference between the 90 t h percentile (0.607 timol/l) and the 10 t h percentile (0.138 nmol/l) 
of plasma concentration of p-carotene 
5 median of plasma p-carotene concentration (jimol/l) in each quintile based on the controls 
The adjusted Odds Ratios (ORs) of respiratory symptoms in 2 n d to 5 t h quintiles of 
plasma B-carotene compared to reference were below one (table 2). The OR of 
respiratory symptoms in subjects with a high (0.607 u.mol/1) versus a low (0.138 
u.mol/1) plasma concentration of p-carotene was borderline statistically significant 
(OR=0 .81 ; 95%CI 0.63-1.04). The results were similar if asthma symptoms, chronic 
bronchitis symptoms or dyspnea were considered separately (table 3). After a more 
stringent definition of the cases and controls with F E N A , the adjusted OR of a high 
versus a low p-carotene concentration decreased slightly (OR=0.65; 95%CI 0.37-
1.14). The inverse relation between plasma p-carotene and case-control status 
tended to be slightly stronger in former smokers (OR=0.61; 95%CI 0.36-1.03) than in 
never smokers (OR=0.89; 95%CI 0.67-1.18) but the difference between former and 
never smokers was not statistically significant. Additionally adjustment for pack-years 
of smoking did not change the OR of respiratory symptoms for a high versus a low 
plasma p-carotene level in former smokers. 
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Table 3: Prevalence Odds Ratios of asthma, chronic bronchitis-like symptoms and dyspnea for 
continuous levels of plasma fi-carotene (n=496 controls) 
Model Asthma symptoms Bronchitis symptoms1' Dyspnea* 
n=180 n=200 n=111 
OR§ 95% Cl § OR§ 95% C!§ OR5 95% Cl § 
Unadjusted 0.80 0.60-1.14 0.85 0.63-1.15 0.88 0.61-1.27 
Age, gender, 0.87 0.62-1.21 0.82 0.59-1.14 0.80 0.53-1.21 
BMI adjusted 
see the case definition in methods 
* excluding subjects with asthma-like symptoms 
* excluding subjects with asthmatic-like and chronic bronchitis-like symptoms 
§ prevalence Odds Ratios (OR) with 95% confidence interval (95%CI) presented for the difference 
between the 90 t h percentile (0.607 nmol/l) and the 10 t h percentile (0.138 nmol/I) of plasma concentration 
of (S-carotene 
The adjusted ORs of respiratory symptoms in 2 n d to 5 t h quintiles of plasma a-
tocopherol compared to reference were around one (table 4). The adjusted OR of 
respiratory symptoms in subjects with a high (39.50 u.mol/1) versus a low (20.42 
u.mol/1) plasma a-tocopherol was slightly elevated but not statistically significant. 
Table 4: Relation between respiratory symptoms and levels of plasma a-tocopherol 
Plasma a-tocopherol Number of Unadjusted Adjusted 
Quintiles Median5 Cases Controls OR OR 95% CI 
1* 20.3 91 97 1.0 1.0 
2 25.0 71 100 0.76 0.70 0.46-1.09 
3 28.6 93 99 1.00 0.85 0.56-1.31 
4 31.9 88 98 0.96 0.77 0.50-1.20 
5 39.3 148 102 1.55 1.17 0.76-1.82 
Continuous * 491 496 1.65 1.36 0.98-1.89 
OR=prevalence Odds Ratio; 95% Cl= 95% Confidence Interval 
adjusted for age, gender, BMI 
T reference category 
* presented for the difference between the 90 t h percentile (39.50 nmol/l) and the 10 t h percentile (20.42 nmol/1) of 
plasma concentration of a-tocopherol 
§ median of plasma a-tocopherol concentration (nmol/1) in each quintile based on the controls 
Considering asthma, chronic bronchitis and dyspnea separately, the adjusted OR of 
plasma a-tocopherol for dyspnea was statistically significantly elevated (Table 5). 
Dyspnea is a common symptom in cardiovascular diseases. Risk factors for 
cardiovascular disease, such as, an elevated plasma total cholesterol level, diastolic 
blood pressure and a decreased concentration of plasma high density lipoprotein 
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cholesterol were associated with dyspnea but not with the other respiratory 
symptoms. Adjustment for these risk factors in the relation between plasma a-
tocopherol and dyspnea did, however, not change the positive association (results 
not shown). After repeating the analysis excluding cases with dyspnea (n=111), the 
adjusted OR of respiratory symptoms for plasma a-tocopherol was not different from 
one (OR=1.24; 9 5 % CI: 0.87-1.78). 
Table 5: Prevalence Odds Ratios of asthma, chronic bronchitis-like symptoms and dyspnea for 
continuous levels of plasma a-tocopherol (n=496 controls) 
Model Asthma symptoms 
n=180 
Bronchitis symptoms* 
n=200 
Dyspnea* 
n=111 
OR5 95% CI 5 OR§ 95% Cl § OR§ 95% Cl § 
Unadjusted 
Age, gender, 
BMI adjusted 
1.63 
1.40 
1.10-2.43 
0.90-2.20 
1.26 
1.16 
0.85-1.88 
0.74-1.82 
2.70 
2.10 
1.734.20 
1.28-3.43 
* 
see the case definition in methods 
* excluding subjects with asthma-like symptoms 
* excluding subjects with asthmatic-like and chronic bronchitis-like symptoms 
5 prevalence Odds Ratios (OR) with 95% confidence interval (95%CI) presented for the difference 
between the 90 t h percentile (39.50 nmol/1) and the 10 t h percentile (20.42 nmol/l) of plasma concentration 
of a-tocopherol 
Cases with asthma and chronic bronchitis symptoms used more diets for diabetes 
and for restriction on fat and cholesterol than controls. This could have lead to 
increased levels of plasma a-tocopherol in cases. Excluding all subjects with these 
diets (27 cases and 16 controls) did not essentially change the adjusted OR of 
plasma a-tocopherol (OR=1.19; 95%CI: 0.82-1.73). Using the more stringent case-
control definition with FEV-i, the adjusted OR for plasma a-tocopherol increased 
slightly (OR=1.60; 95%CI 0.83-3.11) but the OR was not statistically significant. 
There was no essential difference between former (OR=1.15, 9 5 % CI 0.61-2.18) and 
never smokers (OR=1.28, 9 5 % CI 0.82-1.99) in the relation between plasma a-
tocopherol and respiratory symptoms. 
Discussion 
After adjustment for age, gender and BMI, cases tended to have lower plasma 
concentrations of B-carotene than controls but this association was not statistically 
significant at the 5% level. Plasma a-tocopherol concentration was slightly elevated 
in cases compared to controls. This was mainly due to the statistically significantly 
Plasma antioxidants and respiratory symptoms 79 
elevated plasma a-tocopherol concentration in cases with dyspnea compared to 
controls. 
Lower plasma p-carotene concentration in cases compared to controls could 
occur when plasma samples of cases were stored longer than controls. All plasma 
samples were not stored for longer than half a year at -20 °C. A stability study 
showed that this time period was short enough to prevent the loss of plasma 
concentration of a-tocopherol and p-carotene 1 0 9 . The average time and range for 
the plasma samples stored at -20 °C was comparable for cases (mean 111 days) 
and controls (mean 105 days). Therefore, the OR of plasma p-carotene for 
respiratory symptoms was not likely to be affected by storage time. 
Our observation that cases had lower plasma p-carotene concentrations than 
controls is consistent with a recent cross-sectional study by Rautalahti and co-
workers who showed a significant inverse relation between plasma p-carotene and 
COPD symptoms. However, this study was in a large group of male smokers 
(n=29,133) 1 9 . To our knowledge there have been no other results published on the 
relation between plasma p-carotene and respiratory symptoms. 
Plasma levels of p-carotene could be a better marker of exposure in the lung 
tissue than the intake of p-carotene. Studies on dietary p-carotene did not find a 
significant association with the incidence of adult-onset asthma 1 7 , the incidence of 
COPD 1 6 or the prevalence of several respiratory symptoms 9 3 . In contrast, plasma p-
carotene was inversely related to the prevalence of respiratory symptoms in the 
study of Rautalahti and co-workers 1 9 and in the present study. Additionally, the 
Pearson's correlation coefficient between blood concentration of p-carotene and lung 
tissue (r=0.72) was higher than the correlations between dietary intake of p-carotene 
and the concentrations in lung tissue (r=0.54) 4 6 . 
Plasma a-tocopherol concentration was higher in cases with dyspnea than in 
controls. In the selection of cases, dyspnea was included as a symptom for 
emphysema but dyspnea is also a common symptom for cardiovascular disease. 
This was confirmed because cases with dyspnea, but not cases with asthma or 
chronic bronchitis-like symptoms, had higher prevalences of risk factors for 
cardiovascular disease, such as elevated plasma total cholesterol level and diastolic 
blood pressure. Adjustment for these risk factors did, however, not change the 
positive association between plasma a-tocopherol and dyspnea. So, the positive 
association between plasma a-tocopherol and dyspnea remains inexplicable. 
In the present case-control study in non-smokers, plasma a-tocopherol was 
not associated with chronic bronchitis-like and asthmatic symptoms but it was 
positively associated with dyspnea. A recent cross-sectional investigation among 
smokers showed, however, an inverse association between serum levels of a-
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tocopherol and COPD-symptoms, both chronic bronchitis symptoms and dyspnea. 
This study excluded all subjects who reported having symptoms of cardiovascular 
disease at baseline, such as angina pectoris and arrhythmias 1 9 . Since the present 
study was not able to identify these symptoms, cases with dyspnea might have had 
these cardiovascular disease symptoms. To our knowledge, no other studies on the 
relation between plasma oc-tocopherol and chronic respiratory symptoms were 
published. Studies on dietary vitamin E as marker of exposure in relation to 
respiratory disease were inconsistent in their results 1 7 9 3 . However, plasma a-
tocopherol was shown to be a better marker than dietary vitamin E as exposure in 
the lung tissue 4 6 . 
In conclusion, the present case-control study among non-smokers suggested 
that subjects with a high plasma level of p-carotene tended to have fewer chronic 
respiratory symptoms than subjects with a low plasma level of p-carotene. Plasma a-
tocopherol was not associated with asthma and chronic bronchitis-like symptoms. 
Subjects with a high level of plasma a-tocopherol were more likely to have dyspnea 
than subjects with a low level of plasma a-tocopherol. It remains intruiging if a-
tocopherol or other antioxidants are beneficial for respiratory symptoms in smokers 
who are exposed to relatively high oxidant levels. 
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Appendix 
Chronic Respiratory symptoms Questions in the questionnaire 
Cough 
Phlegm 
Productive cough 
SOB when walking actively 
SOB when walking compared to 
persons of the same age 
Wheeze with SOB 
Wheeze without a cold 
Attacks of SOB 
Ever asthma 
Do you cough during wintertime on most days for at least 
three months a year? 
Do you bring up phlegm during wintertime on most days for at 
least three months a year? 
Have you had productive cough for a period of three weeks in 
the last 3 years? 
Are you troubled by shortness of breath when hurrying on 
level ground or when walking at normal pace on a slope or 
flight of stairs? 
Are you short of breath when walking with other people of your 
own age on level ground? 
Has wheezing with shortness of breath, in the last twelve 
months troubled you? 
Has wheezing, not due to a cold or the flu in the last twelve 
months troubled you? 
Are you being woken by attacks of shortness of breath in the 
last twelve months? 
Have you ever had asthma? 
SOB=Shortness of Breath 

CHAPTER 7 
Plasma concentrations of the antioxidants (3-
carotene and a-tocopherol in relation to lung 
function 
Abstract 
Background The aim of this investigation was to study the relation between plasma 
antioxidants (B-carotene and a-tocopherol) and lung function in Dutch adults aged 20-59 
years. 
Methods A random sample (n=367) was drawn from the participants in a population based 
cross-sectional study in 1995. Linear regression analysis was performed with forced 
expiratory volume in one second (FEV-0 or forced vital capacity (FVC) as dependent 
variables and plasma antioxidant concentration as independent variable. We adjusted for 
age, height, gender, smoking status, pack-years of smoking, and alcohol consumption and 
we present the results as a difference between the 90th and 10th percentile of plasma 
antioxidant concentration. 
Results Subjects with a high plasma B-carotene level tended to have a higher FEV, (73 ml, 
SEM 60 ml; p=0.22) and a higher FVC (147 ml, SEM 76 ml; p=0.052) than subjects with a 
low plasma B-carotene level. The difference was only observed in current and never 
smokers but not in former smokers. There was no difference in lung function between 
subjects with high and low plasma a-tocopherol concentrations. 
Conclusions The results suggest that subjects with a high plasma B-carotene tended to have 
a higher FVC than subjects with a low plasma B-carotene concentration. The difference for 
FEV| between high and low levels of plasma B-carotene tended to be in the same positive 
direction as for FVC but this was not statistically significant. Plasma a-tocopherol was not 
associated with lung function. 
Submitted for publication as: 
Linda Grievink. Henriëtte A. Smit, Pieter van't Veer, Bert Brunekreef, Daan Kromhout. Plasma 
concentrations of the antioxidants p-carotene and a-tocopherol in relation to lung function. 
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Introduction 
Antioxidants, such as vitamins C, E and p-carotene may beneficially affect lung 
function 9 6 " 9 8 . These antioxidants can scavenge endogenous and/or environmental 
oxidants in the lung and could, therefore, prevent a permanent loss of lung function 
over time 2 4 . 
Investigating the relation between blood levels of antioxidants and lung 
function is important to elucidate a possible association of antioxidants with 
respiratory disease because lung function is thought to be a more objective 
measurement than self-reported respiratory symptoms and blood levels of 
antioxidants are likely to be better markers of exposure in the lung tissue than dietary 
intake of antioxidants measured by questionnaire 4 6 ' 4 8 ' 1 0 7 . However, most studies so 
far have been investigating the relations between dietary antioxidants and lung 
function 1 3 - 1 5 ' 4 0 ' 9 3 . To our knowledge, there has only been one cross-sectional study 
(798 men) on blood levels of p-carotene in relation to lung function suggesting a 
beneficial e f fec t 4 3 . Another study (83 men) did not show associations between blood 
levels of antioxidants and the development of airway obstruction (FEVi<75%FVC) 
during five subsequent years 4 1 . Thus, very few studies have investigated blood 
levels of antioxidants (p-carotene and a-tocopherol) in relation to lung function. 
Therefore, we studied the relation between the plasma antioxidants (p-
carotene and a-tocopherol) and lung function in a random sample of Dutch adults. 
Methods 
Study population 
A random sample was drawn from the MORGEN-study in 1995 (the monitoring 
project on risk factors and health in the Netherlands). This is a cross-sectional 
investigation on the prevalence of risk factors for chronic diseases in a randomly 
selected sample of the Dutch population aged 20 to 59 years in three towns in the 
Netherlands (Amsterdam, Doetinchem and Maastricht). The random sample was 
selected from a total of 4,238 subjects with plasma samples in 1995 stratified 
according to gender and age (four 10-years age categories) resulting in eight strata 
of equal size (n=56). In the resulting 448 subjects, plasma concentrations of a-
tocopherol and p-carotene were determined. 
Data collection 
All respondents from the MORGEN-study filled out a general and a semi-quantitative 
food frequency questionnaire and underwent a physical examination 8 6 ' 8 7 ' 9 3 . The 
general questionnaire provided information about demographic variables; life-style 
factors, such as smoking (smoking status and pack-years of smoking) and alcohol 
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consumption (non drinkers, light drinkers: >0-3 glasses a day, moderate drinkers: 
more than 3 glasses a day); environmental factors such as dampness of the house; 
respiratory symptoms (selected from the Dutch part of the European Community 
Respiratory Health Survey) 8 4 , 9 9 and the presence of other chronic diseases. The 
physical examination included measurements of height, weight and lung function. In 
addition, blood (non-fasting) was collected in all subjects for routinely measurements 
of plasma total cholesterol and glucose. Plasma antioxidants (a-tocopherol and B-
carotene) were determined in the random sample. 
Blood specimens were collected in ethylene diamine tetraacetic acid (EDTA) 
vacutainer tubes and stored in the refrigerator shielded from the light. Within four 
hours after collection, the blood was centrifuged to obtain plasma. Aliquots of plasma 
were stored at -20 °C for six months or less. After that, plasma samples were stored 
at -80 °C at the National Institute of Public Health and the Environment (RIVM). 
Concentrations of a-tocopherol and p-carotene in each subject were measured by 
reverse-phase high-performance liquid chromatography (HPLC) in one run. The 
method was modified as described by Hess and co-workers 7 5 . The coefficient of 
variation of the HPLC measurement was 4 . 1 % for plasma p-carotene and 3.1 % for 
plasma a-tocopherol. Due to reasons that occurred randomly, such as not having 
enough plasma or a defective HPLC device, plasma antioxidant levels could not be 
determined in nine subjects. 
Lung function was measured with a heated pneumotachometer (Jaeger, 
Germany). Calibration took place twice a day. Trained paramedics performed the 
lung function measurements. Subjects were seated in an upright posture with a fixed 
mouthpiece, which was adjusted for the height of each individual; in addition, a nose 
clip was used. No lung function data was available for 34 subjects because of 
practical reasons that operated randomly, such as non-availability of lung function 
devices, time constraints, etc. All subjects who did not achieve at least three 
technically acceptable manoeuvres, such as manoeuvres with cough, a hesitant start 
or an early termination were excluded from analysis. Additionally, those subjects who 
could not perform two reproducible manoeuvres according to ERS 1993 criteria 7 7 
were excluded from analyses. Analyses were based on the maximum value of the 
reproducible manoeuvres of FEV-i and FVC. 
Data analysis 
Models for FEVi and FVC were fitted with multiple linear regression 6 0 . W e used the 
following basic adjusted model: FEVi or FVC divided by height squared as the 
dependent variable with age, age squared and gender as independent variables. 
This model was based on all subjects (n=6,555) with reproducible lung function 
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measurements during the years of 1994 and 1995 . The shape of the relation 
between each plasma antioxidant and lung function was investigated by classifying 
the independent variables (plasma antioxidants) into quintiles of the total population. 
Since no essential deviation from linearity was observed, plasma antioxidants B-
carotene and a-tocopherol were entered as continuous independent variables into 
the regression model. Regression coefficients (in ml) were calculated for a standard 
height of 1.70 meter and were expressed as the difference in FEV| or FVC between 
the 9 0 t h percentile and the 10 t h percentile of plasma antioxidant concentration. 
Adjustment for plasma total cholesterol is common in studies with 
cardiovascular disease as an endpoint and plasma a-tocopherol as independent 
variable because plasma total cholesterol is potentially a confounding factor in this 
relation. However, plasma total cholesterol is not a known risk factor for lung 
disease. So, we did not adjust for plasma total cholesterol in the relation between 
plasma a-tocopherol and lung function. 
W e evaluated the effect of the following potential confounders in the relation 
between plasma antioxidants and lung function: pack-years of smoking, smoking 
status, educational level, body mass index (BMI), physical activity, dietary 
antioxidants (vitamins C, E and B-carotene) and alcohol consumption. W e could not 
consider heavy alcohol consumption (>6 glasses/day) because of the small 
percentage (2%) present in this sample. In addition, we studied the presence of 
effect modification of smoking status on the relation between plasma antioxidants 
and lung function by stratified analysis. 
Results 
Plasma levels of p-carotene and a-tocopherol could be determined in 439 out of the 
448 subjects. Of those, 34 subjects did not perform a lung function measurement 
and six subjects had missing values for pack years of smoking. Of the remaining 399 
subjects, 385 subjects (96%) had at least three technically acceptable lung function 
manoeuvres, of which 367 subjects had reproducible measurements for FEV-i and 
369 subjects had reproducible measurements for FVC. 
Subjects who were excluded from analyses because they had not performed 
a lung function test (N=34) or if they did not meet acceptability and reproducibility 
criteria for FEVi (N=32) or FVC (N=30) were older, less physical active, had a lower 
educational level and higher body mass index (BMI) than those subjects who were 
included in the analysis (results not shown). 
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Table 1: Mean (SD) characteristics for the overall group and by smoking status 
Characteristics Overall group Smoking status 
Current Former Never 
(n=367) (n=129) (n=104) (n=134) 
Age (years) 39.7(11.7) 40.3(10.7) 44.1 (10.7) 35.6 (12.0) 
Gender (% women) 50.7 52.7 44.2 53.7 
Pack-years* 15.4 (12.7) 17.6(12.9) 12.7(11.8) -
Educational level (%)* 
Low 42.1 48.1 41.7 36.6 
Intermediate 34.2 31.0 36.9 35.1 
High 23.8 20.9 21.4 28.4 
BMI (kg/m2) 24.7 (3.8) 24.4 (3.8) 25.6 (3.8) 24.4 (3.8) 
Physical Activity (%) 69.9 58.1 75.7 76.9 
Alcohol consumption 
none 39.5 37.2 33.7 46.3 
low (>0-3 glass/day) 47.7 43.4 53.8 47.0 
moderate( >3 glass/day) 12.8 19.4 12.5 6.7 
Supplement use (%)§ 11.7 7.8 15.4 12.7 
Respiratory symptoms (%)" 39.5 48.8 40.6 29.9 
for those subjects with technically acceptable and reproducible FEVi manoeuvres 
* one pack-year is equal to smoking 20 cigarettes a day for one year 
* low (intermediate secondary education or less), intermediate (intermediate vocational or higher 
secondary education) and high educational level (higher vocational or university education) 
5 daily vitamin supplement use of vitamin A, C, E and/or multivitamins in the last twelve months 
" one or more of the following respiratory symptoms: cough, phlegm, productive cough, wheeze, 
shortness of breath, nocturnal attacks of shortness of breath, ever asthma 
Table 1 shows the characteristics of the study population by smoking status. Current 
smokers were less physically active compared to former and never smokers. 
Further, current smokers included more moderate alcohol drinkers and subjects with 
respiratory symptoms than never smokers. Former smokers were older and had a 
higher BMI than current and never smokers. In addition, former smokers included 
fewer non-alcohol drinkers compared to never smokers. 
Table 2 presents the mean lung function adjusted for age, height and gender 
and the crude plasma antioxidant levels by smoking status. Current smokers had 
lower plasma p-carotene levels than former and never smokers. Former smokers 
had a higher mean FEVi , FVC and plasma level of a-tocopherol. 
Adjustment for educational level, BMI and physical activity did not essentially 
change the regression coefficients of plasma antioxidants on lung function. These 
variables were, therefore, not included in the adjusted models. 
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Table 2: Mean (SD) lung function and plasma levels of antioxidants 
Variables Overall group Smoking status 
Current Former Never 
Number of subjects 367 129 104 134 
Lung function ( L ) f 
FEV, 3.55 3.46 3.66 3.57 
FVC 4.49 4.46 4.64 4.40 
Plasma levels (umol/l) 
p-carotene 0.31 (0.19) 0.28 (0.16) 0.34 (0.21) 0.33 (0.19) 
a-tocopherol 30.4 (9.5) 30.2 (10.0) 32.3 (9.4) 29.0 (8.8) 
* 
These numbers are for subjects with technically acceptable and reproducible FEVi 
manoeuvres; for technically acceptable and reproducible FVC manoeuvres these numbers were 
respectively 369, 123, 108 and 138 
T Lung function was adjusted for age, height and gender by regression analysis (see methods) and 
presented for a standard height of 1.70 m 
Smoking status and pack-years of smoking were both associated with lung function 
and with plasma antioxidant concentrations (results not shown). Therefore, smoking 
status and pack-years of smoking were always included in all adjusted models. 
Moderate alcohol consumption was associated with a lower plasma p-carotene 
concentration and a higher FEVi and FVC compared to no alcohol consumption. 
This elevated lung function with moderate alcohol consumption was observed only in 
current and never smokers. Moderate alcohol consumption was not associated with 
plasma a-tocopherol concentration (results not shown). Alcohol consumption (light or 
moderate versus none) was additionally included as a confounder in the final model 
on plasma p-carotene and lung function. 
Table 3 presents the relations between plasma p-carotene and lung function. 
After adjustment for age, height, gender, smoking and alcohol consumption in the 
group as a whole, subjects with a high plasma p-carotene level had a slightly higher 
FEVi but this was not statistically significant compared to subjects with a low plasma 
level of p-carotene. The age, height and gender adjusted difference in FEVi between 
subjects with a high and a low plasma p-carotene level was borderline statistically 
significant (mean difference 107 ml, SEM 60 ml; p=0.074). The magnitude of this 
difference decreased by more than a half (52 ml) after adjustment for pack-years of 
smoking and increased slightly (73 ml) after additional adjustment for alcohol 
consumption. The difference in FEVi between subjects with a high and a low plasma 
p-carotene level was observed in current and never smokers but not in former 
smokers. After adjustment for age, height, gender, smoking and alcohol consumption 
in the group as a whole, subjects with a high plasma p-carotene concentration had a 
borderline significantly higher FVC (147 ml, S E M 76 ml; p=0.052) compared to 
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subjects with low levels of plasma p-carotene. The magnitude of this difference (147 
ml) was similar to the magnitude of the difference in FVC (134 ml) between subjects 
with a high and a low plasma p-carotene after adjustment for only age, height and 
gender but the latter association was statistically significant. This difference in FVC 
between high and low levels of plasma p-carotene was observed only in current and 
never smokers. 
Table 4 shows that in the group as a whole, the adjusted difference for FEVi 
and FVC between high and low plasma oc-tocopherol concentration was not different 
from zero. There were no significant differences between the smoking categories, 
although the differences were again in the direction of a higher lung function with 
higher plasma a-tocopherol levels for current and never smokers but not for former 
smokers. 
Adjustment for dietary antioxidants (vitamins C, E and p-carotene) did not 
essentially change the relations between plasma antioxidants and lung function 
(results not shown). 
Discussion 
Subjects with a high plasma p-carotene concentration had a higher FVC compared 
to subjects with a low plasma p-carotene concentration which was borderline 
statistically significant. A higher FEVi for a high versus a low plasma p-carotene level 
tended to be observed but this was not statistically significant. These differences in 
lung function between subjects with high and low levels of plasma p-carotene were 
observed in current and never smokers but not in former smokers. Subjects with a 
high plasma a-tocopherol level did not have a higher lung function than subjects with 
low levels of plasma a-tocopherol. 
Selection bias may have occurred in this random sample because subjects 
who did not have a lung function measurement (n=34) or did not fulfil ERS criteria 
(n=32) were excluded from analysis. However, the reason for not having a lung 
function measurement was practical and occurred randomly because of non-
availability of lung function devices and time constraints suggesting that lung function 
was not likely to be different. In addition, plasma levels of antioxidants were also not 
different in subjects with or without lung function measurements, so selection bias 
did probably not occur in this group. Subjects who did not fulfil ERS criteria were 
estimated to have a lower lung function 
Table 3: The relation'1 between plasma p-carotene and lung function for the overall group and by smoking status 
Lung function Overall group Smoking status 
Adjustments Current Former Never 
FEV, n =367 n=129 n=104 n=134 
P (SEM) P (SEM) P (SEM) P (SEM) 
Age, height & gender (basic) + 107.0 (59.8) 195.0 (116.4) -5.1 (99.5) 66.1 (101.4) 
Basic + smoking * 51.9 (60.0) 163.8 (122.0) -19.4 (97.4) 66.1 (101.4) 
Basic + smoking + alcohol 5 73.0 (59.9) 184.8 (119.3) -0.6 (100.7) 91.3 (102.7) 
FVC n =369 n=123 n=108 n=138 
P (SEM) p (SEM) P (SEM) P (SEM) 
Age, height & gender (basic) f 133.7 (75.2)* 187.8 (148.1) 6.3 (137.5) 189.3 (114.8) 
Basic + smoking * 124.7 (75.8) 210.3 (155.7) 4.0 (138.3) 189.3 (114.8) 
Basic + smoking + alcohol § 147.4 (75.6) 217.7 (153.1) 21.3 (142.9) 217.4 (115.5) 
* p< 0.05 
* see methods for exact adjustment 
* smoking adjustment: pack-years of smoking (zero for never smokers) and smoking status (only for overall group) 
§ alcohol adjustment: alcohol consumption (dummies low or moderate versus none) 
" regression coefficients are presented as a difference in FEVi and FVC (in ml for a height of 1.70 m) between subjects in 
the 90 t h percentile (0.57 nmol/l"1) and those in the 10 t h percentile (0.11 umol/T1) of plasma p-carotene concentration 
Table 4: The relation s between plasma ct-tocopherol and lung function for the overall group and by smoking status 
Lung function Overall group Smoking status 
Adjustments Current Former Never 
FEV, n=367 n=129 n=104 n=134 
P (SEM) P (SEM) P (SEM) P (SEM) 
Age, height & gender (basic) f 21.4 (60.5) 92.8 (93.6) -125.7 (107.3) 56.6 (112.7) 
Basic + smoking * 17.0 (58.9) 88.8 (93.5) -108.4 (105.3) 56.6 (112.7) 
FVC n=369 n=123 n=108 n=138 
P (SEM) P (SEM) P (SEM) P (SEM) 
Age, height & gender (basic) f 29.7 (76.4) 39.3 (120.3) -109.8 (148.8) 139.8 (129.1) 
Basic + smoking * 25.0 (75.5) 39.3 (120.8) -107.2 (149.7) 139.8 (129.1) 
T see methods for exact adjustment 
* smoking adjustment: pack-years of smoking (zero for never smokers) and smoking status (only for overall group) 
s regression coefficients are presented as a difference in FEVi and FVC (in ml for a height of 1.70 m) between subjects in 
the 90 m percentile (42.3 nmol/1"1) and those in the 10 t h percentile (20.2 nmol/l"1) of plasma a-tocopherol concentration 
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Plasma antioxidant levels were, however, not consistently different in subjects who 
were excluded or included in the analysis. So if these subjects had been included in 
the analysis, the difference in lung function for a high versus a low antioxidant level 
would be slightly lower. However, these excluded subjects were only a small 
percentage (8%) of the total study population and the estimated lower lung function 
was small with 5% Therefore, selection bias probably did not have an influential 
impact on the results of the present study. 
Smoking is known to be a confounder in the relation between FEVi 1 1 1 and 
plasma p-carotene 4 3 , 1 0 8 . In this sample, the borderline significant association 
between plasma p-carotene and FEV-i did not remain after adjustment for pack-years 
of smoking. A similar impact of adjustment for pack-years of smoking on the relation 
between plasma p-carotene and FEVi was observed in the study of Chuwers et a l 4 3 . 
Alcohol consumption appeared to be a confounder in the relation between 
plasma p-carotene and lung function, in particular, in current and never smokers. W e 
observed that moderate alcohol consumption versus no alcohol consumption was 
associated with a higher FEVi and FVC. Two other studies suggested that a 
moderate intake of alcohol compared to a low intake was associated with higher 
FVC 1 1 2 and that smokers who were consuming moderate alcohol had a better lung 
function 1 1 3 . Further, the present study showed that the concentration of plasma p-
carotene was lower in subjects with moderate alcohol consumption. This was also 
observed in other studies 1 1 4 1 1 5 . So studies investigating the association between 
plasma p-carotene and lung function that do not adjust for alcohol consumption may 
underestimate this association if alcohol consumption is associated with lung 
function, which is still a point of discussion in the literature. 
A high versus a low plasma concentration of p-carotene may be related to a 
higher lung function if the storage time of the plasma at - 2 0 °C was shorter in those 
subjects with a higher lung function. A stability study showed that plasma 
concentrations of p-carotene and oc-tocopherol were not affected by storage at -20 
°C up to 180 days 1 0 9 . The mean storage time at -20 °C of about half of our plasma 
samples was 80 days (range 14 to 162 days). The other samples were directly 
stored at -80 °C. In addition, storage time at - 2 0 °C was not essentially different for 
subjects with a high versus a low lung function suggesting that our results on plasma 
P-carotene and lung function were not attenuated by storage time. 
In the present study, a high versus a low plasma p-carotene concentration of 
0.46 u.mol/1 (90th versus 10th percentile) was associated with a non-significantly 
higher FEVi of 73 ml and a borderline significantly higher FVC of 147 ml. The 
observed difference in FEVi for a high versus low plasma p-carotene level may be 
clinically relevant because it was about equivalent to three times the annual decline 
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of FENA (25 ml) in non-smoking Dutch adults 1 1 6 . Additionally, it was approximately 
equivalent to the adverse effects of five years of heavy smoking (>25 cigarettes per 
day) on FEVi decline in Dutch adults 1 1 7 . 
The magnitude of the association between plasma p-carotene and lung 
function in our study can be compared with one other cross-sectional study among 
798 men who had been exposed to asbestos and were mostly former (63%) and 
current smokers (22%) 4 3 . In that study, a difference in the concentration of serum p-
carotene of 0.29 u.mol/1 was significantly associated with a 90 ml higher FEVi and an 
82 ml higher FVC 4 3 . A difference of 0.29 u.mol/1 plasma p-carotene in our study 
would be associated with a 46 ml higher FEVi and a 93 ml higher FVC. So, the 
difference in FVC for a high versus a low plasma p-carotene level but not the 
difference in FEVi was comparable with Chuwers et a l 4 3 . 
The present study did not show an association between plasma oc-tocopherol 
and lung function. These results are consistent with one small follow-up study (83 
men); serum levels of a-tocopherol were not associated with the development of 
airway obstruction (FEVi < 7 5 % FVC) during five subsequent year's 4 1 . So far, there 
is no evidence that a-tocopherol levels in blood are related to lung function. 
A higher lung function tended to be observed for high versus low plasma 
antioxidant levels only in current and never smokers and not in former smokers but 
the difference between the smoking groups was not statistically significant. The lack 
of a statistically significant difference between the smoking groups may have 
resulted from a lack of statistical power. Another larger study (n=798) also observed 
in separate analyses that a possible beneficial effect of serum p-carotene on lung 
function was smaller in former smokers compared to never and current smokers 4 3 . 
The authors did, however, not give a possible explanation for the difference between 
the smoking groups. In the present study, former smokers were different from current 
and never smokers in a number of characteristics. Adjustment for all these known 
factors (such as age, body mass index, and alcohol consumption) did not change the 
observed relations in former smokers. Although the mean levels of lung function and 
plasma a-tocopherol were higher in former smokers compared to current and never 
smokers, we have no clear explanation for the observed difference of the relation 
between plasma antioxidants and lung function in former smokers. 
In conclusion, the results of the present study suggest that subjects with a 
high plasma p-carotene concentration tended to have a higher FVC than subjects 
with a low plasma p-carotene concentration. The difference in FEVi between those 
subjects with high and low plasma p-carotene levels tended to be in the same 
positive direction as for FVC but the difference was not statistically significant. 
Plasma a-tocopherol concentration was not associated with lung function. 
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Introduction 
This thesis addressed two main research questions. In the first part, we 
investigated whether antioxidants (in plasma, diet and supplement form) 
could modulate the acute respiratory effects of air pollution in three different 
studies. In the second part, we studied possible relations between 
antioxidants (in plasma and diet) and indicators of asthma and COPD, such 
as respiratory symptoms and lung function in three different population-based 
samples. The main findings of these studies are discussed below. 
Additionally, some methodological considerations of the studies are 
addressed and the results are compared quantitatively with other studies. 
Finally, the biological plausibility of the findings is discussed. 
Main findings 
Antioxidants in relation to the acute respiratory effects of air pollution 
Two intervention studies investigated a possible modulation of the acute 
respiratory effects of ozone by antioxidant supplementation. In addition a 
panel study examined a possible modulation of the acute respiratory effects 
of winter air pollution by antioxidants in diet and serum. The results are 
summarised in table 1. 
Table 1: Results of the studies presented in this thesis on modulation on acute effects of 
air pollution by antioxidants 
Ch. Study 
design 
Main 
pollutant 
Suppl. Antioxidants Outcome Beneficial 
association 
2 Interv. ozone yes vitamins C, E, FEV,, FVC, PEF + 
B-carotene MMEF -
3 Interv. ozone yes vitamins C, E FEV,, FVC + 
MMEF, PEF -
4 Panel PM10, BS, no diet vitamin C PEF, resp. symp. -
N0 2 , S0 2 diet B-carotene PEF, resp. symp. -
plasma p-carotene PEF + 
resp. symp. -
diet & plasma vit E PEF, resp. symp. -
Ch. = Chapter number; Interv. = Intervention studies; BS = black smoke; Suppl. = supplementation 
Resp. symp.: respiratory symptoms and medication use; 
Associations: + = beneficial association; - = no association 
The first intervention study in 1994 was a pilot study among 26 cyclists who 
performed lung function measurements (192 observations) before and after 
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exercise. Half of the group was randomly assigned to a daily antioxidant 
supplementation of vitamins C, E and p-carotene and the other half did not 
receive a placebo. The average 8-hour mean ozone concentration prior to 
post-exercise lung function measurement was 101 u.g/m3 (range 30-205 
Ltg/m 3 ) . This study suggested that there was an effect of ozone on FEV,, FVC 
and PEF in the control group. There was no change in lung function after 
ozone exposure in the supplementation group. The difference in ozone effect 
between the groups was statistically significant for FEV,, FVC and PEF. For 
comparison of the results of chapter 2 and 3, the regression coefficients of 
FEV, and FVC were presented in four different ways in the respective 
appendices. The results of the regression coefficients of FVC on ozone 
tended to be similar for the different ways of presentation: median, 
unweighted mean, mean weighted for inverse of the variance and mean 
weighted for the number of measurements of each subject. However, the 
ozone effect was not significant for the control group and for the difference in 
ozone effects between the study groups (appendix chapter 2) . The results of 
the median and the weighted (for inverse of variance) mean regression 
coefficients of FEV, on ozone were similar but not for the unweighted mean 
and for the mean weighted for number of measurements. So, it appeared that 
in individual regression analysis the interpretation of the results is slightly 
dependent on the presentation of the regression coefficients. 
W e repeated the study in the summer of 1996 with a similar design but 
this time the study was placebo-controlled. In this study, 38 subjects (380 
lung function measurements) participated until the end of the study and the 
antioxidant supplementation consisted of a cocktail of vitamins C and E. The 
average 8-hour mean ozone concentration prior to post-exercise lung function 
measurements was 86 u.g/m3 (range 32-199 u.g/m3). The table in the appendix 
of chapter 3 suggests that the interpretation of the results did not depend on 
different presentations of the regression coefficients. The results suggest a 
significant effect of ozone in the control group but not in the vitamin group. 
The difference in ozone effect between the groups was statistically significant 
for the mean regression coefficients and for the mean regression coefficients 
weighted for the inverse of the variance. So after the comparison of the 
results of chapter 2 and 3, it appeared that in particular in small groups 
(chapter 2), the results become sensitive to alternative ways of presenting the 
group mean effect. 
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In conclusion, both intervention studies suggest that antioxidant vitamin 
supplementation reduces the acute effect of ambient ozone on lung function, 
which is in accordance with the specified hypothesis in chapter 1. 
W e performed a panel study investigating a possible modulation of 
acute respiratory effects of winter air pollution by antioxidant intake or status 
(Chapter 4) . If both panels (with and without chronic respiratory symptoms) 
were taken together, there was no clear overall respiratory effect of air 
pollution. In the panel with chronic respiratory symptoms, positive 
associations among PM10, black smoke, the prevalence of large PEF 
decrements and upper respiratory symptoms were observed. The results 
suggest that subjects with low levels of plasma p-carotene showed an effect 
of air pollution, in particular, for PM10 and black smoke in relation to large 
PEF decrements, whereas subjects with high levels of plasma p-carotene did 
not show an effect of air pollution. No difference in acute respiratory effects of 
air pollution was observed for a high versus a low dietary intake of vitamin C, 
E and p-carotene and for plasma a-tocopherol. 
In conclusion, the results suggest that the acute respiratory effects of 
winter air pollution are reduced in subjects with high serum levels of p-
carotene, which is partly in line with the specified hypothesis in chapter 1. 
Antioxidants in relation to indicators of asthma and COPD 
In this part of the thesis, we investigated whether antioxidants were 
associated with the prevalence of the indicators of asthma and C O P D in the 
M O R G E N study. This study is a cross-sectional investigation on the 
prevalence of risk factors for chronic diseases using self-administered 
questionnaires and a physical examination in a randomly selected sample of 
the Dutch population. The results are summarised in Table 2. 
Dietary antioxidants 
W e examined first the relations between dietary antioxidants (vitamins C, E 
and p-carotene) and the prevalence of a number of respiratory symptoms and 
lung function in a population based sample in 6,555 adults (Chapter 5). 
Our results suggested that a high dietary vitamin C and p-carotene 
intake was associated with a higher FENA, and FVC. Dietary vitamin E was not 
associated with lung function. None of the dietary antioxidants were 
consistently associated with the prevalence of a number of respiratory 
symptoms. So these results are only partly in accordance with the hypothesis 
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(chapter 1), that is, subjects with a high dietary intake of vitamin C and (3-
carotene had a higher lung function compared to subjects with a low dietary 
intake of these antioxidants. 
Table 2: Relations between antioxidants and respiratory symptoms or lung function 
Ch. Main 
endpoint 
Source Antioxidants Association 
beneficial none adverse 
5 respiratory 
symptoms 
diet vitamins C, E, 
p-carotene 
vitamins C, E, 
p-carotene 
5 lung function diet vitamins C, E, 
p-carotene 
vitamin C, 
P-carotene 
vitamin E 
6 respiratory plasma a-tocopherol, p-carotene a-tocopherol a-tocopherol 
symptoms p-carotene (borderline) & dyspnea 
7 lung function plasma a-tocopherol, 
p-carotene 
p-carotene & 
FVC (borderline) 
tendency FEV, 
a-tocopherol 
Ch.: Chapter number; borderline: borderline significant p O.10; 
tendency: same positive direction, but not statistically significant 
Plasma levels of antioxidants 
Since blood levels of antioxidants are likely to be better markers of the 
antioxidant exposure in the lung, we investigated the relation between plasma 
levels of antioxidants and respiratory symptoms or lung function as well. 
First, we examined the relation between plasma levels of B-carotene or 
a-tocopherol and respiratory symptoms in a case-control sample of never and 
long-term former smokers who were selected from the M O R G E N study. Our 
results suggested that cases (subjects with one or more chronic respiratory 
symptoms) tended to have lower plasma B-carotene levels than controls. 
Plasma a-tocopherol was not associated with asthma and chronic bronchitis 
symptoms but was positively associated with dyspnea. This adverse 
association of plasma a-tocopherol could not be explained by adjustment for 
cardiovascular risk factors and remains puzzling. 
Second, we evaluated the relation between plasma antioxidants (B-
carotene and a-tocopherol) and lung function in a random sample (n=367) of 
the M O R G E N study. W e found that subjects with a high plasma B-carotene 
concentration tended to have a higher FVC and FEV, than subjects with a low 
plasma p-carotene concentration but this was not statistically significant for 
FEV,. Plasma a-tocopherol was not associated with lung function. 
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These results are only for plasma B-carotene in line with the hypothesis 
specified in chapter 1. 
Methodological considerations 
Misclassification of exposure 
Intake of antioxidants 
Most large epidemiological studies have been using self-administered food 
frequency questionnaires as a measure of dietary intake because of limited 
resources in relation to the large number of participating subjects. These 
questionnaires introduce inherent measurement errors, in particular, for 
micronutrients such as antioxidant (pro)-vitamins. The measurement error 
occurs because the questionnaires rely on the memory of the subjects, the 
stability of the dietary pattern and because of converting the data on foods 
into nutrients using food composition tables. The errors in the food 
composition tables are probably larger for antioxidant (pro)-vitamins than for 
macronutrients because the variation in the vitamin content in the foods is 
generally greater than the variation in macronutrient content 9 2 . 
The food frequency questionnaire used in this thesis (chapter 4 and 5) 
was developed to measure the habitual consumption of 178 food items during 
the last 12 months 8 6 8 7 . The reproducibility for estimated antioxidant intake 
with this food frequency questionnaire was fairly good, in particular for men as 
measured at six and 12 months intervals. The Pearson's correlation 
coefficient at 12 months for vitamin C was 0.74 for men and 0.70 for women; 
for vitamin E 0.73 for men and 0.67 for women; for p-carotene 0.78 for men 
and 0.59 for women 8 7 . 
Plasma levels of antioxidants 
Vitamin C 
The reproducibility of vitamin C in blood over time was measured within a 
validation study of a food frequency questionnaire. In this study, blood was 
drawn in January or February and in June or July (6 months in between). The 
correlation coefficient was low ( r=0 .29 ) 1 1 S . 
Plasma vitamin C does not reflect the usual individual intake. These 
levels show a S-shaped curve with the intake of vitamin C per day 5 0 ; an 
intake below 20 mg/day is not available for circulation but enters the cells 
immediately 7 9 ; at a daily intake of 30 to 60 mg the curve is steepest and with 
a daily intake of 90 to 150 mg it reaches a plateau which coincides with a 
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plasma level of 1.2 to 1.5 m g / d l 3 4 . Daily intakes above 100 mg will partly be 
excreted in the urine M ' 7 9 . So plasma vitamin C levels are controlled by a 
homeostatic mechanism. This implies that the relation between vitamin C 
intake and blood levels is not l inear 4 B . The cyclists in our second intervention 
study (Chapter 3) had baseline plasma vitamin C levels on average of 1.5 
mg/dl (85 u.mol/1) which is already in the plateau-phase of the curve. In 
conclusion, plasma vitamin C was not a good marker for dietary or 
supplemental intake of vitamin C. The storage of vitamin C is mostly within 
the cells, such as leukocytes. Dietary or supplemental intakes above 100 mg 
have been shown to increase the concentration in these ce l ls 5 0 . 
Vitamin E 
The reproducibility over time for blood vitamin E was estimated from a 
validation study on this food frequency questionnaire 8 7 . In this study blood 
samples were drawn at 4, 6 and 9 months. The reproducibility for levels of 
blood vitamin E was good with a small range in correlation coefficients from 4 
to 9 months (0.81 to 0.77) [personal communication, M.C. Ocké, RIVM, the 
Netherlands]. Plasma levels of oc-tocopherol are moderately related to vitamin 
E supplements 4 8 . W e found that a daily supplementation of 75 mg of a -
tocopherol for 10 weeks increased plasma a-tocopherol levels by 3 8 % 
(chapter 2). A daily supplementation of 100 mg a-tocopherol for 15 weeks 
increased plasma levels by 4 8 % (chapter 3). 
B-Carotene 
Reproducibility over time for blood levels of p-carotene was also calculated 
from a validation study 87'. The reproducibility was fairly good with a small 
range in correlation coefficients from 4 to 9 months (0.75 to 0.64) [personal 
communication, M.C. Ocké, RIVM, the Netherlands]. 
Blood levels of B-carotene are very sensitive to supplemental intake as 
they are not closely regulated by a homeostatic mechanism 4 8 . W e showed 
that a daily supplement of 15 mg for 10 weeks increased the levels of plasma 
p-carotene by 150% (chapter 2). 
Relative validity of antioxidant intake with plasma antioxidant levels 
Most epidemiological studies use plasma levels of antioxidants (a-tocopherol 
and p-carotene) as objective markers for dietary intake. However, the 
correlations between dietary and plasma a-tocopherol and dietary and 
plasma p-carotene are often low. One possible explanation was already 
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mentioned, namely the inadequacy of the food frequency questionnaire to 
measure micronutrients correctly. 
Another explanation for a weak correlation between vitamin E intake 
and a-tocopherol in blood is that the absorption of vitamin E is incomplete 
and variable (20-80% in various studies 3 A ) . Additionally, the efficiency of 
absorption declines with increasing dose or amount per meal 7 g . The 
correlation between levels of a-tocopherol in plasma and diet from a 
validation study developed for the used food frequency questionnaire in this 
thesis was 0.23 for men and 0.15 for women 8 7 . These correlation coefficients 
are low but fit well within the range of correlation coefficients for non-
supplement users found for similar questionnaires 1 0 4 - 1 0 8 1 1 4 1 1 9 . 
An explanation for low correlations between plasma en dietary levels of 
B-carotene is that plasma levels of p-carotene depend on the rate of intestinal 
absorption, the efficiency of the enzymatic transformation into retinoids and 
the rate of clearance from plasma 7 S . The above mentioned validation study 
showed low correlation coefficients (negative for men and 0.13 for women) 
between dietary intake measured with the food frequency questionnaire and 
plasma levels of B-carotene 8 7 . These correlation coefficients are lower 
compared to other validation studies 1 0 4 ' 1 1 4 1 1 9 suggesting that our food 
frequency questionnaire is limited with respect to measuring the intake of B-
carotene. A few factors may explain this. First, the relative validity of the 
vegetable intake, which is the main contributor of the p-carotene intake, was 
poor 8 S . Second, some food items in the questionnaire, such as 'soup' and 
'cabbage & kale' were heterogeneous with respect to p-carotene composition 
88,87 Third, the major sources of p-carotene in the Netherlands are 
yellow/orange and green vegetables and the bioavailability of p-carotene in 
these vegetables is low 3 4 . Furthermore, Dutch regulations do not allow p-
carotene fortifications of foods, which implies that many different foods each 
contributed a little to the total intake of p -carotene 8 7 . 
Since the food frequency questionnaire was probably poor in 
classifying p-carotene intake, the associations between dietary p-carotene 
and respiratory symptoms or lung function in this thesis (chapter 4 & 5) may 
have been biased towards the null due to non-differential misclassification of 
exposure. 
So, plasma levels of a-tocopherol and p-carotene are not a good 
marker for dietary intake of these antioxidants determined with our food 
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frequency questionnaire because of the occurring measurement errors in the 
food frequency questionnaire and the metabolic processes in the body. 
Levels of antioxidants in the lungs 
Plasma levels of antioxidants could be good markers for the level of 
antioxidants in the lungs. All three antioxidants (vitamin C, E and p-carotene) 
are present in the lungs, namely in the lung lining fluids and/or in the cells. 
The effect of supplementation of antioxidants on the concentration in the lung 
lining fluids has recently been investigated 1 Z 0 . Twenty-four healthy non-
smoking adults were daily supplemented with 500 mg vitamin C and 400 mg 
a-tocopherol for 7 days and the change in the levels of vitamin C and a-
tocopherol in plasma and in the epithelial lining fluids were determined. 
Preliminary results suggest that plasma levels of vitamin C and a-tocopherol 
significantly increased in the supplementation group but not in the placebo 
group. However, the levels of these antioxidants in nasal lavage, bronchial 
lavage, and bronchoalveolar lavage did not change in both groups 1 2 ° . It 
should be noted that all subjects had levels of plasma vitamin C well below 
the plateau level and that the period of supplementation was very short. So a 
longer period of supplementation, such as, 10 or 15 weeks which we used in 
our intervention studies might still increase the concentration of antioxidants 
in the lung lining fluids. In addition, an increase of vitamin E in the lung 
epithelial cells rather than in the fluids can not be excluded in this study. 
Plasma levels of antioxidants (p-carotene and a-tocopherol) are 
probably better markers of exposure in the lungs than dietary intake of 
antioxidants. To our knowledge there has only been one study correlating the 
concentrations of antioxidants in the lung tissue, blood levels and dietary 
intake 4 S . In this study, 21 subjects underwent an open lung biopsy in which 
tissue samples were obtained. Blood samples were additionally drawn. 
Bronchoalveolar lavage (BAL) samples were only obtained in 12 subjects and 
p-carotene was often not detectable in BAL- so we omit this in the 
comparisons. In addition, all subjects filled in a semi-quantitative food 
frequency questionnaire with additional questions on vitamin supplementation 
(9 of the 21 subjects used vitamin supplements). Pearson's correlation 
coefficients were calculated between these three media for each antioxidant 
(see table 3). 
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Table 3: Pearson's correlation coefficients between intake (both dietary 
and supplemental), serum and lung tissue antioxidant levels 
Intake Serum 
3-carotene 
Serum 0.26 -
Lung tissue 0.19 0.72 
a-tocopherol 
Serum 0.71 -
Lung tissue 0.20 0.47 
Modified from Redlich et al 46 
As was hypothesised, the levels of antioxidants in blood appeared to be 
better correlated with the levels in the lung tissue than the intake of these 
antioxidants. There are, however, a few limitations to this study. First, the 
number of subjects was very small for a validation study. Second, only one 
blood sample was obtained, whereas three separate tissue samples from 
different parts of the lung were obtained. Third, no adjustments were made for 
total cholesterol levels which could have resulted in the spurious high 
correlation coefficient (r=0.71) between dietary vitamin E and plasma levels of 
a-tocopherol compared to other s t u d i e s 8 7 ' 1 0 6 1 1 9 . 
In conclusion, plasma or serum levels of antioxidants are better 
markers of exposure in the lungs than dietary intake measured by 
questionnaire. 
Selection bias 
In the first part of this thesis, selection bias could not have affected the results 
because subjects in intervention studies and in panel studies were serving as 
their own control in the data analysis. 
In the second part of this thesis, we used the data of the M O R G E N -
study, which is an observational study, and selection bias could have been 
present. Selection bias might have occurred studying the relations between 
antioxidants and lung funcfion (chapter 5 & 7) because subjects who did not 
meet ERS criteria for lung function measurements were excluded from 
analysis on antioxidants and lung function. If selection bias was present, our 
observed association between lung function and antioxidants would be 
slightly lower when these subjects were included in the analysis (see 
discussion sections of chapter 5 & 7). 
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Confounding bias 
Confounding bias occurs when the observed association between exposure 
and effect differs from the true association because of a third variable that is 
correlated with the exposure variable and the health outcome. This third 
variable has to be an independent risk factor of the health outcome 1 2 1 . 
In the first part of this thesis, the characteristics of the subjects could 
not have been confounding variables since each subjects was his/her own 
control in the analysis. In addition, the two intervention studies were 
randomised so known and unknown confounding characteristics were 
probably evenly distributed over the groups. 
In the second part of this thesis, several subject characteristics were 
known to be risk factors for respiratory symptoms (chapter 5 & 6) and lung 
function (chapter 5 & 7), such as age, gender, and smoking. These risk 
factors were also associated with the antioxidant intake or plasma. So we 
adjusted for these known confounding factors in the relations between 
antioxidants and respiratory symptoms or lung function. In conclusion, known 
confounding factors were taken into account. W e can, however, not exclude 
that due to measurement error in the confounders some residual bias might 
have occurred in the observed associations. 
Study design 
In the second part of this thesis, the relations between antioxidants and the 
indicators of asthma and COPD were investigated cross-sectionally. In 
chapter 5, we did not find a relation between dietary antioxidants and 
respiratory symptoms. With such a design, it is possible that subjects altered 
their diet as a result of their symptoms and a potentially protective effect could 
have been biased towards the null hypothesis. It should be noted, however, 
that scientific evidence is scarce on the possible relation between 
antioxidants and respiratory disease and that, therefore, the general public is 
probably not aware of such a possible relation. 
Another problem with this study design is that the exposure data 
(antioxidants) are simultaneously ascertained with the disease information 
(respiratory symptoms or lung function) 1 2 1 . The previous exposure to 
antioxidants of subjects might be more relevant because a time interval of 
several years is expected (lag time) between exposure and the onset of the 
chronic effects, such as, increased respiratory symptoms or a decreased lung 
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function. However, so far the precise etiological relevant time period until the 
occurrence of asthma and COPD is unclear. 
Comparison with other studies 
Antioxidants in relation to the acute respiratory effects of air pollution 
As described in the main findings, we found a significant decrease in FEV, 
(186 ml) and FVC (183 ml) in the control group with an increase of 100 u.g/m3 
ozone. The supplementation group (vitamin C, E and p-carotene) did, 
however, not show a significant effect of ozone on FEV, (-20 ml) and FVC (25 
ml) (chapter 2) . In chapter 3, FEV, (77 ml) and FVC (136 ml) decreased 
significantly with an increase of 100 (ig/m 3 ozone in the control group. In the 
supplementation group (vitamin C and E), FVC (40 ml) decreased also 
significantly with an increase of 100 u^/m 3 ozone but FEV, did not decrease 
significantly (9 ml). The differences in ozone effect for FEV, and FVC 
between the control and supplementation group were statistically significant in 
both intervention studies. 
Our results are consistent with the results of the other studies on 
modulation of the acute effects of ozone on pulmonary function by antioxidant 
supplements 1 0 ' 3 1 3 3 , although the level of ozone exposure and dose and sort 
of antioxidant supplementation were different. In one of the earlier 
experimental studies, a supplementation of vitamin C and E showed a mean 
decrease of FEV, (57 ml) and of FVC (40 ml) after two hours of exposure to 
600 u.g/m3 ozone with exercise, while the placebo group showed a 
significantly larger mean decrement of FEV, (79 ml) and FVC (64 ml) 1 0 . A 
similar decrease in FEV, (77 ml) and in FVC (74 ml) was observed after 
exposure for 2 hours to 800 u.g/m3 ozone with intermittent exercise in the 
placebo group while the supplementation group (vitamin C, E and vegetable 
cocktail) showed a significantly lower decrease in FEV, (42 ml) and FVC (35 
ml). These results were preliminary because of the total of 30 healthy 
subjects only 18 subjects were included in the analysis 3 3 . Both studies were 
experimental in design. There has only been one study under ambient 
conditions and that was among street workers (n=49) of Mexico-city 3 1 . These 
street workers received a similar cocktail as our cyclists in 1994 and 
performed repeated lung function measurements. They were, however, not 
exercising heavily but the ambient ozone concentration was higher (163 
u.g/m3). This study had a cross-over design and in the first phase, an increase 
of 100 u.g/m3 ozone would significantly decrease FEV, (211 ml) and FVC (160 
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ml) in the placebo group while the supplement group did not decrease FEV, 
(46 ml) and FVC (31 ml) significantly. The second phase of this study did not 
show clear effects of ozone because the washout period (2 weeks) between 
the supplementation of antioxidants and placebos was probably too short 3 1 . 
So all studies and, in particular, the Mexican study showed similar 
decreases in lung function after ozone exposure in the control group and 
supplementation group compared to our intervention studies. The difference 
in decreases in lung function between the study groups were, however, 
smaller in the experimental studies compared to studies under ambient 
conditions. These experimental studies had, however, much higher levels of 
ozone exposure which makes comparison to the effect of ambient air pollution 
difficult. 
To our knowledge, our panel study on a possible modulation of dietary 
and plasma antioxidants on the acute effects of winter air pollution was the 
first study investigating a possible modulation of these antioxidants in diet and 
in blood. So we can not compare our results quantitatively with other studies. 
Our results do suggest that plasma B-carotene can possibly modulate the 
acute effects of winter air pollutants, in particular, PM10 and black smoke on 
large PEF decrements. 
Antioxidants in relation to indicators of asthma and COPD 
In chapter 5, our results suggest that a high intake (213 mg) of vitamin C was 
associated with a 53 ml higher FEV, and a 79 ml higher FVC compared to a 
low intake of vitamin C (68 mg). This was consistent with other studies on 
vitamin C intake in relation to lung function 1 3 ' 1 5 ' 4 0 . A difference of 40 mg of 
vitamin C intake was associated with 25 ml higher FEV, and 23 ml higher 
FVC in a large (n=2,633) general population sample 1 3 . In the NHANES I 
(n=2,526) a 40 ml difference in FEV, was shown between the highest fertile 
(mean 178 mg) and lowest fertile (mean 17 mg) of vitamin C intake 4 C . This 
difference (161 mg) between the highest and lowest fertile was similar 
compared to the difference between our 90 t h and 10 t h percentile of vitamin C 
intake (145 mg). A difference of 140 mg of vitamin C intake was associated 
with a difference in FEV, of 98 ml and FVC of 140 ml in a small group (n=178) 
of elderly subjects 1 5 . 
Subjects with a high intake of B-carotene (3.7 mg) had a 60 ml higher 
FEV, and a 75 ml higher FVC compared to subjects with a low intake (1.2 
mg) (chapter 5). W e can not compare our results quantitatively with other 
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studies because other published studies did not address the relation between 
dietary p-carotene and lung function. 
Dietary vitamin E was not associated with lung function (chapter 5). 
This is consistent with a large population sample (n=2,633) after adjustment 
for vitamin C 1 3 , but inconsistent with a small sample (n=178) of elderly 1 S . 
In this thesis, most of the dietary antioxidants (vitamin C, E and p-
carotene) were not consistently associated with the prevalence of several 
respiratory symptoms. This is difficult to compare quantitatively with other 
studies because the outcome variable, such as respiratory symptoms or 
disease status and the studied lag time differ between the studies. However, 
most prospective and cross-sectional studies did not find a relation with 
vitamin C and (indicators of) asthma and COPD 1 8 ' 1 7 3 9 . Most studies on dietary 
vitamin E and p-carotene did find positive associations with respiratory 
symptoms or disease status as outcome 1 7 ' 1 9 . 
In chapter 6, we found that cases (n=491) tended to have lower levels 
of plasma p-carotene than controls (n=496) (OR=0.81; 9 5 % CI: 0.63-1.04). 
Both cases and controls were non-smoking adults. These lower levels of p-
carotene was also observed in a group of male smokers with C O P D 
symptoms in a cross-sectional study (n=29,133) 1 9 . In this study plasma p-
carotene was lower in subjects with chronic bronchitis symptoms (OR=0.59; 
95%CI : 0.55-0.62) and with dyspnea (OR=0.62; 95%CI: 0.58-0.66) compared 
to subjects without respiratory symptoms 1 9 . In our study, plasma a-tocopherol 
was not associated with respiratory symptoms but positively associated with 
dyspnea. However in the above-mentioned study among male smokers, 
plasma a-tocopherol concentration was negatively associated with chronic 
bronchitis and dyspnea symptoms 1 9 . 
W e found that subjects with a high plasma p-carotene concentration 
(0.57 u.mol/1) had a 147 ml higher FVC than subjects with a low plasma p-
carotene concentration (0.11 u.mol/1). A higher FEV, (73 ml) for high versus 
low levels of plasma p-carotene was observed but this difference was not 
statistically significant (chapter 7). The magnitude of the association was 
similar for FVC but not for FEV, in a cross-sectional study among 798 men 
who had been exposed to asbestos 4 3 . A difference in the concentration of 
serum p-carotene of 0.29 u.mol/1 in this study was associated with a 90 ml 
higher FEV, and an 82 ml higher FVC. 
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W e did not find an association between plasma oc-tocopherol and lung 
function. This was consistent with the only other study investigating serum oc-
tocopherol levels in relation to the development of airway obstruction 4 1 . 
Biological plausibility of the associations 
In the following paragraphs the biological plausibility of the associations 
between antioxidants and the acute respiratory effects of air pollution, and 
indicators of asthma and COPD is discussed. 
Mechanisms of acute effects of air pollution 
Ozone and to a smaller extent N 0 2 react rapidly with poly-unsaturated fatty 
acids (PUFAs) in the lung initiating lipid peroxidation 1 2 2 . This causes a 
reduction in the membrane fluidity and permeability and starts the 'oxidative 
stress' 1 2 3 (see mechanisms of chronic inflammation). In addition, ozone and 
N 0 2 can directly release arachidonic acid from the membrane bilayer. 
Arachidonic acid, a precursor of prostaglandins and leukotrienes, is a poly-
unsaturated fatty acid which is, in particular, prone to oxidation because of its 
four double bonds 1 2 3 . In this way, elevated levels of leukotrienes may cause 
tissue damage and attract inflammatory cells 2 5 . An increase in inflammatory 
mediators was shown in bronchoalveolar lavage within one hour 7 3 , 7 4 , six 
hours 6 6 , 18 hours 7 3 , 7 4 , and 24 hours 6 6 of acute ozone exposure. This 
increase of inflammatory mediators was different for each mediator in time 
86,73,74 
Antioxidants, in particular, vitamin C, may modulate the reactivity of 
oxidants (ozone and N 0 2 ) by reacting directly with them before oxidants can 
injure the lung tissue which could have lead to increased levels of the 
inflammatory cells 5 6 , 1 2 2 . Vitamin E is in particular known for stopping the 
process of lipid peroxidation 1 2 2 . After exposure to other air pollutants, such as 
particulate matter and black smoke, the amount of inflammatory cells and 
indirect the level of oxygen metabolites can increase 1 2 4 . Antioxidants might 
also react with these oxygen metabolites preventing a further influx of 
inflammatory cells and decreasing so the damage to the lung tissues. 
Since lung function decrements after ozone exposure occur earlier in 
time, within one hour after the exposure compared to the increase of 
inflammatory cells, another hypothesis was suggested: maximal inspiratory 
capacity was reduced through stimulation of the neural receptors in the upper 
airways by cyclooxygenase products of arachidonic acid 6 7 . This is confirmed 
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in another more recent study of Hazucha et al 9 5 who showed that an anti-
inflammatory drug with antioxidant capacity (ibuprofen) suppressed the 
release of metabolites of arachidonic acid and decrements in lung function 
but not the release of inflammatory cells. Vitamins C and E have been shown 
to affect arachidonic acid metabolism, but the role of these vitamins in this 
metabolism is not fully understood 1 0 ' 2 0 ' 6 8 . 
Mechanisms of asthma and COPD through chronic inflammation 
Most of the acute respiratory effects of air pollution, such as pulmonary 
function decrements are mild and reversible in nature, in particular, in healthy 
individuals. However, there are suggestions that repeated peak exposures to 
ambient air pollution might lead to the occurrence of asthma or C O P D or 
deteriorate the health in those subjects in whom chronic respiratory disease is 
present 1 2 5 - 1 2 7 . 
Acute and chronic tissue damages of the airways are partly caused by 
'oxidative stress' 1 2 B . The term 'oxidative stress' indicates an increased free-
radical formation in the body when antioxidant defences are not adequate 
and increased damage or cell injury is likely 1 2 9 , 1 3 C . Exogenous oxidants or free 
radicals such as cigarette smoke and air pollution can cause direct or indirect 
'oxidative stress' in the lungs m . These exogenous oxidants can trigger 
inflammatory cells, such as neutrophils, macrophages, and eosinophils to 
produce reactive oxygen metabolites (that is, endogenous oxidant sources) 
increasing further the 'oxidative s t r e s s ' 2 5 1 2 8 ' 1 3 1 . These inflammatory cells can 
also be triggered by the so-called 'respiratory burst' generating a large 
amount of reactive oxygen species Z 5 . Triggers of the 'respiratory burst' 
include leukotrienes, fatty acids and immune complexes 1 2 3 . During the 
'respiratory burst' the inflammatory cells have an increased oxygen uptake 
and produce by different reactions reactive oxygen species. The produced 
reactive oxygen species (radicals and non-radicals) from the 'respiratory 
burst' can cause epithelial damage and mucus hypersecretion, important 
features of asthma and chronic bronchitis. 
Asthma can, therefore, be considered as a chronic inflammatory 
process. The observed asthmatic hyperresponsiveness has been suggested 
to be a consequence of the inflammatory reaction and epithelial damage 
25,26,131 
Chronic bronchitis has similar features as asthma, such as chronic 
airflow obstruction 1 3 2 and inflammation as was observed by increased 
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inflammatory mediators 1 3 3 . Smoking is a major cause of chronic bronchitis but 
not all smokers develop symptoms of chronic bronchitis 1 3 2 . 
Chronic increased levels of the leukocyte elastase released from 
neutrophils might cause emphysema. The enzyme a r antitrypsin (or alpha-1-
protease inhibitor) can inhibit the activity of elastase. This enzyme can be 
deficient by inheritance in some subjects. Cigarette smoking but also the 
increase of inflammatory cells such as the influx of leukocytes might increase 
the changes of lung tissue destruction as a result of the concomitant release 
of oxidative proteins which reduces a1-antitrypsin and thereby induce lung 
emphysema **we.««-i». 
Antioxidants could neutralise the induced oxidative damage to lung 
proteins, the produced reactive oxygen species and protect against lipid 
peroxidation. In this way, an increased antioxidant status might decrease 
chronic inflammation 1 3 7 . In case of inflammation the antioxidants might 
additionally preserve the inhibitory activity of a r antitrypsin and so the integrity 
of the alveolar membrane 1 3 S . The results of a recent cross-sectional study in 
non-smoking subjects (n=132) showed that elevated levels of lipid 
peroxidation products as a measure of 'oxidative stress' and lower levels of 
serum bilirubine, which is an antioxidant, were associated with a lower 
percent predicted F E V , 1 3 8 . 
Are antioxidants beneficial in asthma and COPD? 
In the second part of this thesis we found that dietary vitamin C and B-
carotene were associated with a higher lung function (chapter 5). Plasma p-
carotene tended to be associated with a lower prevalence of respiratory 
symptoms (chapter 6) and with a higher lung function (chapter 7) . Dietary 
vitamin E and plasma a-tocopherol were not associated with respiratory 
symptoms or lung function. 
Our results should be placed in a broader perspective. Two recent p-
carotene supplementation trials observed higher lung cancer incidences with 
daily supplementation of 20-30 mg p-carotene 4 4 A B . This was in particular the 
case in subgroups of subjects, who smoked and drank more 1 3 9 . However, 
baseline dietary intake and serum levels of p-carotene were inversely related 
to lung cancer incidence in the control groups of both trials and in other 
observational studies. Albanes and co-workers 1 3 9 suggested that baseline p-
carotene might serve as a marker for other substances that are the actual 
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protective agents or that p-carotene is a general indicator for other beneficial 
dietary or protective life-style practices. For example, plasma levels of 
carotenoids showed a fairly high (r=0.54) correlation with the total intake of 
vegetables and fruits 1 4 ° . Additionally, an increased intake of fruits and 
vegetables (from 3 or less to 8 servings) for 8 weeks showed an increased 
plasma concentration of p-carotene, a-carotene and vitamin C 1 4 1 . 
Subjects with a high exposure to oxidants, such as smokers, are more 
likely to benefit from high intake or plasma levels of antioxidants. However, 
we were not able to perform statistical evaluation of the presence of effect 
modification of smoking status on the associations among dietary and blood 
levels of antioxidants, lung function and respiratory symptoms because of the 
relatively small number in each group for the different smoking groups. In 
addition, the relation between plasma antioxidants and respiratory symptoms 
was only studied in non-smokers. So, it remains intriguing if particular 
sensitive subgroups in the population, such as smokers are likely to have 
more benefit of the antioxidants. 
In addition, we could not evaluate the independent effect of dietary 
vitamin C and p-carotene (chapter 5) because both antioxidants are highly 
correlated through their presence in the same food groups (fruits and 
vegetables). So we can not exclude the possibility that our results for vitamin 
C and p-carotene represent a healthy dietary pattern or life style rather than 
the effect of the antioxidants alone. 
Future studies 
Since very few studies were performed to evaluate a possible beneficial effect 
of antioxidants on both the acute respiratory effects of ambient air pollution 
and on the indicators of asthma and COPD, more studies are needed. It is 
important to elucidate whether vitamin C, p-carotene or other antioxidants are 
beneficial. Furthermore, to understand if antioxidants are really the actors, 
which are beneficial, studies are needed to determine which other factors that 
could be beneficial, co-vary with antioxidants. 
In order to increase our understanding intervention and observational 
studies on the acute effects of air pollution are helpful. Firstly, more 
panel/intervention studies on the acute effects of air pollution under ambient 
conditions should be performed rather than under laboratory conditions 
because a combination of pollutants which occurs under ambient conditions 
might be more relevant. So far most of the studies investigated a possible 
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modulation of the acute effects of air pollution on lung function by 
antioxidants. However, a modulation of the effect of air pollution on the 
inflammatory markers might be more important because these respiratory 
effects might not be as reversible as lung function decrements. Secondly, 
most studies on the modulation of acute effects of air pollution by antioxidants 
have been performed in healthy subjects while most effect might be expected 
from sensitive subgroups, such as subjects with asthma and C O P D as was 
observed in chapter 4 and in a recent study under laboratory conditions 3 2 . 
Thirdly, the doses of supplements should be within the range which might be 
reached by a change of diet because long-term supplementation with 
relatively high doses (pharmacological doses) has shown to have adverse 
effects in studies with other outcomes, such as lung c a n c e r 4 4 4 6 . In addition, 
researchers commented on these studies that synthetic supplements of B-
carotene do not have the same isomer structure as naturally occurs in fruits 
and vegetables 1 4 2 ' 1 4 3 . Therefore, an intervention study in which the diet is 
changed towards a higher intake of antioxidants with more fruits and 
vegetables or is supplemented with cocktails of naturally occurring 
antioxidants might be advisable. 
For a clearer picture on the evidence of a possible beneficial effect of 
individual antioxidants on asthma and COPD, different studies are needed. 
Blood should be collected in large prospective studies as an objective marker 
for antioxidant status. In these studies, lung function and respiratory 
symptoms should be measured every few years as outcomes to determine 
the relevant lag time for a beneficial effect of these antioxidants. When the 
relevant lag time has been established, intervention studies could explain if 
single antioxidants, a cocktail of antioxidants or a change in diet towards 
more fruits and vegetables is important in preventing the occurrence of 
asthma and COPD. In addition, the large prospective studies could elucidate 
if antioxidants are only beneficial in specific subgroups, such as smokers who 
are exposed to high levels of oxidants. 
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SUMMARY 
There is a growing recognition that air pollution even at low levels could have 
adverse health effects. In addition, there is an increasing recognition that the 
incidence of asthma has been increasing and that COPD is one of the important 
chronic diseases in Western countries. So new protective factors, such as 
antioxidants, have been evaluated in relation to the acute effects of air pollution and 
in relation to chronic conditions, such as asthma and COPD. 
Chapter 1 describes the results of other studies on the two main research 
questions in this thesis. This thesis is divided into two parts and for each part one 
main research question was specified. In the first part (chapter 3-6), the question 
was whether the acute respiratory effects of air pollution under ambient conditions 
can be modulated by antioxidants. In the second part (chapter 5-7), we studied the 
associations between antioxidant (pro)-vitamins in diet and blood and the prevalence 
of the indicators of asthma and COPD in different population-based samples of the 
cross-sectional MORGEN-study (the monitoring project on risk factors and health in 
the Netherlands). 
In chapter 2, we evaluated whether acute lung function effects of ozone can 
be modulated by antioxidant vitamin supplementation in 26 amateur cyclists in the 
summer of 1994. Repeated lung function measurements were performed before and 
after training sessions or competitive races on 4 to 14 occasions. The cyclists were 
randomly assigned to two study groups. The supplementation group (n=12) received 
daily antioxidant supplements (15 mg B-carotene, 75 mg vitamin E and 650 mg 
vitamin C) for 3 months. The control group did not receive supplementation. For 
each subject, post-exercise lung function was regressed on the previous 8-hour 
mean ozone concentration (mean 101 j ig/m 3 ) . The individual regression coefficients 
were pooled for each study group and weighted with the inverse of the variance. For 
the supplementation group, there was no effect of ozone on forced vital capacity 
(FVC), forced expiratory volume in 1 second (FEVi) , peak expiratory flow (PEF) and 
maximal mid-expiratory flow (MMEF). For the control group there was a significant 
effect of ozone on FEVi , FVC and PEF. The difference between the groups was 2.08 
[95% confidence interval (CI): 1.31, 2.85] ml/u.g/m 3 for FVC, 1.66 (95% CI: 0.62, 
2.70) ml/ng/m 3 for FEV,. 6.83 (95% CI: 3.17,10.49) ml/sec/u.g/m 3 for PEF and 0.42 
(95% CI: -1.38, 2.22) ml/sec/ug/m 3 for MMEF. 
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In chapter 3, we investigated whether acute effects of ozone on lung function can be 
modulated by antioxidant vitamin supplementation in a placebo-controlled study. 
Lung function was measured in Dutch cyclists (n=38) before and after each training 
on a number of occasions (n=380) in the summer of 1996. The vitamin group (n=20) 
received daily 100 mg vitamin E and 500 mg vitamin C for 15 weeks. Individual linear 
regression analysis was performed with post-exercise lung function as dependent 
variable and 8-hour mean ozone concentration as independent variable (mean 86 
ug/m 3 ) . Medians were calculated for each study group. After excluding subjects with 
insufficient compliance from the analysis, a difference in ozone exposure of 100 
u.g/m3 would decrease FEVi with 95 ml (95% confidence interval (95% CI): -265 to -
53 ml) in the placebo group and with 1 ml (95%CI - 9 4 to 132 ml) in the vitamin 
group; for FVC this was -125 ml (95% CI - 3 8 4 to - 3 6 ) in the placebo group and -42 
ml (95%o CI - 1 3 0 to 35 ml) in the vitamin group. The differences in ozone effect on 
lung function between the control and vitamin group were statistically significant. 
In chapter 4, we investigated whether a high dietary intake or serum 
concentration of antioxidant (pro-) vitamins could attenuate the acute respiratory 
effects of air pollution in panels of subjects (n=227) with chronic respiratory 
symptoms in the winters of 1993/1994 and 1994/1995. Subjects performed daily PEF 
measurements in the morning and evening and reported the occurrence of 
respiratory symptoms in two panels (urban and non-urban) each winter for 3 months. 
Logistic regression analysis was used with the prevalences of large PEF decrements 
(more than 10% or more than 2 0 % below the median) or respiratory symptoms as 
dependent variables. The air pollutants, particles <10 u,m in diameter (PM10), black 
smoke (BS), S 0 2 and N 0 2 were the independent variables. Analyses were 
performed separately for subjects below and above the median levels of antioxidants 
(dietary vitamin C, p-carotene and serum p-carotene). In subjects with low levels of 
serum p-carotene (<0.30 u,mol/l), air pollution, in particular, PM10 and BS was found 
to increase the prevalence of large PEF decrements but there was no effect on 
respiratory symptoms. In subjects with high levels of serum p-carotene, there were 
no respiratory effects of air pollution. The effect of air pollution on the prevalence of 
large PEF decrements and respiratory symptoms was not different for subjects with 
a high versus low dietary intake of vitamin C or p-carotene. 
In conclusion, the results of the intervention studies described in chapter 2 
and 3 suggested that antioxidant (pro)-vitamin supplementation might protect partly 
against acute effects of ozone on lung function in heavily exercising cyclists. The 
results of chapter 4 suggest that high serum levels of p-carotene attenuated the 
respiratory effects of air pollution, in particular, the prevalence of large PEF 
decrements in a panel of subjects with chronic respiratory symptoms. Dietary vitamin 
C and p-carotene did not modify the acute respiratory effects of winter air pollution. 
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In chapter 5, we examined the relations between the intake of the antioxidants 
(pro)-vitamins C, E and p-carotene and the presence of respiratory symptoms and 
lung function. Complete data were collected in the MORGEN-study in a random 
sample of 6,555 Dutch adults aged 20-59 years during 1994 and 1995. Antioxidant 
intake was assessed by a semi-quantitative food frequency questionnaire. 
Respiratory symptoms (cough, phlegm, productive cough, wheeze, and shortness of 
breath) were assessed by a self-administered questionnaire. Prevalence odds ratios 
for symptoms were calculated using logistic regression analysis. Linear regression 
analysis was used for FEVi and FVC. The results are presented as a comparison 
between the 9 0 t h and the 1 0 t h percentiles of antioxidant intake. Vitamin C intake was 
not associated with most symptoms but was inversely related with cough. Subjects 
with a high intake of vitamin C had a 53 ml (95%CI: 23-83 ml) higher FEVi and 79 ml 
(95%CI: 42-116 ml) higher FVC than those with a low vitamin C intake. Vitamin E 
intake showed no association with most symptoms and lung function, but had a 
positive association with productive cough. The intake of p-carotene was not 
associated with most symptoms but had a positive association with wheeze. 
However, subjects with a high intake of p-carotene had a 60 ml (95%CI: 31-89 ml) 
higher FEV, and 75 ml (95%CI: 40-110 ml) higher FVC than those with a low intake 
of p-carotene. 
In chapter 6, we examined the relations between plasma levels of 
antioxidants, p-carotene and a-tocopherol, and chronic respiratory symptoms in a 
case-control sample with Dutch adults who were never or long-term former smokers. 
This sample was selected from the population-based MORGEN-study and plasma 
concentrations of antioxidants were determined in 496 controls and 491 cases. 
Cases were subjects who reported one or more respiratory symptoms. Odds ratios 
(ORs) were calculated for the chronic respiratory symptoms using logistic regression 
analysis and are presented for a difference between the 9 0 t h percentile (high) and 
the 1 0 t h percentile (low) of plasma antioxidant concentration. ORs were adjusted for 
age, gender and body mass index. The adjusted OR of plasma p-carotene for 
respiratory symptoms was below one (OR=0.81; 95%CI: 0.63-1.04). The OR of 
plasma a-tocopherol was slightly elevated for respiratory symptoms but this was 
mostly because of the elevated OR for dyspnea (OR=2.10; 95%CI: 1.28-3.43). 
Dyspnea is, however, also a common symptom in cardiovascular diseases. 
Additional adjustment for cardiovascular risk factors did not change the positive 
association between dyspnea and plasma a-tocopherol. 
In chapter 7, we investigated the relation between plasma antioxidants (p-
carotene and a-tocopherol) and lung function in Dutch adults. A random sample 
(n=367) was drawn from the participants in the M O R G E N study in 1995. Linear 
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regression analysis was performed with FEVi or FVC as dependent variables and 
plasma antioxidant concentration as independent variable. W e adjusted for age, 
height, gender, smoking status, pack-years of smoking, and alcohol consumption 
and we presented the results as a difference between the 90th and 10th percentile of 
plasma antioxidant concentration. Subjects with a high plasma p-carotene level 
tended to have a higher FEVi (73 ml, standard error of the mean (SEM) 60 ml; 
p=0.22) and a higher FVC (147 ml, S E M 76 ml; p=0.052) than subjects with a low 
plasma p-carotene level. This difference in lung function was only observed in 
current and never smokers but not in former smokers. There was no difference in 
lung function between subjects with high and low plasma a-tocopherol 
concentrations. 
In conclusion, we found that dietary vitamin C and p-carotene were positively 
associated with FEVi and FVC (chapter 5). Plasma p-carotene tended to be 
positively associated with FEVi and FVC but this was not statistically significant for 
FEVi (chapter 7) . Dietary vitamin E (chapter 5) and plasma a-tocopherol (chapter 7) 
were not associated with lung function. Plasma p-carotene tended to be inversely 
associated with respiratory symptoms. Plasma a-tocopherol was not associated with 
asthma or C O P D symptoms but was positively associated with dyspnea (chapter 6). 
None of the dietary antioxidants (vitamin C, E and p-carotene) were consistently 
associated with respiratory symptoms (chapter 5). 
In chapter 8, we conclude that measurement error in dietary antioxidants 
measured with our food frequency questionnaire is relatively large and that blood 
levels of antioxidants might better reflect the concentration of the antioxidants in the 
lungs. Our results of the intervention studies are comparable with those of other 
studies, both under ambient and laboratory conditions. Our results of the beneficial 
association of dietary vitamin C and plasma p-carotene on lung function were also 
observed by other cross-sectional studies. The lack of an association of dietary 
vitamin E and plasma a-tocopherol on lung function and respiratory symptoms is 
inconsistent with other studies. Future studies are needed to elucidate the 
mechanism of the observed associations. The following questions are important to 
take into account: (1) could antioxidants attenuate the effect of air pollution on 
inflammatory markers, (2) what is the relevant lag time for a beneficial effect of 
antioxidants, in particular, vitamin C and p-carotene on indicators of asthma and 
C O P D and (3) are antioxidants vitamin C and/or p-carotene or other substances 
associated with these antioxidants or a healthy life style the actual beneficial factors 
in relation to indicators of asthma and COPD. 
SAMENVATTING 
Met deze Nederlandse samenvatting geef ik kort de inhoud van mijn proefschrift weer. Ik heb 
hem geschreven voor de belangstellenden die niet bekend zijn met het vakgebied 
epidemiologie en het onderwerp, zoals familie en vrienden. 
Er bestaat een toenemend besef dat lage concentraties luchtverontreiniging zelfs slecht 
zijn voor de gezondheid, vooral voor de luchtwegen en longen. Ook is duidelijk 
geworden dat het aantal mensen dat astma krijgt toeneemt en dat chronische 
obstructieve longziekten (COPD) een belangrijke chronische ziekten categorie vormen 
in Westerse landen. Daarom wordt er gezocht naar nieuwe mogelijk beschermende 
factoren in de voeding, zoals antioxidanten, in relatie tot de acute effecten van 
luchtverontreiniging en in relatie tot chronische ziekten, zoals astma en COPD. Het 
begrip C O P D omvat de ziekten chronische bronchitis en longemfyseem. 
In hoofdstuk 1 beschrijf ik de resultaten van gepubliceerd wetenschappelijk 
onderzoek op het gebied van de twee vraagstellingen die centraal staan in dit 
proefschrift. Dit proefschrift is opgesplitst in twee delen. In het eerste deel (hoofdstuk 2, 
3, 4) staat de vraag centraal of acute effecten van luchtverontreiniging in de buitenlucht 
op de luchtwegen kunnen worden tegengegaan door antioxidanten. In het tweede deel 
(hoofdstuk 4, 5, 6) staat de vraag centraal of er een verband is tussen antioxidant 
vitamines en de aanwezigheid van astma en COPD. De onderzochte antioxidant 
vitamines in dit proefschrift zijn vitamine C, E en B-caroteen. Vitamine C en B-caroteen 
komen voornamelijk voor in groente en fruit en vitamine E in noten en plantaardige oliën 
en vetten. 
In hoofdstuk 2 is gekeken of de acute effecten van ozon op longfunctie 
veranderd kunnen worden door het geven van voedingssupplementen met antioxidant 
vitamines (capsules) bij 26 amateur wielrenners gedurende de zomer van 1994. Per 
persoon werden er 4 tot 14 keer longfunctiemetingen uitgevoerd voor en na de 
trainingen of wedstrijden. Aan het begin van het onderzoek werden de wielrenners 
willekeurig toegewezen aan één van de twee groepen. In de antioxidanten groep zaten 
12 wielrenners die dagelijks antioxidant capsules gedurende 3 maanden kregen (15 mg 
P-caroteen, 75 mg vitamine E, en 650 mg vitamine C). De controle groep bestond uit 14 
wielrenners die geen capsules kregen. 
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De gemiddelde ozon concentratie over de 8 uur voorafgaand aan de 
longfunctiemetingen na trainingen/ wedstrijden was 101 \ig/m3 gedurende de 
onderzoeksperiode. Na statistische analyse bleek dat er in de antioxidanten 
groep geen effect was van ozon op de volgende longfunctieparameters: FEVi 
(=volume lucht die in 1 seconde kan worden uitgeblazen bij een geforceerde 
uitademing), FVC (=totale longinhoud bij een geforceerde uitademing), PEF (ook 
wel piekstroom genoemd en is gelijk aan de maximale uitademingssnelheid). De 
controle groep liet wel een statistisch significant effect van ozon op de FEVi , 
FVC en PEF zien, namelijk de longfunctie daalde bij hogere ozon concentraties 
in de buitenlucht. Het verschil tussen de controle en antioxidanten groep in het 
effect van ozon was significant voor de meeste longfunctie variabelen ( F E V L 
FVC en PEF). 
Hoofdstuk 3 gaat over een onderzoek uitgevoerd in 1996 die vergelijkbaar 
is met het onderzoek in 1994. Alleen werden er meer personen gemeten en de 
controle groep kreeg placebo capsules (neppillen). Longfunctie werd in totaal 
380 keer gemeten bij 38 wielrenners voor en na de trainingen gedurende de 
zomer van 1996. De wielrenners werden willekeurig toegewezen aan een van de 
beide groepen. De vitamine groep kreeg dagelijks 100 mg vitamine E en 500 mg 
vitamine C voor 15 weken. De controle groep kreeg dagelijks placebo capsules 
die zichtbaar niet waren te onderscheiden van de vitamine capsules. De 
gemiddelde ozon concentratie over de 8 uur voorafgaand aan de 
longfunctiemetingen na trainingen was 86 u.g/m3 gedurende deze 
onderzoeksperiode. Na het uitsluiten van personen in de statistische analyses 
die niet genoeg capsules hadden geslikt, was er een significant effect van ozon 
op de longfunctie in de controle groep, maar niet in de vitamine groep. Uitgedrukt 
in getallen gaf een verschil in ozon blootstelling van 100 u.g/m3 een 95 ml afname 
in FEVi in de controle groep en een 1 ml afname in vitamine groep. Voor FVC 
was de afname 125 ml in de controle groep en 42 ml in de vitamine groep. De 
verschillen in het effect van ozon op de longfunctie tussen de controle en 
vitamine groep was statistisch significant. 
In hoofdstuk 4 onderzochten we of een hoge inname via de voeding of 
een hoge bloed concentratie van antioxidant vitamines de acute effecten van 
luchtverontreiniging op de luchtwegen kunnen tegengaan. Het onderzoek vond 
plaats gedurende 2 winters (1993/1994 & 1994/1995) bij 227 volwassenen van 
50 tot 70 jaar oud met chronische luchtwegklachten. De antioxidanten inname via 
de voeding werd gemeten met behulp van een voedselfrequentievragenlijst. Dit 
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is een vragenlijst waarin de frequentie van een aantal voedingsmiddelen, die veel 
gegeten worden door de algemene bevolking, wordt nagevraagd. De piekstroom 
(PEF) werd 's ochtends en 's avonds dagelijks voor 3 maanden gemeten door de 
deelnemers zelf en de uitkomsten worden samen met het voorkomen van 
luchtwegklachten opgeschreven in een dagboekje. In dit onderzoek werd onder 
andere gekeken naar de verbanden tussen het vóórkomen van grote dalingen in 
piekstroom of luchtwegklachten met luchtverontreinigingsconcentraties van fijn 
stof met een diameter kleiner dan 10u,m (PM10), zwarte rook, zwaveldioxide 
( S 0 2 ) en stikstofdioxide ( N 0 2 ) . Deze verbanden werden apart bestudeerd voor 
mensen met hoge en lage niveaus van antioxidanten in de voeding (vitamine C, 
en p-caroteen) of p-caroteen in bloed. Uit de resultaten bleek dat personen met 
lage niveaus van p-caroteen in bloed vaak grote piekstroom dalingen hadden na 
verhoogde luchtverontreinigingsconcentraties. Bij personen met hoge niveaus 
van p-caroteen in bloed waren er geen grote piekstroom dalingen na verhoogde 
luchtverontreingings-concentraties. De acute effecten van luchtverontreiniging op 
de luchtwegen waren niet verschillend voor personen met hoge of lage inname 
van vitamine C of p-caroteen via de voeding. 
Uit voorgaande drie hoofdstukken kunnen de volgende conclusies 
getrokken worden. De twee interventie onderzoeken in hoofdstuk 2 en 3 
suggereren dat antioxidant vitamine supplementen mogelijk zouden kunnen 
beschermen tegen de effecten van ozon op de longfunctie bij zich hevig 
inspannende wielrenners. De resultaten van hoofdstuk 4 suggereren dat hoge 
niveaus van p-caroteen in bloed de acute effecten van luchtverontreiniging in de 
winter kunnen tegen gaan bij een groep volwassenen met chronische 
luchtwegklachten. Vitamine C en p-caroteen inname via de voeding veranderde 
de acute effecten van luchtverontreiniging in de winter niet. 
In het tweede deel van dit proefschrift (hoofdstuk 5,6,7) werd het verband 
tussen niveau's van antioxidant vitamine inname via de voeding en in bloed en 
de aanwezigheid van astma en COPD onderzocht in verschillende steekproeven 
van de bevolking. De steekproeven kwamen voort uit een dwarsdoorsnede 
onderzoek naar risicofactoren en de aanwezigheid van chronische ziekten in de 
Nederlandse bevolking bij de leeftijdsgroep van 20 tot 59 jaar. Dit onderzoek is 
uitgevoerd op de GGD-en in 3 steden, namelijk Amsterdam, Doetinchem en 
Maastricht. Dit onderzoek heet het MORGEN-project en de afkorting staat voor 
het MOnitoring project over Risicofactoren en GEzondheid in Nederland. 
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In hoofdstuk 5 bestudeerden we het verband tussen de inname van 
antioxidant vitamines via de voeding en de aanwezigheid van luchtwegklachten 
en longfunctie. Complete gegevens van 6.555 volwassenen waren verzameld in 
het MORGEN-project gedurende 1994 en 1995. Antioxidant inname (vitamine C, 
E en p-caroteen) werd gemeten met behulp van een voedselfrequentie 
vragenlijst. Chronische luchtweg-klachten in het afgelopen jaar (hoesten, slijm 
opgeven, hoesten met slijm opgeven, piepen op de borst, kortademigheid) 
werden nagevraagd met een schriftelijke vragenlijst. Na statistische analyse 
bleek dat vitamine C inname niet gerelateerd was aan de meeste 
luchtwegklachten. Personen met een hoge inname hadden, echter, wel minder 
hoestklachten. Personen met een hoge inname van vitamine C hadden een 
significant hogere FEVi (53 ml) en FVC (79 ml) dan personen met een lage 
inname vitamine C. Vitamine E vertoonde geen verband met de meeste 
luchtwegklachten en met longfunctie. Personen met een hoge inname van 
vitamine E hadden, echter, wel meer klachten van hoesten met slijm opgeven. 
De inname van p-caroteen hing niet samen met de meeste luchtwegklachten, 
maar personen met een hoge inname hadden meer klachten van piepen op de 
borst. Echter, personen met een hoge inname van p-caroteen hadden een 
significant hogere FEVt (60 ml) en FVC (75 ml) dan personen met een lage 
inname van p-caroteen. 
In hoofdstuk 6 beschrijven we een onderzoek naar het verband tussen 
niveaus van antioxidanten in bloed (p-caroteen en ot-tocopherol) en chronische 
luchtwegklachten in een patiënt-controle steekproef bij volwassenen die nooit of 
langer dan 10 jaar geen sigaretten hebben gerookt. Deze steekproef kwam uit 
het MORGEN-project en de antioxidantconcentraties in bloed zijn bepaald bij 496 
controles (mensen zonder luchtwegklachten) en 491 patiënten (mensen met één 
of meer chronische luchtwegklachten). Het verband tussen antioxidanten en 
chronische luchtwegklachten werd gecorrigeerd voor leeftijd, geslacht en 
Quetelet Index (maat voor overgewicht, uitgedrukt als het gewicht in kg / lengte 
in meters 2 ) . Na correctie voor deze factoren hadden personen met 
luchtwegklachten een lager niveau van p-caroteen in bloed dan personen zonder 
luchtwegklachten. De concentratie van a-tocoferol in het bloed was niet 
verschillend tussen personen met en zonder luchtwegklachten. Alleen personen 
met kortademigheidklachten hadden een hogere concentratie a-tocoferol in 
bloed dan personen zonder chronische luchtwegklachten. Kortademigheid is, 
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echter, ook een belangrijk symptoom voor personen met hart- en vaatziekten. Na 
correctie voor risico factoren van hart- en vaatziekten hadden mensen met 
kortademigheidklachten nog steeds hogere a-tocoferol niveaus in hun bloed. 
In hoofdstuk 7 onderzochten we het verband tussen antioxidanten (p-
caroteen en a-tocoferol) in bloed en longfunctie in een groep volwassenen. Een 
steekproef werd getrokken van bijna 400 mensen uit alle deelnemers van het 
M O R G E N project waarvan gegevens waren verzameld in 1995. Het verband 
werd voor de volgende variabelen gecorrigeerd: leeftijd, lengte, geslacht, 
rookstatus (nooit roker, ex-roker of huidig roker), het aantal pakjes-jaren van 
roken (bestaat uit de duur van roken in jaren en het gemiddeld aantal pakjes 
sigaretten wat men gerookt heeft) en alcohol consumptie. Uit de resultaten bleek 
dat na correctie voor deze variabelen, personen met een hoge concentratie van 
P-caroteen in bloed een hogere FEVi (73 ml) en een hogere FVC hadden (147 
ml) dan personen met een lager p-caroteen niveau in bloed. Het verband tussen 
P-caroteen in bloed en FEVi was echter niet significant. Een hoger longfunctie 
niveau bij een hoger bloed niveau van p-caroteen werd alleen waargenomen bij 
personen die nu sigaretten rookten en die nooit sigaretten hebben gerookt, maar 
niet bij ex-rokers van sigaretten. Er was geen verschil in het longfunctie niveau 
tussen personen die hoge en lage concentraties van a-tocoferol in bloed hadden. 
De volgende conclusies kunnen getrokken worden uit de drie 
voorafgaande hoofdstukken. Een hogere inname van vitamine C en p-caroteen 
via de voeding en een hoger niveau van p-caroteen in bloed hingen samen met 
het hebben van een betere longfunctie. Vitamine E inname via de voeding en a-
tocoferol niveau in bloed hingen niet samen met longfunctie. Personen met 
chronische luchtwegklachten hadden een lagere concentratie p-caroteen in het 
bloed dan personen zonder luchtwegklachten. De concentratie a-tocoferol in 
bloed was niet verschillend voor personen met astma- en COPD-achtige 
klachten, maar was hoger in personen met klachten van kortademigheid. Geen 
van de antioxidanten uit de voeding hing eenduidig samen met de aanwezigheid 
van chronische luchtwegklachten. 
In hoofdstuk 8 concluderen we dat het aantal meetfouten bij het bepalen 
van antioxidanten in de voeding met behulp van onze voedselfrequentie 
vragenlijst groot is. Niveaus van antioxidanten in het bloed geven mogelijk beter 
de concentratie in de longen weer dan antioxidanten gemeten in de voeding. 
Onze resultaten van beide onderzoeken bij wielrenners dat antioxidanten een 
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mogelijke bescherming biedt tegen het effect van ozon op de longfunctie, zijn 
vergelijkbaar met de resultaten van andere onderzoeken die zowel zijn 
uitgevoerd onder laboratorium omstandigheden als in de buitenlucht. De 
gunstige resultaten van de verbanden tussen vitamine C inname via de voeding, 
p-caroteen niveau in bloed en longfunctie zijn vergelijkbaar met andere 
onderzoeken. Het gebrek aan effect van vitamine E inname via de voeding en oc-
tocoferol concentratie in bloed op de longfunctie of luchtwegklachten komt niet 
altijd overeen met de resultaten van andere onderzoeken. 
Nieuwe onderzoeken zijn nodig in de toekomst om het mechanisme dat 
de gevonden resultaten kan verklaren, op te helderen. Voorbeelden van 
vraagstellingen zijn: (1) Kunnen antioxidanten ook het effect van 
luchtverontreiniging op de ontstekingscellen (deze zijn verhoogd bij onder andere 
astmapatiënten) beïnvloeden; (2) Wat is de relevante tijdsperiode waarin 
antioxidanten (vitamine C en p-caroteen) de longfunctie of luchtwegklachten 
kunnen beïnvloeden; en (3) Zijn het wel de antioxidanten (vitamine C en p-
caroteen) zelf die de gunstige werking laten zien of zijn het andere stoffen of 
factoren zoals een gezonde levensstijl die sterk samenhangen met de 
antioxidanten. 
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